+关注
IcyAlchemist
暂无个人介绍
IP属地:未知
310
关注
21
粉丝
0
主题
0
勋章
主贴
热门
IcyAlchemist
2021-12-13
Like and comment
2 Top Biotech Stocks To Buy Right Now
IcyAlchemist
2021-12-13
Like and comment
OPEC upbeat on 2022 oil demand, says Omicron impact to be mild
IcyAlchemist
2021-12-13
Like and comment.
Toplines Before US Market Open on Monday
IcyAlchemist
2021-12-12
Like and comment
Is Inflation Going to Cool Down Anytime Soon?
IcyAlchemist
2021-12-12
Like and comment
US IPO Week Ahead: IoT solutions, wine, and satellites in a 3 IPO week
IcyAlchemist
2021-12-09
Like and comment
2 Short-Squeeze Candidates That Could Go Parabolic Soon
IcyAlchemist
2021-12-09
Like and comment
10 Biggest Price Target Changes For Thursday
IcyAlchemist
2021-12-08
Really?
GameStop Stock Could Soar After Its Recent Plunge. Here's Why.
IcyAlchemist
2021-12-08
Like and comment
Waymo's slow-going in Arizona opens up U.S. robotaxi race
IcyAlchemist
2021-12-08
Like and comment
Toplines Before US Market Open on Wednesday
IcyAlchemist
2021-12-05
Like and comment
Bitcoin and Ether prices drop sharply, falling more than 20%
IcyAlchemist
2021-12-04
Like and comment
Wall St ends lower on Omicron worries, Fed taper angst
IcyAlchemist
2021-12-04
Like and comment
US IPO Week Ahead: Digital banking and cloud infrastructure lead a 4 IPO week
IcyAlchemist
2021-12-03
Like and comment
Bank of Montreal beats profit estimates, raises dividend by 25%
IcyAlchemist
2021-12-02
Like and comment
The omicron panic is overdone. Buy the dips in these stocks, says JPMorgan.
IcyAlchemist
2021-12-02
Like and commenr
Toplines Before US Market Open on Tuesday
IcyAlchemist
2021-11-30
Like and comment
ImmunoGen Stock Soars On Positive Data From Ovarian Cancer Drug Trial
IcyAlchemist
2021-11-30
Like and comment
Blockchain stocks climbed in morning trading
IcyAlchemist
2021-11-30
Like and comment
Stocks open lower as investors assess omicron concerns
IcyAlchemist
2021-11-28
Like and comment
Google, Dell Lead Five Diverse Stocks Near Buy Points
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3586429646894350","uuid":"3586429646894350","gmtCreate":1623335813852,"gmtModify":1623335813852,"name":"IcyAlchemist","pinyin":"icyalchemist","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":21,"headSize":310,"tweetSize":148,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":604210548,"gmtCreate":1639401073484,"gmtModify":1639401074510,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586429646894350","idStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604210548","repostId":"2191600757","repostType":4,"repost":{"id":"2191600757","kind":"highlight","pubTimestamp":1639398749,"share":"https://ttm.financial/m/news/2191600757?lang=&edition=full","pubTime":"2021-12-13 20:32","market":"us","language":"en","title":"2 Top Biotech Stocks To Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2191600757","media":"Motley Fool","summary":"Growing global demand for prescription drugs in the years ahead bodes well for these two stocks. Buy them now while they're still cheap.","content":"<p>There's a concise saying in investing that, when properly applied, can make you a better investor. It is as follows: \"The trend is your friend.\" While it's often ascribed to momentum trading, the quote is arguably more beneficial to long-term investing. That's because while short-term price movements of stocks are really anyone's guess, long-term investing success largely depends on picking high-quality, reasonably priced stocks in growing industries.</p>\n<p>Given that the global pharmaceutical industry is forecasted to grow at nearly 5% annually from $1.3 trillion last year to $1.6 trillion by 2025, leading pharma stocks are set to do well going forward. Here are two biotech bargains you should consider purchasing now before everyone else does.</p>\n<h2>1. AstraZeneca</h2>\n<p>The first biotech stock to buy is <b>AstraZeneca</b> (NASDAQ:AZN). The drugmaker has reported impressive year-to-date growth in both its revenue and its core earnings per share (EPS).</p>\n<p>Excluding the acquisition of the rare-disease drugmaker known as Alexion Pharmaceuticals that closed earlier this year, AstraZeneca's year-to-date revenue jumped 25.4% against the year-ago period to $24.1 billion. This robust revenue growth was driven by several factors. The first was the introduction of the company's COVID-19 vaccine, which chipped in $2.2 billion or 45.4% of AstraZeneca's year-to-date revenue growth, excluding the Alexion acquisition.</p>\n<p>Second, the oncology segment revenue led by Tagrisso, Imfinzi, and Lynparza grew $1.6 billion, or 19%, year-to-date compared to the year-ago period, to $9.7 billion. This contributed to 31.9% of AstraZeneca's year-to-date revenue growth, not counting the Alexion acquisition. Double-digit year-to-date growth rates from the company's CVRM (cardiovascular, renal, and metabolism) and RI (respiratory and immunology) segments more than offset the revenue decline in its other medicines segment, which made up the remainder of AstraZeneca's revenue growth this year.</p>\n<p>Due to AstraZeneca's significantly higher revenue base year to date, its core EPS soared 22% against the prior-year period to $3.59. Better yet, this high overall growth is likely to continue in the medium-term as a result of AstraZeneca's pipeline of 175 projects at various phases of clinical development. That's why analysts are forecasting that the stock will deliver 20%+ annual earnings growth to shareholders over the next five years.</p>\n<p>And investors can snatch up AstraZeneca's 2.5% dividend yield and strong growth prospects at a forward P/E ratio of just 13.8, which is what makes the stock such a great buy at this time.</p>\n<h2>2. Merck</h2>\n<p>The second biotech stock to contemplate purchasing at the present time is <b>Merck</b> (NYSE:MRK). Like AstraZeneca, Merck has had a tremendous year thus far. First, the company's year-to-date total revenue has surged to $35.2 billion, which represents a 15.1% growth rate compared to the year-ago period.</p>\n<p>Merck's oncology segment, headed by its crown jewel Keytruda, was able to grow its year-to-date segment revenue 22.1% over the year-ago period, to $13.8 billion. Strong momentum from each of Keytruda, Lynparza, and Lenvima helped the oncology segment grow its year-to-date revenue by $2.5 billion, which is 54.2% of the company's total year-to-date revenue growth.</p>\n<p>Even with Keytruda accounting for 35.8% of its year-to-date revenue, Merck appears well-prepared for the drug's loss of exclusivity in major markets that will occur in 2028 for a couple of reasons.</p>\n<p>For <a href=\"https://laohu8.com/S/AONE.U\">one</a>, the vaccine segment saw its total year-to-date revenue fly 22% higher compared to the year-ago period, to $7.1 billion. Also, the animal-health segment advanced its revenue by 21.8% year to date against the year-ago period, to $4.3 billion. Simply put, these two segments combined are about as large as the oncology segment and are growing at equally remarkable rates.</p>\n<p>Second, the company just completed its acquisition of Acceleron last month. Through the deal, Merck receives a late-stage pulmonary arterial hypertension drug known as sotatercept that possesses plenty of blockbuster potential. The company also receives 20% to 25% royalties from <b>Bristol Myers Squibb</b> (NYSE:BMY) on the anemia drug known as Reblozyl, which has blockbuster potential in its own right.</p>\n<p>Merck's strong operating fundamentals are expected to continue for the foreseeable future, which is evidenced by the analyst forecast of 15% annual earnings growth over the next five years. When weighed against the forward P/E ratio of just 10, Merck boasts an attractive mix of value and growth. Merck's 3.8% dividend yield is also triple the <b>S&P 500</b>'s 1.3%, which is yet another reason investors should consider the stock.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Top Biotech Stocks To Buy Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Top Biotech Stocks To Buy Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-13 20:32 GMT+8 <a href=https://www.fool.com/investing/2021/12/13/2-top-biotech-stocks-to-buy-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There's a concise saying in investing that, when properly applied, can make you a better investor. It is as follows: \"The trend is your friend.\" While it's often ascribed to momentum trading, the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/13/2-top-biotech-stocks-to-buy-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东","BK4532":"文艺复兴科技持仓","AZN":"阿斯利康","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4559":"巴菲特持仓","BK4007":"制药","BMY":"施贵宝","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4516":"特朗普概念","BK4534":"瑞士信贷持仓"},"source_url":"https://www.fool.com/investing/2021/12/13/2-top-biotech-stocks-to-buy-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191600757","content_text":"There's a concise saying in investing that, when properly applied, can make you a better investor. It is as follows: \"The trend is your friend.\" While it's often ascribed to momentum trading, the quote is arguably more beneficial to long-term investing. That's because while short-term price movements of stocks are really anyone's guess, long-term investing success largely depends on picking high-quality, reasonably priced stocks in growing industries.\nGiven that the global pharmaceutical industry is forecasted to grow at nearly 5% annually from $1.3 trillion last year to $1.6 trillion by 2025, leading pharma stocks are set to do well going forward. Here are two biotech bargains you should consider purchasing now before everyone else does.\n1. AstraZeneca\nThe first biotech stock to buy is AstraZeneca (NASDAQ:AZN). The drugmaker has reported impressive year-to-date growth in both its revenue and its core earnings per share (EPS).\nExcluding the acquisition of the rare-disease drugmaker known as Alexion Pharmaceuticals that closed earlier this year, AstraZeneca's year-to-date revenue jumped 25.4% against the year-ago period to $24.1 billion. This robust revenue growth was driven by several factors. The first was the introduction of the company's COVID-19 vaccine, which chipped in $2.2 billion or 45.4% of AstraZeneca's year-to-date revenue growth, excluding the Alexion acquisition.\nSecond, the oncology segment revenue led by Tagrisso, Imfinzi, and Lynparza grew $1.6 billion, or 19%, year-to-date compared to the year-ago period, to $9.7 billion. This contributed to 31.9% of AstraZeneca's year-to-date revenue growth, not counting the Alexion acquisition. Double-digit year-to-date growth rates from the company's CVRM (cardiovascular, renal, and metabolism) and RI (respiratory and immunology) segments more than offset the revenue decline in its other medicines segment, which made up the remainder of AstraZeneca's revenue growth this year.\nDue to AstraZeneca's significantly higher revenue base year to date, its core EPS soared 22% against the prior-year period to $3.59. Better yet, this high overall growth is likely to continue in the medium-term as a result of AstraZeneca's pipeline of 175 projects at various phases of clinical development. That's why analysts are forecasting that the stock will deliver 20%+ annual earnings growth to shareholders over the next five years.\nAnd investors can snatch up AstraZeneca's 2.5% dividend yield and strong growth prospects at a forward P/E ratio of just 13.8, which is what makes the stock such a great buy at this time.\n2. Merck\nThe second biotech stock to contemplate purchasing at the present time is Merck (NYSE:MRK). Like AstraZeneca, Merck has had a tremendous year thus far. First, the company's year-to-date total revenue has surged to $35.2 billion, which represents a 15.1% growth rate compared to the year-ago period.\nMerck's oncology segment, headed by its crown jewel Keytruda, was able to grow its year-to-date segment revenue 22.1% over the year-ago period, to $13.8 billion. Strong momentum from each of Keytruda, Lynparza, and Lenvima helped the oncology segment grow its year-to-date revenue by $2.5 billion, which is 54.2% of the company's total year-to-date revenue growth.\nEven with Keytruda accounting for 35.8% of its year-to-date revenue, Merck appears well-prepared for the drug's loss of exclusivity in major markets that will occur in 2028 for a couple of reasons.\nFor one, the vaccine segment saw its total year-to-date revenue fly 22% higher compared to the year-ago period, to $7.1 billion. Also, the animal-health segment advanced its revenue by 21.8% year to date against the year-ago period, to $4.3 billion. Simply put, these two segments combined are about as large as the oncology segment and are growing at equally remarkable rates.\nSecond, the company just completed its acquisition of Acceleron last month. Through the deal, Merck receives a late-stage pulmonary arterial hypertension drug known as sotatercept that possesses plenty of blockbuster potential. The company also receives 20% to 25% royalties from Bristol Myers Squibb (NYSE:BMY) on the anemia drug known as Reblozyl, which has blockbuster potential in its own right.\nMerck's strong operating fundamentals are expected to continue for the foreseeable future, which is evidenced by the analyst forecast of 15% annual earnings growth over the next five years. When weighed against the forward P/E ratio of just 10, Merck boasts an attractive mix of value and growth. Merck's 3.8% dividend yield is also triple the S&P 500's 1.3%, which is yet another reason investors should consider the stock.","news_type":1,"symbols_score_info":{"AZN":0.9,"BMY":0.9,"MRK":0.9}},"isVote":1,"tweetType":1,"viewCount":1805,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604210953,"gmtCreate":1639400993494,"gmtModify":1639400994551,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586429646894350","idStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment ","listText":"Like and comment ","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604210953","repostId":"1167803518","repostType":4,"repost":{"id":"1167803518","kind":"news","pubTimestamp":1639398916,"share":"https://ttm.financial/m/news/1167803518?lang=&edition=full","pubTime":"2021-12-13 20:35","market":"us","language":"en","title":"OPEC upbeat on 2022 oil demand, says Omicron impact to be mild","url":"https://stock-news.laohu8.com/highlight/detail?id=1167803518","media":"Reuters","summary":"OPEC on Monday raised its world oil demand forecast for the first quarter of 2022 but left its full-","content":"<p>OPEC on Monday raised its world oil demand forecast for the first quarter of 2022 but left its full-year growth prediction steady, saying the Omicron coronavirus variant would have a mild impact as the world gets used to dealing with the pandemic.</p>\n<p>The Organization of the Petroleum Exporting Countries (OPEC) said in a monthly report it expects oil demand to average 99.13 million barrels per day (bpd) in the first quarter of 2022, up 1.11 million bpd from its forecast last month.</p>\n<p>\"Some of the recovery previously expected in the fourth quarter of 2021 has been shifted to the first quarter of 2022, followed by a more steady recovery throughout the second half of 2022,\" OPEC said in the report.</p>\n<p>\"Moreover, the impact of the new Omicron variant is projected to be mild and short-lived, as the world becomes better equipped to manage COVID-19 and its related challenges.\"</p>\n<p>OPEC maintained its forecast that world oil demand will grow by 5.65 million bpd in 2021, after last year's historic decline at the start of the pandemic.</p>\n<p>In 2022, OPEC expects further growth in demand of 4.15 million bpd, unchanged from last month, which will push world consumption above 2019 levels.</p>\n<p>OPEC and its allies, known as OPEC+, are gradually unwinding record output cuts put in place last year. Earlier this month, OPEC+ agreed to boost monthly output by 400,000 bpd in January, despite concern about the new variant.</p>\n<p>The report showed OPEC output in November rose by 290,000 bpd to 27.72 million bpd led by increases in top two producers Saudi Arabia and Iraq and a recovery from outages in Nigeria.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>OPEC upbeat on 2022 oil demand, says Omicron impact to be mild</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOPEC upbeat on 2022 oil demand, says Omicron impact to be mild\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-13 20:35 GMT+8 <a href=https://www.reuters.com/business/energy/opec-upbeat-2022-oil-demand-says-omicron-impact-be-mild-2021-12-13/><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>OPEC on Monday raised its world oil demand forecast for the first quarter of 2022 but left its full-year growth prediction steady, saying the Omicron coronavirus variant would have a mild impact as ...</p>\n\n<a href=\"https://www.reuters.com/business/energy/opec-upbeat-2022-oil-demand-says-omicron-impact-be-mild-2021-12-13/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.reuters.com/business/energy/opec-upbeat-2022-oil-demand-says-omicron-impact-be-mild-2021-12-13/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167803518","content_text":"OPEC on Monday raised its world oil demand forecast for the first quarter of 2022 but left its full-year growth prediction steady, saying the Omicron coronavirus variant would have a mild impact as the world gets used to dealing with the pandemic.\nThe Organization of the Petroleum Exporting Countries (OPEC) said in a monthly report it expects oil demand to average 99.13 million barrels per day (bpd) in the first quarter of 2022, up 1.11 million bpd from its forecast last month.\n\"Some of the recovery previously expected in the fourth quarter of 2021 has been shifted to the first quarter of 2022, followed by a more steady recovery throughout the second half of 2022,\" OPEC said in the report.\n\"Moreover, the impact of the new Omicron variant is projected to be mild and short-lived, as the world becomes better equipped to manage COVID-19 and its related challenges.\"\nOPEC maintained its forecast that world oil demand will grow by 5.65 million bpd in 2021, after last year's historic decline at the start of the pandemic.\nIn 2022, OPEC expects further growth in demand of 4.15 million bpd, unchanged from last month, which will push world consumption above 2019 levels.\nOPEC and its allies, known as OPEC+, are gradually unwinding record output cuts put in place last year. Earlier this month, OPEC+ agreed to boost monthly output by 400,000 bpd in January, despite concern about the new variant.\nThe report showed OPEC output in November rose by 290,000 bpd to 27.72 million bpd led by increases in top two producers Saudi Arabia and Iraq and a recovery from outages in Nigeria.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":3424,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604237329,"gmtCreate":1639400832390,"gmtModify":1639400842604,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586429646894350","idStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment. ","listText":"Like and comment. ","text":"Like and comment.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604237329","repostId":"1161576842","repostType":4,"repost":{"id":"1161576842","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639400492,"share":"https://ttm.financial/m/news/1161576842?lang=&edition=full","pubTime":"2021-12-13 21:01","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1161576842","media":"Tiger Newspress","summary":"U.S. stock-index futures pointed to muted gains for major indexes ahead of a busy week of central-ba","content":"<p>U.S. stock-index futures pointed to muted gains for major indexes ahead of a busy week of central-bank decisions in major economies.</p>\n<p>At 8:00 a.m. ET, S&P 500 e-minis were up 11.25 points, or 0.24%, Nasdaq 100 e-minis were up 67 points, or 0.41%, and Dow e-minis were up 24 points, or 0.07%.<img src=\"https://static.tigerbbs.com/2db870f3d308c4d0618dd8c4333e65dd\" tg-width=\"1080\" tg-height=\"383\" referrerpolicy=\"no-referrer\">The key inflation reading came ahead of the Federal Reserve’s two-day policy meeting this week where the policymakers are expected to discuss speeding up the end of its bond-buying program.</p>\n<p>Fed Chair Jerome Powell, as well as a parade of Fed speakers, all recently suggested the central bank could end the $120 billion monthly bond purchase program sooner than the current timeline of June 2022.</p>\n<p>“We believe markets can continue to take a higher inflation reading in their stride, though additional volatility remains a risk. With Fed policy staying relatively accommodative, the backdrop for equities is still positive, and we favor winners from global growth,” said Mark Haefele, Chief Investment Officer of UBS Global Wealth Management.</p>\n<p>As of Sunday, the U.S. was approaching 800,000 coronavirus-related deaths. The new variant has pushed some government officials to reinstate health restrictions to slow the spread.</p>\n<p><b>Stocks making the biggest moves premarket: </b></p>\n<p><b><a href=\"https://laohu8.com/S/HOG\">Harley-Davidson</a></b>– The motorcycle maker’s stock surged 11.7% in the premarket after it announced that it is merging its “Livewire” electric motorcycle unit with a special purpose acquisition company. Livewire will have an enterprise value of about $1.8 billion and will trade on the New York Stock Exchange under the ticker symbol “LVW.”</p>\n<p><b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>,<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> </b>– <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> rose 1.4% in the premarket while <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> jumped 4.4% after a new Israeli study showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>’s pre-market gains were trimmed following news of its deal to acquire Arena Pharmaceuticals.</p>\n<p><b><a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals</a> </b>– The drugmaker agreed to be acquired by <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> for $100 per share in cash, or about $6.7 billion. Arena soared 93.1% in premarket trading following news of the transaction.</p>\n<p><b><a href=\"https://laohu8.com/S/PTON\">Peloton Interactive, Inc.</a></b> – The fitness equipment maker rebounded 2.6% in premarket action after falling 7% over the past three sessions. Pelotonreleased an ad featuring actor Chris Noth promoting the value of the company’s equipment, after his character’s death in the “Sex and the City” reboot following a Peloton ride.</p>\n<p><b><a href=\"https://laohu8.com/S/DLTR\">Dollar Tree</a> </b>– The discount retailer’s stock fell 1% in premarket trading after activist investor Mantle Ridge announced its intention to try to replace the entire Dollar Tree board. Dollar Tree called the move “unwarrantedly aggressive” and said it had offered to explore a settlement with Mantle Ridge, which owns 5.7% of Dollar Tree.</p>\n<p><b><a href=\"https://laohu8.com/S/AAPL\">Apple</a> </b>– <a href=\"https://laohu8.com/S/AAPL\">Apple</a> rose 1.1% in the premarket after J.P. Morgan Securities raised its price target for the stock to a Street-high of $210 per share from $180 a share, and reiterated it as a top pick going into 2022.</p>\n<p>Nasdaq-100 additions – Stocks being added to the index as of Monday, December 20, rose in premarket trading following news of their inclusion. The stocks include <b><a href=\"https://laohu8.com/S/PANW\">Palo Alto Networks</a></b>, up 2.7%;<b><a href=\"https://laohu8.com/S/ABNB\">Airbnb, Inc.</a></b> , up 2.1%;<b><a href=\"https://laohu8.com/S/FTNT\">Fortinet</a></b> , up 3.7%;<b><a href=\"https://laohu8.com/S/LCID\">Lucid Group Inc</a></b>, up 5.9%;<b><a href=\"https://laohu8.com/S/ZS\">Zscaler Inc.</a></b>, up 3.4%; and <b><a href=\"https://laohu8.com/S/DDOG\">Datadog</a></b>, up 3.1%.</p>\n<p>Nasdaq-100 subtractions – Stocks being replaced in the Nasdaq-100 include <b><a href=\"https://laohu8.com/S/CDW\">CDW Corp</a></b> , down 1.8% in the premarket;<b><a href=\"https://laohu8.com/S/FOXA\">Fox Corporation Class A</a></b> , down 2.2%;<b><a href=\"https://laohu8.com/S/CERN\">Cerner</a></b> , down 1.8%;<b><a href=\"https://laohu8.com/S/CHKP\">Check Point</a></b> , down 1.1%;<b><a href=\"https://laohu8.com/S/TCOM\">Trip.com Group Limited</a></b> , down 1.2%; and <b><a href=\"https://laohu8.com/S/INCY\">Incyte</a></b>, down 0.6%.</p>\n<p><b><a href=\"https://laohu8.com/S/RIVN\">Rivian Automotive, Inc.</a></b> – The electric vehicle maker’s stock rose 1.9% in the premarket following news that its R1T had been named Motor Trend’s truck of the year, beating out entries from Ford, GM and Hyundai.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 21:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock-index futures pointed to muted gains for major indexes ahead of a busy week of central-bank decisions in major economies.</p>\n<p>At 8:00 a.m. ET, S&P 500 e-minis were up 11.25 points, or 0.24%, Nasdaq 100 e-minis were up 67 points, or 0.41%, and Dow e-minis were up 24 points, or 0.07%.<img src=\"https://static.tigerbbs.com/2db870f3d308c4d0618dd8c4333e65dd\" tg-width=\"1080\" tg-height=\"383\" referrerpolicy=\"no-referrer\">The key inflation reading came ahead of the Federal Reserve’s two-day policy meeting this week where the policymakers are expected to discuss speeding up the end of its bond-buying program.</p>\n<p>Fed Chair Jerome Powell, as well as a parade of Fed speakers, all recently suggested the central bank could end the $120 billion monthly bond purchase program sooner than the current timeline of June 2022.</p>\n<p>“We believe markets can continue to take a higher inflation reading in their stride, though additional volatility remains a risk. With Fed policy staying relatively accommodative, the backdrop for equities is still positive, and we favor winners from global growth,” said Mark Haefele, Chief Investment Officer of UBS Global Wealth Management.</p>\n<p>As of Sunday, the U.S. was approaching 800,000 coronavirus-related deaths. The new variant has pushed some government officials to reinstate health restrictions to slow the spread.</p>\n<p><b>Stocks making the biggest moves premarket: </b></p>\n<p><b><a href=\"https://laohu8.com/S/HOG\">Harley-Davidson</a></b>– The motorcycle maker’s stock surged 11.7% in the premarket after it announced that it is merging its “Livewire” electric motorcycle unit with a special purpose acquisition company. Livewire will have an enterprise value of about $1.8 billion and will trade on the New York Stock Exchange under the ticker symbol “LVW.”</p>\n<p><b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>,<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> </b>– <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> rose 1.4% in the premarket while <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> jumped 4.4% after a new Israeli study showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>’s pre-market gains were trimmed following news of its deal to acquire Arena Pharmaceuticals.</p>\n<p><b><a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals</a> </b>– The drugmaker agreed to be acquired by <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> for $100 per share in cash, or about $6.7 billion. Arena soared 93.1% in premarket trading following news of the transaction.</p>\n<p><b><a href=\"https://laohu8.com/S/PTON\">Peloton Interactive, Inc.</a></b> – The fitness equipment maker rebounded 2.6% in premarket action after falling 7% over the past three sessions. Pelotonreleased an ad featuring actor Chris Noth promoting the value of the company’s equipment, after his character’s death in the “Sex and the City” reboot following a Peloton ride.</p>\n<p><b><a href=\"https://laohu8.com/S/DLTR\">Dollar Tree</a> </b>– The discount retailer’s stock fell 1% in premarket trading after activist investor Mantle Ridge announced its intention to try to replace the entire Dollar Tree board. Dollar Tree called the move “unwarrantedly aggressive” and said it had offered to explore a settlement with Mantle Ridge, which owns 5.7% of Dollar Tree.</p>\n<p><b><a href=\"https://laohu8.com/S/AAPL\">Apple</a> </b>– <a href=\"https://laohu8.com/S/AAPL\">Apple</a> rose 1.1% in the premarket after J.P. Morgan Securities raised its price target for the stock to a Street-high of $210 per share from $180 a share, and reiterated it as a top pick going into 2022.</p>\n<p>Nasdaq-100 additions – Stocks being added to the index as of Monday, December 20, rose in premarket trading following news of their inclusion. The stocks include <b><a href=\"https://laohu8.com/S/PANW\">Palo Alto Networks</a></b>, up 2.7%;<b><a href=\"https://laohu8.com/S/ABNB\">Airbnb, Inc.</a></b> , up 2.1%;<b><a href=\"https://laohu8.com/S/FTNT\">Fortinet</a></b> , up 3.7%;<b><a href=\"https://laohu8.com/S/LCID\">Lucid Group Inc</a></b>, up 5.9%;<b><a href=\"https://laohu8.com/S/ZS\">Zscaler Inc.</a></b>, up 3.4%; and <b><a href=\"https://laohu8.com/S/DDOG\">Datadog</a></b>, up 3.1%.</p>\n<p>Nasdaq-100 subtractions – Stocks being replaced in the Nasdaq-100 include <b><a href=\"https://laohu8.com/S/CDW\">CDW Corp</a></b> , down 1.8% in the premarket;<b><a href=\"https://laohu8.com/S/FOXA\">Fox Corporation Class A</a></b> , down 2.2%;<b><a href=\"https://laohu8.com/S/CERN\">Cerner</a></b> , down 1.8%;<b><a href=\"https://laohu8.com/S/CHKP\">Check Point</a></b> , down 1.1%;<b><a href=\"https://laohu8.com/S/TCOM\">Trip.com Group Limited</a></b> , down 1.2%; and <b><a href=\"https://laohu8.com/S/INCY\">Incyte</a></b>, down 0.6%.</p>\n<p><b><a href=\"https://laohu8.com/S/RIVN\">Rivian Automotive, Inc.</a></b> – The electric vehicle maker’s stock rose 1.9% in the premarket following news that its R1T had been named Motor Trend’s truck of the year, beating out entries from Ford, GM and Hyundai.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","FOXA":"福克斯-A","BNTX":"BioNTech SE","RIVN":"Rivian Automotive, Inc.","CDW":"CDW Corporation","FTNT":"飞塔信息","CERN":"美国塞纳","ARNA":"阿里那","PANW":"Palo Alto Networks","DDOG":"Datadog","LCID":"Lucid Group Inc","HOG":"哈雷戴维森","INCY":"因塞特医疗","ABNB":"爱彼迎","PTON":"Peloton Interactive, Inc.","AAPL":"苹果","PFE":"辉瑞",".DJI":"道琼斯","TCOM":"携程网","ZS":"Zscaler Inc.","CHKP":"Check Point软件科技"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161576842","content_text":"U.S. stock-index futures pointed to muted gains for major indexes ahead of a busy week of central-bank decisions in major economies.\nAt 8:00 a.m. ET, S&P 500 e-minis were up 11.25 points, or 0.24%, Nasdaq 100 e-minis were up 67 points, or 0.41%, and Dow e-minis were up 24 points, or 0.07%.The key inflation reading came ahead of the Federal Reserve’s two-day policy meeting this week where the policymakers are expected to discuss speeding up the end of its bond-buying program.\nFed Chair Jerome Powell, as well as a parade of Fed speakers, all recently suggested the central bank could end the $120 billion monthly bond purchase program sooner than the current timeline of June 2022.\n“We believe markets can continue to take a higher inflation reading in their stride, though additional volatility remains a risk. With Fed policy staying relatively accommodative, the backdrop for equities is still positive, and we favor winners from global growth,” said Mark Haefele, Chief Investment Officer of UBS Global Wealth Management.\nAs of Sunday, the U.S. was approaching 800,000 coronavirus-related deaths. The new variant has pushed some government officials to reinstate health restrictions to slow the spread.\nStocks making the biggest moves premarket: \nHarley-Davidson– The motorcycle maker’s stock surged 11.7% in the premarket after it announced that it is merging its “Livewire” electric motorcycle unit with a special purpose acquisition company. Livewire will have an enterprise value of about $1.8 billion and will trade on the New York Stock Exchange under the ticker symbol “LVW.”\nPfizer,BioNTech SE – Pfizer rose 1.4% in the premarket while BioNTech SE jumped 4.4% after a new Israeli study showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant. Pfizer’s pre-market gains were trimmed following news of its deal to acquire Arena Pharmaceuticals.\nArena Pharmaceuticals – The drugmaker agreed to be acquired by Pfizer for $100 per share in cash, or about $6.7 billion. Arena soared 93.1% in premarket trading following news of the transaction.\nPeloton Interactive, Inc. – The fitness equipment maker rebounded 2.6% in premarket action after falling 7% over the past three sessions. Pelotonreleased an ad featuring actor Chris Noth promoting the value of the company’s equipment, after his character’s death in the “Sex and the City” reboot following a Peloton ride.\nDollar Tree – The discount retailer’s stock fell 1% in premarket trading after activist investor Mantle Ridge announced its intention to try to replace the entire Dollar Tree board. Dollar Tree called the move “unwarrantedly aggressive” and said it had offered to explore a settlement with Mantle Ridge, which owns 5.7% of Dollar Tree.\nApple – Apple rose 1.1% in the premarket after J.P. Morgan Securities raised its price target for the stock to a Street-high of $210 per share from $180 a share, and reiterated it as a top pick going into 2022.\nNasdaq-100 additions – Stocks being added to the index as of Monday, December 20, rose in premarket trading following news of their inclusion. The stocks include Palo Alto Networks, up 2.7%;Airbnb, Inc. , up 2.1%;Fortinet , up 3.7%;Lucid Group Inc, up 5.9%;Zscaler Inc., up 3.4%; and Datadog, up 3.1%.\nNasdaq-100 subtractions – Stocks being replaced in the Nasdaq-100 include CDW Corp , down 1.8% in the premarket;Fox Corporation Class A , down 2.2%;Cerner , down 1.8%;Check Point , down 1.1%;Trip.com Group Limited , down 1.2%; and Incyte, down 0.6%.\nRivian Automotive, Inc. – The electric vehicle maker’s stock rose 1.9% in the premarket following news that its R1T had been named Motor Trend’s truck of the year, beating out entries from Ford, GM and Hyundai.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"AAPL":0.9,"ABNB":0.9,"ARNA":0.9,"BNTX":0.9,"CDW":0.9,"CERN":0.9,"CHKP":0.9,"DDOG":0.9,"FOXA":0.9,"FTNT":0.9,"HOG":0.9,"INCY":0.9,"LCID":0.9,"PANW":0.9,"PFE":0.9,"PTON":0.9,"RIVN":0.9,"TCOM":0.9,"ZS":0.9}},"isVote":1,"tweetType":1,"viewCount":1608,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604968891,"gmtCreate":1639312960511,"gmtModify":1639313184310,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586429646894350","idStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment ","listText":"Like and comment ","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604968891","repostId":"2190719916","repostType":4,"repost":{"id":"2190719916","kind":"highlight","pubTimestamp":1639280175,"share":"https://ttm.financial/m/news/2190719916?lang=&edition=full","pubTime":"2021-12-12 11:36","market":"us","language":"en","title":"Is Inflation Going to Cool Down Anytime Soon?","url":"https://stock-news.laohu8.com/highlight/detail?id=2190719916","media":"Motley Fool","summary":"Two Motley Fool contributors discuss the issue weighing on a lot of people's minds.","content":"<p>Investors and the general public as a whole are worried about the surging rate of inflation, and these concerns continue to drive some of the volatility we're seeing in the broader market. In this segment of<i> Backstage Pass</i>, recorded on <b>Nov. 10</b>, Fool contributors Connor Allen and Rachel Warren discuss inflation and investing in this challenging market environment.</p>\n<p><b>Connor Allen</b>: But to go back to the original question about transitory inflation, I think most people have hopped off that bus by now. I think right when this started, a lot of people were on the transitory bus. They thought a lot of the bottlenecks and the supply chain issues that were being caused we're going to get solved and basically deflation will come and replace that and prices would go back to normal. I don't think a lot of people think that anymore.</p>\n<p>Because when you think about a company that's selling a product, and they realize that the market will pay $5 for something that used to be $3 and are they ever going to bring it back to $3? I don't think so. I think that's hard to make companies do, especially when there's such a variety of costs across all industries and all companies. You don't know what costs are going to come down when.</p>\n<p>Gas is <a href=\"https://laohu8.com/S/AONE.U\">one</a> that's a major issue. I think that probably is the number one issue for a lot of increasing costs for companies because everything's delivered, whether it's delivered to a warehouse like <b>Amazon</b>, whether it's delivered to a retail store like <b>Macy's</b>, or whether it's delivered to your home. There's a lot of different things and the cost obviously of gas being I think it's around a national averaged around $3.20 I believe.</p>\n<p>That's a cost that you can't get around, and you can't really innovate around those gas prices. Obviously, electric vehicles could potentially be that fix, but those costs are going up as well. [laughs] There's some projections that I was reading about how the national average of gas prices could be around $5 a gallon by the end of the year.</p>\n<p>That could be really painful, not only on my wallet, but [laughs] not on a lot of Americans' wallets. Hopefully we can get that down. But to be honest with you, I'm expecting long-term inflation. I'm not expecting this to be a transitory thing.</p>\n<p><b>Rachel Warren:</b> I agree with you Connor and unfortunately, I don't really see this inflation just dying down overnight or going anywhere anytime soon. I think it's going to be much more of a gradual recovery and perhaps in some cases like what you were saying, we're going to see permanent pricing increases in some of these consumer good categories.</p>\n<p>I think it's something that businesses and consumers are going to have to contend with for a long time. I think people are adjusting to these changes hard as they are. I think it's also helpful to remember this isn't just a U.S. issue. This is a global problem for companies and consumers.</p>\n<p>I saw this interesting article on <i>CNBC</i> today and the Chief Financial Officer of a large Belgian Dutch grocer called <b>Ahold Delhaize</b> was talking about how the company is dealing with the supply chain bottlenecks that are also having this impact on inflation and everything else and she said, \"I think what we're definitely seeing is inflation is picking up. But what I would also say is that when you look at food at the smaller share of the wallet in some other categories.\"</p>\n<p>Another thing was, a lot of these companies are saying this is something we are going to be seeing for quite a long time. The CEO of <b>Siemens</b> <b>Energy</b> told <i>CNBC</i>, the industrial world is going to be dealing with the supply chain bottleneck issues for a long time, which is also driving these other inflation problems. I don't think it's something that's going anywhere, anytime soon.</p>\n<p>As a consumer, it's obviously not fun to see. I think it's something to be patient with and deal with as it comes. But jumping off of what Taylor was saying in terms of staying invested in the stock market, but maybe you do adjust the type of stocks that you buy during these times and sometimes especially during bumpy periods in the market, it can be a good time to look at your portfolio and see maybe it needs some rebalancing.</p>\n<p>Maybe the balance of stocks that are more prone to headwinds during these bumpy times could use some balancing with more stalwart stocks that aren't necessarily as prone to these inflationary pressures. I think even amid rising prices and high inflation, you think of companies like Amazon that reported impacted earnings due to related supply chain constraints. The market still managed to deliver record highs.</p>\n<p>Recently over the last few weeks we had that happen a couple of times. Try not to focus too much on one day in the stock market. When you look at the market performance over the long term, investors who they'd invested in the market has generated pretty great portfolio returns. I'm personally not changing the way I'm investing right now, but I may change some of the type of stocks I buy in the coming months for sure.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Inflation Going to Cool Down Anytime Soon?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Inflation Going to Cool Down Anytime Soon?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-12 11:36 GMT+8 <a href=https://www.fool.com/investing/2021/12/11/is-inflation-going-to-cool-down-anytime-soon/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors and the general public as a whole are worried about the surging rate of inflation, and these concerns continue to drive some of the volatility we're seeing in the broader market. In this ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/11/is-inflation-going-to-cool-down-anytime-soon/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/12/11/is-inflation-going-to-cool-down-anytime-soon/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190719916","content_text":"Investors and the general public as a whole are worried about the surging rate of inflation, and these concerns continue to drive some of the volatility we're seeing in the broader market. In this segment of Backstage Pass, recorded on Nov. 10, Fool contributors Connor Allen and Rachel Warren discuss inflation and investing in this challenging market environment.\nConnor Allen: But to go back to the original question about transitory inflation, I think most people have hopped off that bus by now. I think right when this started, a lot of people were on the transitory bus. They thought a lot of the bottlenecks and the supply chain issues that were being caused we're going to get solved and basically deflation will come and replace that and prices would go back to normal. I don't think a lot of people think that anymore.\nBecause when you think about a company that's selling a product, and they realize that the market will pay $5 for something that used to be $3 and are they ever going to bring it back to $3? I don't think so. I think that's hard to make companies do, especially when there's such a variety of costs across all industries and all companies. You don't know what costs are going to come down when.\nGas is one that's a major issue. I think that probably is the number one issue for a lot of increasing costs for companies because everything's delivered, whether it's delivered to a warehouse like Amazon, whether it's delivered to a retail store like Macy's, or whether it's delivered to your home. There's a lot of different things and the cost obviously of gas being I think it's around a national averaged around $3.20 I believe.\nThat's a cost that you can't get around, and you can't really innovate around those gas prices. Obviously, electric vehicles could potentially be that fix, but those costs are going up as well. [laughs] There's some projections that I was reading about how the national average of gas prices could be around $5 a gallon by the end of the year.\nThat could be really painful, not only on my wallet, but [laughs] not on a lot of Americans' wallets. Hopefully we can get that down. But to be honest with you, I'm expecting long-term inflation. I'm not expecting this to be a transitory thing.\nRachel Warren: I agree with you Connor and unfortunately, I don't really see this inflation just dying down overnight or going anywhere anytime soon. I think it's going to be much more of a gradual recovery and perhaps in some cases like what you were saying, we're going to see permanent pricing increases in some of these consumer good categories.\nI think it's something that businesses and consumers are going to have to contend with for a long time. I think people are adjusting to these changes hard as they are. I think it's also helpful to remember this isn't just a U.S. issue. This is a global problem for companies and consumers.\nI saw this interesting article on CNBC today and the Chief Financial Officer of a large Belgian Dutch grocer called Ahold Delhaize was talking about how the company is dealing with the supply chain bottlenecks that are also having this impact on inflation and everything else and she said, \"I think what we're definitely seeing is inflation is picking up. But what I would also say is that when you look at food at the smaller share of the wallet in some other categories.\"\nAnother thing was, a lot of these companies are saying this is something we are going to be seeing for quite a long time. The CEO of Siemens Energy told CNBC, the industrial world is going to be dealing with the supply chain bottleneck issues for a long time, which is also driving these other inflation problems. I don't think it's something that's going anywhere, anytime soon.\nAs a consumer, it's obviously not fun to see. I think it's something to be patient with and deal with as it comes. But jumping off of what Taylor was saying in terms of staying invested in the stock market, but maybe you do adjust the type of stocks that you buy during these times and sometimes especially during bumpy periods in the market, it can be a good time to look at your portfolio and see maybe it needs some rebalancing.\nMaybe the balance of stocks that are more prone to headwinds during these bumpy times could use some balancing with more stalwart stocks that aren't necessarily as prone to these inflationary pressures. I think even amid rising prices and high inflation, you think of companies like Amazon that reported impacted earnings due to related supply chain constraints. The market still managed to deliver record highs.\nRecently over the last few weeks we had that happen a couple of times. Try not to focus too much on one day in the stock market. When you look at the market performance over the long term, investors who they'd invested in the market has generated pretty great portfolio returns. I'm personally not changing the way I'm investing right now, but I may change some of the type of stocks I buy in the coming months for sure.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":3121,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604968919,"gmtCreate":1639312887026,"gmtModify":1639312921841,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586429646894350","idStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment ","listText":"Like and comment ","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604968919","repostId":"1103250344","repostType":4,"repost":{"id":"1103250344","kind":"news","pubTimestamp":1639280672,"share":"https://ttm.financial/m/news/1103250344?lang=&edition=full","pubTime":"2021-12-12 11:44","market":"sh","language":"en","title":"US IPO Week Ahead: IoT solutions, wine, and satellites in a 3 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1103250344","media":"renaissancecap...","summary":"The IPO market is expected to stay relatively quiet in the week ahead with three IPOs scheduled to r","content":"<p>The IPO market is expected to stay relatively quiet in the week ahead with three IPOs scheduled to raise $789 million.</p>\n<p>IoT solutions developer<b>Samsara</b>(IOT) plans to raise $753 million at an $11.6 billion market cap. This \"internet-of-things\" company provides a cloud-based platform that connects the assets of businesses with physical operations, enhancing operational efficiency and asset and employee productivity. Fast growing but highly unprofitable, Samsara saw double-digit growth for customers with $100k+ ARR in the 9mo FY22.</p>\n<p>Wine brand<b>Fresh Vine Wine</b>(VINE) plans to raise $21 million at a $116 million market cap. This celebrity-founded company produces low carb, low calorie premium wines. Growing but highly unprofitable, Fresh Vine sells its wines through wholesale, retail, and DTC channels, and is able to conduct wholesale distribution in all 50 states and Puerto Rico.</p>\n<p>Micro-cap satellite developer<b>Sidus Space</b>(SIDU) plans to raise $15 million at an $81 million market cap. This company provides commercial satellite services such as design, manufacture, launch, and data collection. Sidus Space has generated space-related manufacturing revenues to date, but is highly unprofitable with negative gross margin in the 9mo21.</p>\n<p><img src=\"https://static.tigerbbs.com/ead80e54642569e2b7b368c8d50dc265\" tg-width=\"1409\" tg-height=\"457\" referrerpolicy=\"no-referrer\"></p>","source":"lsy1619493174116","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: IoT solutions, wine, and satellites in a 3 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: IoT solutions, wine, and satellites in a 3 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-12 11:44 GMT+8 <a href=https://www.renaissancecapital.com/IPO-Center/News/89474/US-IPO-Week-Ahead-IoT-solutions-wine-and-satellites-in-a-3-IPO-week><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market is expected to stay relatively quiet in the week ahead with three IPOs scheduled to raise $789 million.\nIoT solutions developerSamsara(IOT) plans to raise $753 million at an $11.6 ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89474/US-IPO-Week-Ahead-IoT-solutions-wine-and-satellites-in-a-3-IPO-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","SIDU":"Sidus Space Inc.",".DJI":"道琼斯","IOT":"Samsara, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89474/US-IPO-Week-Ahead-IoT-solutions-wine-and-satellites-in-a-3-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1103250344","content_text":"The IPO market is expected to stay relatively quiet in the week ahead with three IPOs scheduled to raise $789 million.\nIoT solutions developerSamsara(IOT) plans to raise $753 million at an $11.6 billion market cap. This \"internet-of-things\" company provides a cloud-based platform that connects the assets of businesses with physical operations, enhancing operational efficiency and asset and employee productivity. Fast growing but highly unprofitable, Samsara saw double-digit growth for customers with $100k+ ARR in the 9mo FY22.\nWine brandFresh Vine Wine(VINE) plans to raise $21 million at a $116 million market cap. This celebrity-founded company produces low carb, low calorie premium wines. Growing but highly unprofitable, Fresh Vine sells its wines through wholesale, retail, and DTC channels, and is able to conduct wholesale distribution in all 50 states and Puerto Rico.\nMicro-cap satellite developerSidus Space(SIDU) plans to raise $15 million at an $81 million market cap. This company provides commercial satellite services such as design, manufacture, launch, and data collection. Sidus Space has generated space-related manufacturing revenues to date, but is highly unprofitable with negative gross margin in the 9mo21.","news_type":1,"symbols_score_info":{".DJI":0,".IXIC":0,".SPX":0,"IOT":0,"SIDU":0,"VINE":0}},"isVote":1,"tweetType":1,"viewCount":2543,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602719340,"gmtCreate":1639065421675,"gmtModify":1639066018747,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586429646894350","idStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment ","listText":"Like and comment ","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/602719340","repostId":"2190617302","repostType":4,"repost":{"id":"2190617302","kind":"highlight","pubTimestamp":1639063118,"share":"https://ttm.financial/m/news/2190617302?lang=&edition=full","pubTime":"2021-12-09 23:18","market":"us","language":"en","title":"2 Short-Squeeze Candidates That Could Go Parabolic Soon","url":"https://stock-news.laohu8.com/highlight/detail?id=2190617302","media":"Motley Fool","summary":"Cortexyme and Heron Therapeutics are two of the most heavily shorted biopharma stocks right now.","content":"<p>Short squeezes can deliver enormous returns for investors in the blink of an eye. Several so-called \"meme stocks\" generated jaw-dropping gains for investors earlier this year due to this phenomenon.</p>\n<p>The mechanics of a short squeeze are fairly straightforward. Short-sellers, or investors betting against an equity, are essentially forced to cover their position in response to an uptick in investors buying the stock. The net result, more often than not, is a brief, parabolic-like move higher in the stock in question.</p>\n<p>Last month, short-sellers seemingly took advantage of the widespread weakness across the biopharma space. As a result, scores of biopharma equities sport sizable short positions as a percentage of the outstanding shares. The Alzheimer's specialist <b>Cortexyme</b> (NASDAQ:CRTX) and the commercial-stage biotech <b>Heron Therapeutics</b> (NASDAQ:HRTX) were two of the most heavily shorted pharma stocks at last count. These two drugmakers, however, could prove to be terrible stocks to bet against. Here's why.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b6841093892c649c73d00f9f0f9f2663\" tg-width=\"700\" tg-height=\"533\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Cortexyme: Alzheimer's drugs are too risky to short</h2>\n<p>Cortexyme, a small-molecule drug developer, became a huge target for short-sellers after its experimental Alzheimer's disease treatment atuzaginstat flopped in a late-stage trial toward the end of October. In fact, the biotech's shares were <i>the</i> most heavily shorted equity among biopharmas at last count, a little over two weeks ago. Short-sellers are clearly betting that atuzaginstat is basically dead on arrival. That rather dire take might not be the case, however.</p>\n<p>During a recent conference call, Cortexyme management said that the drug does appear to show a worthwhile clinical benefit for Alzheimer's patients who also tested positive for the gum-disease bacteria Porphyromonas gingivalis. While this analysis is far from definitive, it may help the company identify the correct patient population to evaluate atuzaginstat in, via another late-stage trial. Cortexyme intends to do just that. Almost immediately after the drug disappointed in this all-comer study, management announced plans to target a more-focused group of patients in another pivotal study.</p>\n<p>Why is Cortexyme an outstanding short-squeeze candidate? Even as a drug exclusively for Alzheimer's disease patients with an active P. gingivalis infection, it should still generate mega-blockbuster sales (greater than $5 billion). That's a massive revenue stream for a company with a $420 million market cap at present. Cortexyme plans to provide an update to investors on this upcoming clinical trial in the first quarter of 2022. This update could very well spark a short squeeze in the biotech's stock.</p>\n<h2>Heron Therapeutics: Down but not out</h2>\n<p>Heron Therapeutics has been a top short-seller target for well over a year now. As a result, the biotech's stock is currently <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the most heavily shorted within its immediate peer group. Bears have bet against this small-cap pharma stock for two clear reasons. First, Heron's chemotherapy-induced nausea and vomiting franchise has underwhelmed from a commercial standpoint.</p>\n<p>Second, the biotech's highly anticipated acute pain medication Zynrelef didn't get the type of broad label from the Food and Drug Administration (FDA) that would have allowed it to become a major growth driver right off the bat. Heron is working with the FDA to expand Zynrelef's label, but this process will take a while to work through.</p>\n<p>The good news is that Zynrelef still holds the potential to rake in upward of $500 million in sales by the middle of the decade. That's a nice chunk of change for a biotech with a sub-$1 billion market cap.</p>\n<p>Why might Heron be gearing up for a noteworthy short squeeze? It is expected to announce important commercial and regulatory updates for Zynrelef before the end of February 2022. If the drug's commercial launch continues to show promise and its label-expansion plans remain on track, the stock should reverse course. The biotech's shares, after all, are currently trading at under 3 times 2023 sales, which is a dirt cheap valuation for a commercial-stage biotech.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Short-Squeeze Candidates That Could Go Parabolic Soon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Short-Squeeze Candidates That Could Go Parabolic Soon\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-09 23:18 GMT+8 <a href=https://www.fool.com/investing/2021/12/09/2-short-squeeze-stock-candidates-that-could-go-par/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Short squeezes can deliver enormous returns for investors in the blink of an eye. Several so-called \"meme stocks\" generated jaw-dropping gains for investors earlier this year due to this phenomenon.\n...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/09/2-short-squeeze-stock-candidates-that-could-go-par/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HRTX":"Heron Therapeutics Inc.","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2021/12/09/2-short-squeeze-stock-candidates-that-could-go-par/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190617302","content_text":"Short squeezes can deliver enormous returns for investors in the blink of an eye. Several so-called \"meme stocks\" generated jaw-dropping gains for investors earlier this year due to this phenomenon.\nThe mechanics of a short squeeze are fairly straightforward. Short-sellers, or investors betting against an equity, are essentially forced to cover their position in response to an uptick in investors buying the stock. The net result, more often than not, is a brief, parabolic-like move higher in the stock in question.\nLast month, short-sellers seemingly took advantage of the widespread weakness across the biopharma space. As a result, scores of biopharma equities sport sizable short positions as a percentage of the outstanding shares. The Alzheimer's specialist Cortexyme (NASDAQ:CRTX) and the commercial-stage biotech Heron Therapeutics (NASDAQ:HRTX) were two of the most heavily shorted pharma stocks at last count. These two drugmakers, however, could prove to be terrible stocks to bet against. Here's why.\nImage source: Getty Images.\nCortexyme: Alzheimer's drugs are too risky to short\nCortexyme, a small-molecule drug developer, became a huge target for short-sellers after its experimental Alzheimer's disease treatment atuzaginstat flopped in a late-stage trial toward the end of October. In fact, the biotech's shares were the most heavily shorted equity among biopharmas at last count, a little over two weeks ago. Short-sellers are clearly betting that atuzaginstat is basically dead on arrival. That rather dire take might not be the case, however.\nDuring a recent conference call, Cortexyme management said that the drug does appear to show a worthwhile clinical benefit for Alzheimer's patients who also tested positive for the gum-disease bacteria Porphyromonas gingivalis. While this analysis is far from definitive, it may help the company identify the correct patient population to evaluate atuzaginstat in, via another late-stage trial. Cortexyme intends to do just that. Almost immediately after the drug disappointed in this all-comer study, management announced plans to target a more-focused group of patients in another pivotal study.\nWhy is Cortexyme an outstanding short-squeeze candidate? Even as a drug exclusively for Alzheimer's disease patients with an active P. gingivalis infection, it should still generate mega-blockbuster sales (greater than $5 billion). That's a massive revenue stream for a company with a $420 million market cap at present. Cortexyme plans to provide an update to investors on this upcoming clinical trial in the first quarter of 2022. This update could very well spark a short squeeze in the biotech's stock.\nHeron Therapeutics: Down but not out\nHeron Therapeutics has been a top short-seller target for well over a year now. As a result, the biotech's stock is currently one of the most heavily shorted within its immediate peer group. Bears have bet against this small-cap pharma stock for two clear reasons. First, Heron's chemotherapy-induced nausea and vomiting franchise has underwhelmed from a commercial standpoint.\nSecond, the biotech's highly anticipated acute pain medication Zynrelef didn't get the type of broad label from the Food and Drug Administration (FDA) that would have allowed it to become a major growth driver right off the bat. Heron is working with the FDA to expand Zynrelef's label, but this process will take a while to work through.\nThe good news is that Zynrelef still holds the potential to rake in upward of $500 million in sales by the middle of the decade. That's a nice chunk of change for a biotech with a sub-$1 billion market cap.\nWhy might Heron be gearing up for a noteworthy short squeeze? It is expected to announce important commercial and regulatory updates for Zynrelef before the end of February 2022. If the drug's commercial launch continues to show promise and its label-expansion plans remain on track, the stock should reverse course. The biotech's shares, after all, are currently trading at under 3 times 2023 sales, which is a dirt cheap valuation for a commercial-stage biotech.","news_type":1,"symbols_score_info":{"CRTX":0.9,"HRTX":0.9}},"isVote":1,"tweetType":1,"viewCount":2304,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602710172,"gmtCreate":1639065290056,"gmtModify":1639065969239,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586429646894350","idStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/602710172","repostId":"1134628800","repostType":4,"repost":{"id":"1134628800","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639064594,"share":"https://ttm.financial/m/news/1134628800?lang=&edition=full","pubTime":"2021-12-09 23:43","market":"us","language":"en","title":"10 Biggest Price Target Changes For Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=1134628800","media":"Benzinga","summary":"SVB Leerink boosted the price target on Edwards Lifesciences Corporation from $130 to $135. Edwards ","content":"<ul>\n <li>SVB Leerink boosted the price target on <b>Edwards Lifesciences Corporation</b> from $130 to $135. Edwards Lifesciences shares rose 1% to trade at $120.68 on Thursday.</li>\n <li>Keybanc raised <b>The Sherwin-Williams Company</b> price target from $350 to $384. Sherwin-Williams shares rose 1% to $345.68 on Thursday.</li>\n <li>Piper Sandler cut <b>Udemy, Inc.</b> price target from $37 to $34. Udemy shares fell 2% to trade at $20.65 on Thursday.</li>\n <li>Needham lowered the price target on <b>Esperion Therapeutics, Inc.</b> from $20 to $12. Esperion Therapeutics shares dropped 9% to $5.34 on Thursday.</li>\n <li>JP Morgan lifted <b>Phillips 66</b> price target from $83 to $93. Phillips 66 shares rose 0.7% to $72.36 on Thursday.</li>\n <li>RBC Capital cut the price target for <b>Cincinnati Financial Corporation</b> from $135 to $130. Cincinnati Financial shares fell 1.7% to $115.23 on Thursday.</li>\n <li>Chardan Capital raised <b>Dicerna Pharmaceuticals, Inc.</b> price target from $28 to $38.25. Dicerna Pharmaceuticals shares rose 0.1% to $38.03 on Thursday.</li>\n <li>Morgan Stanley boosted the price target on <b>Oshkosh Corporation</b> from $134 to $144. Oshkosh shares fell 1.4% to trade at $111.45 on Thursday.</li>\n <li>Wells Fargo cut the price target for <b>Dow Inc.</b> from $75 to $67. Dow shares fell 0.8% to $54.49 on Thursday.</li>\n <li>Barclays raised <b>McKesson Corporation</b> price target from $270 to $290. McKesson shares rose 1.1% to $229.33 on Thursday.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10 Biggest Price Target Changes For Thursday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10 Biggest Price Target Changes For Thursday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-09 23:43</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>SVB Leerink boosted the price target on <b>Edwards Lifesciences Corporation</b> from $130 to $135. Edwards Lifesciences shares rose 1% to trade at $120.68 on Thursday.</li>\n <li>Keybanc raised <b>The Sherwin-Williams Company</b> price target from $350 to $384. Sherwin-Williams shares rose 1% to $345.68 on Thursday.</li>\n <li>Piper Sandler cut <b>Udemy, Inc.</b> price target from $37 to $34. Udemy shares fell 2% to trade at $20.65 on Thursday.</li>\n <li>Needham lowered the price target on <b>Esperion Therapeutics, Inc.</b> from $20 to $12. Esperion Therapeutics shares dropped 9% to $5.34 on Thursday.</li>\n <li>JP Morgan lifted <b>Phillips 66</b> price target from $83 to $93. Phillips 66 shares rose 0.7% to $72.36 on Thursday.</li>\n <li>RBC Capital cut the price target for <b>Cincinnati Financial Corporation</b> from $135 to $130. Cincinnati Financial shares fell 1.7% to $115.23 on Thursday.</li>\n <li>Chardan Capital raised <b>Dicerna Pharmaceuticals, Inc.</b> price target from $28 to $38.25. Dicerna Pharmaceuticals shares rose 0.1% to $38.03 on Thursday.</li>\n <li>Morgan Stanley boosted the price target on <b>Oshkosh Corporation</b> from $134 to $144. Oshkosh shares fell 1.4% to trade at $111.45 on Thursday.</li>\n <li>Wells Fargo cut the price target for <b>Dow Inc.</b> from $75 to $67. Dow shares fell 0.8% to $54.49 on Thursday.</li>\n <li>Barclays raised <b>McKesson Corporation</b> price target from $270 to $290. McKesson shares rose 1.1% to $229.33 on Thursday.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ESPR":"Esperion Therapeutics Inc.","DOW":"陶氏化学","SHW":"宣伟公司","OSK":"Oshkosh","PSX":"Phillips 66","UDMY":"Udemy, Inc.","CINF":"辛辛那提金融","EW":"爱德华兹","DRNA":"Dicerna Pharmaceuticals, Inc.","MCK":"麦克森药物批发"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134628800","content_text":"SVB Leerink boosted the price target on Edwards Lifesciences Corporation from $130 to $135. Edwards Lifesciences shares rose 1% to trade at $120.68 on Thursday.\nKeybanc raised The Sherwin-Williams Company price target from $350 to $384. Sherwin-Williams shares rose 1% to $345.68 on Thursday.\nPiper Sandler cut Udemy, Inc. price target from $37 to $34. Udemy shares fell 2% to trade at $20.65 on Thursday.\nNeedham lowered the price target on Esperion Therapeutics, Inc. from $20 to $12. Esperion Therapeutics shares dropped 9% to $5.34 on Thursday.\nJP Morgan lifted Phillips 66 price target from $83 to $93. Phillips 66 shares rose 0.7% to $72.36 on Thursday.\nRBC Capital cut the price target for Cincinnati Financial Corporation from $135 to $130. Cincinnati Financial shares fell 1.7% to $115.23 on Thursday.\nChardan Capital raised Dicerna Pharmaceuticals, Inc. price target from $28 to $38.25. Dicerna Pharmaceuticals shares rose 0.1% to $38.03 on Thursday.\nMorgan Stanley boosted the price target on Oshkosh Corporation from $134 to $144. Oshkosh shares fell 1.4% to trade at $111.45 on Thursday.\nWells Fargo cut the price target for Dow Inc. from $75 to $67. Dow shares fell 0.8% to $54.49 on Thursday.\nBarclays raised McKesson Corporation price target from $270 to $290. McKesson shares rose 1.1% to $229.33 on Thursday.","news_type":1,"symbols_score_info":{"CINF":0.9,"DOW":0.9,"DRNA":0.9,"ESPR":0.9,"EW":0.9,"MCK":0.9,"OSK":0.9,"PSX":0.9,"SHW":0.9,"UDMY":0.9}},"isVote":1,"tweetType":1,"viewCount":1836,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602383179,"gmtCreate":1638972268751,"gmtModify":1638972269010,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586429646894350","idStr":"3586429646894350"},"themes":[],"htmlText":"Really? ","listText":"Really? ","text":"Really?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/602383179","repostId":"1196974870","repostType":4,"repost":{"id":"1196974870","kind":"news","pubTimestamp":1638971896,"share":"https://ttm.financial/m/news/1196974870?lang=&edition=full","pubTime":"2021-12-08 21:58","market":"us","language":"en","title":"GameStop Stock Could Soar After Its Recent Plunge. Here's Why.","url":"https://stock-news.laohu8.com/highlight/detail?id=1196974870","media":"TheStreet","summary":"Down more than 25% since late November, here’s what could happen next for the original meme stock.\nA","content":"<p>Down more than 25% since late November, here’s what could happen next for the original meme stock.</p>\n<p>As seen in recent days, GameStop stock has been affected by the stock market’s latest round of volatility. Due to news of the Covid-19 Omicron variant, plus talk from the Federal Reserve about an end to its “easy money” policies, stocks across-the-board have declined since late November.</p>\n<p>During the same timeframe, shares in the video game retailer and “meme stock bluechip” have fallen by some 25%. But now, as Omicron worries may be fading, and volatility could soon clear up, what’s the next move for GameStop?</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/795e002c4033cf494520d82da3291dd6\" tg-width=\"1240\" tg-height=\"698\" width=\"100%\" height=\"auto\"><span>Figure 1: GameStop store.</span></p>\n<p>Put simply, it’s debatable. Bulls can point to certain factors to support their views, as can bears. With this, let’s dive in, and explore what could push shares higher (or lower) from here.</p>\n<p><b>How GME Stock Could Rebound After The Omicron Selloff</b></p>\n<p>With its rapid drop during the week ending Dec 3, it may seem as if this stock is starting to lose its “unsinkable” reputation earned after holding onto most of its gains from its incredible run earlier this year.</p>\n<p>But while many in the so-called “Ape army” may have trimmed/exited positions last week, there could be something that stops this latest selloff from being the beginning of the end for GME stock.</p>\n<p>That would be the company’s upcoming earnings release on Dec 8. If coupled with a recovery from the Omicron selloff, shares could experience a big rebound in price.</p>\n<p>This may be especially true if, along with better-than-expected earnings, the company releases more details about its e-commerce plans, plus other initiatives, such as its rumored move into NFTs (non-fungible tokens). News like it could help convince “Apes” still long the stock to maintain their positions, and convince others who got out after last week’s volatility to dive back into it.</p>\n<p><b>Why The GameStop Price Collapse May Continue</b></p>\n<p>While it may be premature to say that many in the “Ape” community are ready to throw in the towel on GME stock, there is some evidence pointing in this direction.</p>\n<p>Chatter on Reddit’s various stock-trading subreddits is dropping once again. Although according to <i>ApeWisdom.io</i> mentions are up 47% in the last 24 hours, the current level of discussion about it on the platform is down considerably from the elevated levels seen last month.</p>\n<p>The main rationale behind holding this stock (to short-squeeze it) has fallen off as well. According to Fintel.io,short interest has dropped to just under 11%.</p>\n<p>GME’s waning appeal as a squeeze play may explain some of the frustration expressed by Reddit traders, after Fidelity Investments incorrectly stated the number of shares available to short through its platform.</p>\n<p><b>Bottom Line</b></p>\n<p>Bouncing between $160 and $170 per share today, it’s not definitive as to where GME stock is headed from here.</p>\n<p>But Wednesday’s earnings report and management updates may prove crucial to reinstill confidence among “Apes”.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GameStop Stock Could Soar After Its Recent Plunge. Here's Why. </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGameStop Stock Could Soar After Its Recent Plunge. Here's Why. \n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-08 21:58 GMT+8 <a href=https://www.thestreet.com/memestocks/gme/heres-why-gme-stock-could-soar-after-its-recent-plunge><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Down more than 25% since late November, here’s what could happen next for the original meme stock.\nAs seen in recent days, GameStop stock has been affected by the stock market’s latest round of ...</p>\n\n<a href=\"https://www.thestreet.com/memestocks/gme/heres-why-gme-stock-could-soar-after-its-recent-plunge\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站"},"source_url":"https://www.thestreet.com/memestocks/gme/heres-why-gme-stock-could-soar-after-its-recent-plunge","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196974870","content_text":"Down more than 25% since late November, here’s what could happen next for the original meme stock.\nAs seen in recent days, GameStop stock has been affected by the stock market’s latest round of volatility. Due to news of the Covid-19 Omicron variant, plus talk from the Federal Reserve about an end to its “easy money” policies, stocks across-the-board have declined since late November.\nDuring the same timeframe, shares in the video game retailer and “meme stock bluechip” have fallen by some 25%. But now, as Omicron worries may be fading, and volatility could soon clear up, what’s the next move for GameStop?\nFigure 1: GameStop store.\nPut simply, it’s debatable. Bulls can point to certain factors to support their views, as can bears. With this, let’s dive in, and explore what could push shares higher (or lower) from here.\nHow GME Stock Could Rebound After The Omicron Selloff\nWith its rapid drop during the week ending Dec 3, it may seem as if this stock is starting to lose its “unsinkable” reputation earned after holding onto most of its gains from its incredible run earlier this year.\nBut while many in the so-called “Ape army” may have trimmed/exited positions last week, there could be something that stops this latest selloff from being the beginning of the end for GME stock.\nThat would be the company’s upcoming earnings release on Dec 8. If coupled with a recovery from the Omicron selloff, shares could experience a big rebound in price.\nThis may be especially true if, along with better-than-expected earnings, the company releases more details about its e-commerce plans, plus other initiatives, such as its rumored move into NFTs (non-fungible tokens). News like it could help convince “Apes” still long the stock to maintain their positions, and convince others who got out after last week’s volatility to dive back into it.\nWhy The GameStop Price Collapse May Continue\nWhile it may be premature to say that many in the “Ape” community are ready to throw in the towel on GME stock, there is some evidence pointing in this direction.\nChatter on Reddit’s various stock-trading subreddits is dropping once again. Although according to ApeWisdom.io mentions are up 47% in the last 24 hours, the current level of discussion about it on the platform is down considerably from the elevated levels seen last month.\nThe main rationale behind holding this stock (to short-squeeze it) has fallen off as well. According to Fintel.io,short interest has dropped to just under 11%.\nGME’s waning appeal as a squeeze play may explain some of the frustration expressed by Reddit traders, after Fidelity Investments incorrectly stated the number of shares available to short through its platform.\nBottom Line\nBouncing between $160 and $170 per share today, it’s not definitive as to where GME stock is headed from here.\nBut Wednesday’s earnings report and management updates may prove crucial to reinstill confidence among “Apes”.","news_type":1,"symbols_score_info":{"GME":0.9}},"isVote":1,"tweetType":1,"viewCount":1345,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602389534,"gmtCreate":1638972240990,"gmtModify":1638972245822,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586429646894350","idStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602389534","repostId":"2189642036","repostType":4,"repost":{"id":"2189642036","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638972089,"share":"https://ttm.financial/m/news/2189642036?lang=&edition=full","pubTime":"2021-12-08 22:01","market":"us","language":"en","title":"Waymo's slow-going in Arizona opens up U.S. robotaxi race","url":"https://stock-news.laohu8.com/highlight/detail?id=2189642036","media":"Reuters","summary":"CHANDLER, Ariz., Dec 8 (Reuters) - Alphabet Inc's Waymo risks losing its lead in the U.S. race to pr","content":"<p>CHANDLER, Ariz., Dec 8 (Reuters) - Alphabet Inc's Waymo risks losing its lead in the U.S. race to prove robotaxis are a viable business as it sticks to a limited service and rivals backed by automakers near their own launches.</p>\n<p>Companies including Ford Motor Co's Argo AI and General Motors Co's Cruise are competing for the billions of dollars in financing needed to automate driving through artificial intelligence software and expensive sensors.</p>\n<p>Waymo has led the field. In the first and only fully driverless taxi service in the country, Waymo has driven thousands of people since opening a year ago east of Phoenix to anyone who downloads its ride-hailing app. And since August, hundreds in San Francisco have trialed cabs with safety drivers aboard.</p>\n<p>But Waymo lacks investment from a major automaker, which analysts say could hamper efforts to grow its fleet.</p>\n<p>Plans Waymo touted in 2018 to buy up to 62,000 Chrysler Pacifica minivans and 20,000 Jaguar I-Pace SUVs have not materialized. A big order for cameras to give eyes to its vehicles was scaled back, a person familiar with the matter said. Partnership talks in the past with automaker Hyundai Motor Co also fell through, another source said.</p>\n<p>Waymo's ride-hailing service in Arizona has not expanded beyond suburbs. It inquired about permitting for Phoenix airport rides in 2018 but has not pursued the process or approached San Francisco's airport at all, according to government records obtained by Reuters.</p>\n<p>Waymo cars still have lessons to learn. Some mall drop-offs in Arizona seen by Reuters blocked access to disabled parking spots for minutes in what disability advocates described as a potential legal violation.</p>\n<p>Raj Rajkumar, professor of electrical and computer engineering at Carnegie Mellon University, said high staffing costs also could contribute to Waymo's slow expansion. Riders in Arizona told Reuters that support crews in person or monitoring remotely have had to re-direct vehicles paralyzed by, among other sights, freight pallets, an errant stop sign and road-paving gear.</p>\n<p>Waymo has a different view.</p>\n<p>Partnerships with several automakers from around the world, rather than investment from just <a href=\"https://laohu8.com/S/AONE.U\">one</a>, serve what it describes as unparalleled ambitions across trucking, grocery delivery and more. Waymo said it has met all production goals, introduced hundreds of I-Pace crossovers.</p>\n<p>\"It would make little sense to place a bet on an individual OEM (equipment maker) - that would increase our risk and give us fewer future paths to market,\" the company said. \"The future of autonomy is about much more than ride-hail services.\"</p>\n<p>At the Reuters Next conference last week, Waymo Co-CEO Tekedra Mawakana said the company was in \"a robust phase of not only developing the technology but also developing commercial opportunities.\"</p>\n<p>\"There's a lot that goes into doing this the first time,\" she said. \"Then you build a playbook and it's just much easier to replicate it in future cities.\"</p>\n<p>Waymo recently began testing in central Phoenix, though without riders. It said personnel costs are not a determining factor in plans, and its system tries to avoid pulling over in disabled parking spots.</p>\n<p>Cruise aims to be permitted next year for a middle-of-the-night, driverless offering in San Francisco, and Tesla Inc Chief Executive Elon Musk continues to promise fully self-driving cars. Argo says it will partner with Lyft to open robotaxis in Miami before the new year - with a safety driver present.</p>\n<p>All the companies have missed targets or downsized plans, but some observers see a shift in Waymo's standing.</p>\n<p>\"Waymo is playing catch-up now,\" said Grayson Brulte, president at autonomous mobility consultancy Brulte & Co.</p>\n<p><b>WAYMO VS TESLA</b></p>\n<p>Born in 2009 as a project inside Google, Waymo has raised $5.75 billion in funding since 2020.</p>\n<p>Some analysts viewed the resignations this year of former CEO John Krafcik and other executives as a sign of Alphabet management's disappointment in slow progress, a charge Waymo denies. Krafcik remains an advisor.</p>\n<p>Waymo's strategy prioritizes safety and incorporating feedback. It has avoided a major accident, a testament to its caution.</p>\n<p>Hang Zhao, assistant professor at Tsinghua University and a former Waymo scientist, said that though it requires more engineers, Waymo has taken a safe approach to solving AI problems, especially in contrast to Tesla's tactics.</p>\n<p>Tesla did not respond to requests for comment.</p>\n<p>Swamy Kotagiri, chief executive of Waymo investor and auto industry supplier Magna International Inc , told analysts in July that he anticipates \"a long road\" for fully autonomous cars, adding that even by 2030 only \"a small number\" would be produced.</p>\n<p>Waymo's heady progress and optimism catalyzed the industry, with its then-chief Chris Urmson saying in 2015 that he expected his son to rely on autonomous vehicles in 2020.</p>\n<p>Urmson's new company Aurora, backed by big automakers, now targets 2024 to commercialize autonomous rides. But his earlier vision has come true, narrowly. In Chandler, the suburban hub of Waymo's commercial operation, Intel Corp engineer John Mitkowski is among residents commuting for work daily by driverless minivan.</p>\n<p>\"Just get in, go,\" Mitkowski said of his 3-mile, $8 Waymo trip each way.</p>\n<p>But he needs alternatives when flying or going to the nearby university or some favorite golf courses. His wife is too scared to ride in a robotaxi and his daughter, fresh out of university, opts for the convenience of her car.</p>\n<p>Waymo's limited supply in Arizona has led to 30-minute waits this year, according to customer Jordan Ranous, who has turned to rideshare service Lyft, where dinnertime trips cost $4 more for pick-up 26 minutes sooner.</p>\n<p>The majority of people opening Waymo's app see waits under 10 minutes, and ridership is growing, the company said.</p>\n<p>Mawakana, a half-year into her elevated role, said she has learned not to estimate timelines. She declined to predict when Waymo would drop safety drivers in San Francisco or might demonstrate profitability.</p>\n<p>\"What we've learned is it's not as important,\" she said of forecasts.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Waymo's slow-going in Arizona opens up U.S. robotaxi race</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWaymo's slow-going in Arizona opens up U.S. robotaxi race\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-08 22:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CHANDLER, Ariz., Dec 8 (Reuters) - Alphabet Inc's Waymo risks losing its lead in the U.S. race to prove robotaxis are a viable business as it sticks to a limited service and rivals backed by automakers near their own launches.</p>\n<p>Companies including Ford Motor Co's Argo AI and General Motors Co's Cruise are competing for the billions of dollars in financing needed to automate driving through artificial intelligence software and expensive sensors.</p>\n<p>Waymo has led the field. In the first and only fully driverless taxi service in the country, Waymo has driven thousands of people since opening a year ago east of Phoenix to anyone who downloads its ride-hailing app. And since August, hundreds in San Francisco have trialed cabs with safety drivers aboard.</p>\n<p>But Waymo lacks investment from a major automaker, which analysts say could hamper efforts to grow its fleet.</p>\n<p>Plans Waymo touted in 2018 to buy up to 62,000 Chrysler Pacifica minivans and 20,000 Jaguar I-Pace SUVs have not materialized. A big order for cameras to give eyes to its vehicles was scaled back, a person familiar with the matter said. Partnership talks in the past with automaker Hyundai Motor Co also fell through, another source said.</p>\n<p>Waymo's ride-hailing service in Arizona has not expanded beyond suburbs. It inquired about permitting for Phoenix airport rides in 2018 but has not pursued the process or approached San Francisco's airport at all, according to government records obtained by Reuters.</p>\n<p>Waymo cars still have lessons to learn. Some mall drop-offs in Arizona seen by Reuters blocked access to disabled parking spots for minutes in what disability advocates described as a potential legal violation.</p>\n<p>Raj Rajkumar, professor of electrical and computer engineering at Carnegie Mellon University, said high staffing costs also could contribute to Waymo's slow expansion. Riders in Arizona told Reuters that support crews in person or monitoring remotely have had to re-direct vehicles paralyzed by, among other sights, freight pallets, an errant stop sign and road-paving gear.</p>\n<p>Waymo has a different view.</p>\n<p>Partnerships with several automakers from around the world, rather than investment from just <a href=\"https://laohu8.com/S/AONE.U\">one</a>, serve what it describes as unparalleled ambitions across trucking, grocery delivery and more. Waymo said it has met all production goals, introduced hundreds of I-Pace crossovers.</p>\n<p>\"It would make little sense to place a bet on an individual OEM (equipment maker) - that would increase our risk and give us fewer future paths to market,\" the company said. \"The future of autonomy is about much more than ride-hail services.\"</p>\n<p>At the Reuters Next conference last week, Waymo Co-CEO Tekedra Mawakana said the company was in \"a robust phase of not only developing the technology but also developing commercial opportunities.\"</p>\n<p>\"There's a lot that goes into doing this the first time,\" she said. \"Then you build a playbook and it's just much easier to replicate it in future cities.\"</p>\n<p>Waymo recently began testing in central Phoenix, though without riders. It said personnel costs are not a determining factor in plans, and its system tries to avoid pulling over in disabled parking spots.</p>\n<p>Cruise aims to be permitted next year for a middle-of-the-night, driverless offering in San Francisco, and Tesla Inc Chief Executive Elon Musk continues to promise fully self-driving cars. Argo says it will partner with Lyft to open robotaxis in Miami before the new year - with a safety driver present.</p>\n<p>All the companies have missed targets or downsized plans, but some observers see a shift in Waymo's standing.</p>\n<p>\"Waymo is playing catch-up now,\" said Grayson Brulte, president at autonomous mobility consultancy Brulte & Co.</p>\n<p><b>WAYMO VS TESLA</b></p>\n<p>Born in 2009 as a project inside Google, Waymo has raised $5.75 billion in funding since 2020.</p>\n<p>Some analysts viewed the resignations this year of former CEO John Krafcik and other executives as a sign of Alphabet management's disappointment in slow progress, a charge Waymo denies. Krafcik remains an advisor.</p>\n<p>Waymo's strategy prioritizes safety and incorporating feedback. It has avoided a major accident, a testament to its caution.</p>\n<p>Hang Zhao, assistant professor at Tsinghua University and a former Waymo scientist, said that though it requires more engineers, Waymo has taken a safe approach to solving AI problems, especially in contrast to Tesla's tactics.</p>\n<p>Tesla did not respond to requests for comment.</p>\n<p>Swamy Kotagiri, chief executive of Waymo investor and auto industry supplier Magna International Inc , told analysts in July that he anticipates \"a long road\" for fully autonomous cars, adding that even by 2030 only \"a small number\" would be produced.</p>\n<p>Waymo's heady progress and optimism catalyzed the industry, with its then-chief Chris Urmson saying in 2015 that he expected his son to rely on autonomous vehicles in 2020.</p>\n<p>Urmson's new company Aurora, backed by big automakers, now targets 2024 to commercialize autonomous rides. But his earlier vision has come true, narrowly. In Chandler, the suburban hub of Waymo's commercial operation, Intel Corp engineer John Mitkowski is among residents commuting for work daily by driverless minivan.</p>\n<p>\"Just get in, go,\" Mitkowski said of his 3-mile, $8 Waymo trip each way.</p>\n<p>But he needs alternatives when flying or going to the nearby university or some favorite golf courses. His wife is too scared to ride in a robotaxi and his daughter, fresh out of university, opts for the convenience of her car.</p>\n<p>Waymo's limited supply in Arizona has led to 30-minute waits this year, according to customer Jordan Ranous, who has turned to rideshare service Lyft, where dinnertime trips cost $4 more for pick-up 26 minutes sooner.</p>\n<p>The majority of people opening Waymo's app see waits under 10 minutes, and ridership is growing, the company said.</p>\n<p>Mawakana, a half-year into her elevated role, said she has learned not to estimate timelines. She declined to predict when Waymo would drop safety drivers in San Francisco or might demonstrate profitability.</p>\n<p>\"What we've learned is it's not as important,\" she said of forecasts.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GM":"通用汽车","BK4561":"索罗斯持仓","BK4527":"明星科技股","BK4099":"汽车制造商","BK4534":"瑞士信贷持仓","LYFT":"Lyft, Inc.","BK4555":"新能源车","BK4503":"景林资产持仓","F":"福特汽车","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4022":"陆运","BK4566":"资本集团","BK4536":"外卖概念","BK4505":"高瓴资本持仓","BK4535":"淡马锡持仓","UBER":"优步","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓","GOOGL":"谷歌A","BK4548":"巴美列捷福持仓","TSLA":"特斯拉","BK4551":"寇图资本持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2189642036","content_text":"CHANDLER, Ariz., Dec 8 (Reuters) - Alphabet Inc's Waymo risks losing its lead in the U.S. race to prove robotaxis are a viable business as it sticks to a limited service and rivals backed by automakers near their own launches.\nCompanies including Ford Motor Co's Argo AI and General Motors Co's Cruise are competing for the billions of dollars in financing needed to automate driving through artificial intelligence software and expensive sensors.\nWaymo has led the field. In the first and only fully driverless taxi service in the country, Waymo has driven thousands of people since opening a year ago east of Phoenix to anyone who downloads its ride-hailing app. And since August, hundreds in San Francisco have trialed cabs with safety drivers aboard.\nBut Waymo lacks investment from a major automaker, which analysts say could hamper efforts to grow its fleet.\nPlans Waymo touted in 2018 to buy up to 62,000 Chrysler Pacifica minivans and 20,000 Jaguar I-Pace SUVs have not materialized. A big order for cameras to give eyes to its vehicles was scaled back, a person familiar with the matter said. Partnership talks in the past with automaker Hyundai Motor Co also fell through, another source said.\nWaymo's ride-hailing service in Arizona has not expanded beyond suburbs. It inquired about permitting for Phoenix airport rides in 2018 but has not pursued the process or approached San Francisco's airport at all, according to government records obtained by Reuters.\nWaymo cars still have lessons to learn. Some mall drop-offs in Arizona seen by Reuters blocked access to disabled parking spots for minutes in what disability advocates described as a potential legal violation.\nRaj Rajkumar, professor of electrical and computer engineering at Carnegie Mellon University, said high staffing costs also could contribute to Waymo's slow expansion. Riders in Arizona told Reuters that support crews in person or monitoring remotely have had to re-direct vehicles paralyzed by, among other sights, freight pallets, an errant stop sign and road-paving gear.\nWaymo has a different view.\nPartnerships with several automakers from around the world, rather than investment from just one, serve what it describes as unparalleled ambitions across trucking, grocery delivery and more. Waymo said it has met all production goals, introduced hundreds of I-Pace crossovers.\n\"It would make little sense to place a bet on an individual OEM (equipment maker) - that would increase our risk and give us fewer future paths to market,\" the company said. \"The future of autonomy is about much more than ride-hail services.\"\nAt the Reuters Next conference last week, Waymo Co-CEO Tekedra Mawakana said the company was in \"a robust phase of not only developing the technology but also developing commercial opportunities.\"\n\"There's a lot that goes into doing this the first time,\" she said. \"Then you build a playbook and it's just much easier to replicate it in future cities.\"\nWaymo recently began testing in central Phoenix, though without riders. It said personnel costs are not a determining factor in plans, and its system tries to avoid pulling over in disabled parking spots.\nCruise aims to be permitted next year for a middle-of-the-night, driverless offering in San Francisco, and Tesla Inc Chief Executive Elon Musk continues to promise fully self-driving cars. Argo says it will partner with Lyft to open robotaxis in Miami before the new year - with a safety driver present.\nAll the companies have missed targets or downsized plans, but some observers see a shift in Waymo's standing.\n\"Waymo is playing catch-up now,\" said Grayson Brulte, president at autonomous mobility consultancy Brulte & Co.\nWAYMO VS TESLA\nBorn in 2009 as a project inside Google, Waymo has raised $5.75 billion in funding since 2020.\nSome analysts viewed the resignations this year of former CEO John Krafcik and other executives as a sign of Alphabet management's disappointment in slow progress, a charge Waymo denies. Krafcik remains an advisor.\nWaymo's strategy prioritizes safety and incorporating feedback. It has avoided a major accident, a testament to its caution.\nHang Zhao, assistant professor at Tsinghua University and a former Waymo scientist, said that though it requires more engineers, Waymo has taken a safe approach to solving AI problems, especially in contrast to Tesla's tactics.\nTesla did not respond to requests for comment.\nSwamy Kotagiri, chief executive of Waymo investor and auto industry supplier Magna International Inc , told analysts in July that he anticipates \"a long road\" for fully autonomous cars, adding that even by 2030 only \"a small number\" would be produced.\nWaymo's heady progress and optimism catalyzed the industry, with its then-chief Chris Urmson saying in 2015 that he expected his son to rely on autonomous vehicles in 2020.\nUrmson's new company Aurora, backed by big automakers, now targets 2024 to commercialize autonomous rides. But his earlier vision has come true, narrowly. In Chandler, the suburban hub of Waymo's commercial operation, Intel Corp engineer John Mitkowski is among residents commuting for work daily by driverless minivan.\n\"Just get in, go,\" Mitkowski said of his 3-mile, $8 Waymo trip each way.\nBut he needs alternatives when flying or going to the nearby university or some favorite golf courses. His wife is too scared to ride in a robotaxi and his daughter, fresh out of university, opts for the convenience of her car.\nWaymo's limited supply in Arizona has led to 30-minute waits this year, according to customer Jordan Ranous, who has turned to rideshare service Lyft, where dinnertime trips cost $4 more for pick-up 26 minutes sooner.\nThe majority of people opening Waymo's app see waits under 10 minutes, and ridership is growing, the company said.\nMawakana, a half-year into her elevated role, said she has learned not to estimate timelines. She declined to predict when Waymo would drop safety drivers in San Francisco or might demonstrate profitability.\n\"What we've learned is it's not as important,\" she said of forecasts.","news_type":1,"symbols_score_info":{"F":0.9,"GM":0.9,"GOOGL":0.9,"LYFT":0.9,"TSLA":0.9,"UBER":0.9}},"isVote":1,"tweetType":1,"viewCount":3235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602389971,"gmtCreate":1638972220484,"gmtModify":1638972223651,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586429646894350","idStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment ","listText":"Like and comment ","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602389971","repostId":"1183863090","repostType":4,"repost":{"id":"1183863090","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638968845,"share":"https://ttm.financial/m/news/1183863090?lang=&edition=full","pubTime":"2021-12-08 21:07","market":"us","language":"en","title":"Toplines Before US Market Open on Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1183863090","media":"Tiger Newspress","summary":"U.S. futures climbed for a third day after rising the most since March on Tuesday,as investors asses","content":"<p>U.S. futures climbed for a third day after rising the most since March on Tuesday,as investors assessed the uncertain effects of the Omicron variant on the economy.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 48 points, or 0.13%.The S&P 500 e-minis were up 8 points, or 0.17%, and Nasdaq 100 e-minis were up 38.25 points, or 0.23%.</p>\n<p><img src=\"https://static.tigerbbs.com/31985372e2ecc4486843a08080c6b077\" tg-width=\"1080\" tg-height=\"412\" width=\"100%\" height=\"auto\"></p>\n<p>Markets cheered news that BioNTech and Pfizer said that a three-shot course of their COVID-19 vaccine was shown to generate a neutralising effect against the new Omicron variant in a laboratory test.</p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p><b>Pfizer(PFE),BioNTech(BNTX)</b> – The companies said studies showed that three doses of their Covid-19 vaccine neutralized the omicron variant, while two doses still offered protection. Pfizer and BioNTech also said they’re continuing to work on an omicron-specific vaccine. Pfizer and BioNTech came well off earlier premarket lows on the news, with Pfizer up 0.7% and BioNTech trimming its loss to 1%.</p>\n<p><b>RLX Technology(RLX)</b> – RLX Technology announced that its board of directors has authorized a share repurchase program under which the Company may repurchase up to $500 million of its shares over a period until December 31, 2023.The shares jumped 9.7% in premarket trading.</p>\n<p><b>SentinelOne(</b><b>S</b><b>)</b> – SentinelOne stock plunged 10% in premarket trading after soaring 13.4% yesterday.SentinelOne reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.18) by 44.44 percent. This is a 69.41 percent increase over losses of $(0.85) per share from the same period last year. The company reported quarterly sales of $56.02 million which beat the analyst consensus estimate of $49.57 million by 13.01 percent.</p>\n<p><b>Stitch Fix(SFIX)</b> – Stitch was hammered by 24.3% in the premarket after issuing current-quarter revenue guidance and membership metrics that fell short of Wall Street forecasts. The online apparel retailer did post a narrower-than-expected loss for its latest quarter and better-than-expected revenue, but not enough to sway investor concerns.</p>\n<p><b>ChargePoint Holdings(CHPT)</b> – ChargePoint posted an adjusted loss of 14 cents per share for its latest quarter, 1 cent wider than anticipated, while the charging station network operator saw revenue slightly above estimates. The company did give stronger-than-expected current-quarter revenue guidance and raised its full-year outlook. Despite the upbeat outlook, ChargePoint fell 3.8% in premarket trading.</p>\n<p><b>PagerDuty(PD)</b> – PagerDuty reported an adjusted quarterly loss of 7 cents per share, 2 cents narrower than analysts had predicted, while revenue topped Street forecasts. The maker of IT response software also gave better-than-expected current-quarter revenue guidance, and its stock surged 11% in premarket action.</p>\n<p><b>Campbell Soup(CPB)</b> – The food producer beat estimates by 8 cents with adjusted quarterly earnings of 89 cents per share, although revenue was slightly below analyst forecasts. Campbell said demand remains elevated for its products, and that it’s been able to moderate the impact of higher input costs through strong pricing and productivity improvements. The stock fell 0.6% in the premarket.</p>\n<p><b>Thor Industries(THO)</b> – The recreational vehicle maker earned $4.34 per share for its latest quarter, well above the $3.24 consensus estimate. Revenue was also above Wall Street forecasts amid continued strong demand. Thor rose 2.5% in premarket trading.</p>\n<p><b>Weber(WEBR)</b> – The grill maker’s stock jumped 10.3% in the premarket after it reported a narrower-than-expected loss for its latest quarter and beat Wall Street revenue forecasts. Weber lost 13 cents per share, 5 cents less than analysts had anticipated.</p>\n<p><b>Toll Brothers(TOL)</b> – Toll Brothers earned $3.02 per share for its latest quarter, compared with a consensus estimate of $2.49, while the luxury home builder also reported better-than-expected revenue. It is also projecting 20% growth in fiscal 2022 revenue as demand remains elevated. Toll added 2.1% in the premarket.</p>\n<p><b>BlackRock(BLK)</b> – The asset management firm is pulling about $2 trillion of assets from <b>State Street(STT)</b>, which had served as the sole custodian of BlackRock’s ETFs. BlackRock will be shifting some of its ETF custodianship to <b>Citigroup(C)</b>,<b>JPMorgan Chase(JPM)</b> and <b>Bank of America(BAC)</b>.</p>\n<p><b>Dave & Buster’s</b><b>(PLAY)</b> – Dave & Buster’s beat estimates by 8 cents with a quarterly profit of 23 cents per share, while the operator of entertainment center-themed restaurants also saw revenue come in above Street forecasts. Dave & Buster’s rallied 5.6% in the premarket.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-08 21:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. futures climbed for a third day after rising the most since March on Tuesday,as investors assessed the uncertain effects of the Omicron variant on the economy.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 48 points, or 0.13%.The S&P 500 e-minis were up 8 points, or 0.17%, and Nasdaq 100 e-minis were up 38.25 points, or 0.23%.</p>\n<p><img src=\"https://static.tigerbbs.com/31985372e2ecc4486843a08080c6b077\" tg-width=\"1080\" tg-height=\"412\" width=\"100%\" height=\"auto\"></p>\n<p>Markets cheered news that BioNTech and Pfizer said that a three-shot course of their COVID-19 vaccine was shown to generate a neutralising effect against the new Omicron variant in a laboratory test.</p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p><b>Pfizer(PFE),BioNTech(BNTX)</b> – The companies said studies showed that three doses of their Covid-19 vaccine neutralized the omicron variant, while two doses still offered protection. Pfizer and BioNTech also said they’re continuing to work on an omicron-specific vaccine. Pfizer and BioNTech came well off earlier premarket lows on the news, with Pfizer up 0.7% and BioNTech trimming its loss to 1%.</p>\n<p><b>RLX Technology(RLX)</b> – RLX Technology announced that its board of directors has authorized a share repurchase program under which the Company may repurchase up to $500 million of its shares over a period until December 31, 2023.The shares jumped 9.7% in premarket trading.</p>\n<p><b>SentinelOne(</b><b>S</b><b>)</b> – SentinelOne stock plunged 10% in premarket trading after soaring 13.4% yesterday.SentinelOne reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.18) by 44.44 percent. This is a 69.41 percent increase over losses of $(0.85) per share from the same period last year. The company reported quarterly sales of $56.02 million which beat the analyst consensus estimate of $49.57 million by 13.01 percent.</p>\n<p><b>Stitch Fix(SFIX)</b> – Stitch was hammered by 24.3% in the premarket after issuing current-quarter revenue guidance and membership metrics that fell short of Wall Street forecasts. The online apparel retailer did post a narrower-than-expected loss for its latest quarter and better-than-expected revenue, but not enough to sway investor concerns.</p>\n<p><b>ChargePoint Holdings(CHPT)</b> – ChargePoint posted an adjusted loss of 14 cents per share for its latest quarter, 1 cent wider than anticipated, while the charging station network operator saw revenue slightly above estimates. The company did give stronger-than-expected current-quarter revenue guidance and raised its full-year outlook. Despite the upbeat outlook, ChargePoint fell 3.8% in premarket trading.</p>\n<p><b>PagerDuty(PD)</b> – PagerDuty reported an adjusted quarterly loss of 7 cents per share, 2 cents narrower than analysts had predicted, while revenue topped Street forecasts. The maker of IT response software also gave better-than-expected current-quarter revenue guidance, and its stock surged 11% in premarket action.</p>\n<p><b>Campbell Soup(CPB)</b> – The food producer beat estimates by 8 cents with adjusted quarterly earnings of 89 cents per share, although revenue was slightly below analyst forecasts. Campbell said demand remains elevated for its products, and that it’s been able to moderate the impact of higher input costs through strong pricing and productivity improvements. The stock fell 0.6% in the premarket.</p>\n<p><b>Thor Industries(THO)</b> – The recreational vehicle maker earned $4.34 per share for its latest quarter, well above the $3.24 consensus estimate. Revenue was also above Wall Street forecasts amid continued strong demand. Thor rose 2.5% in premarket trading.</p>\n<p><b>Weber(WEBR)</b> – The grill maker’s stock jumped 10.3% in the premarket after it reported a narrower-than-expected loss for its latest quarter and beat Wall Street revenue forecasts. Weber lost 13 cents per share, 5 cents less than analysts had anticipated.</p>\n<p><b>Toll Brothers(TOL)</b> – Toll Brothers earned $3.02 per share for its latest quarter, compared with a consensus estimate of $2.49, while the luxury home builder also reported better-than-expected revenue. It is also projecting 20% growth in fiscal 2022 revenue as demand remains elevated. Toll added 2.1% in the premarket.</p>\n<p><b>BlackRock(BLK)</b> – The asset management firm is pulling about $2 trillion of assets from <b>State Street(STT)</b>, which had served as the sole custodian of BlackRock’s ETFs. BlackRock will be shifting some of its ETF custodianship to <b>Citigroup(C)</b>,<b>JPMorgan Chase(JPM)</b> and <b>Bank of America(BAC)</b>.</p>\n<p><b>Dave & Buster’s</b><b>(PLAY)</b> – Dave & Buster’s beat estimates by 8 cents with a quarterly profit of 23 cents per share, while the operator of entertainment center-themed restaurants also saw revenue come in above Street forecasts. Dave & Buster’s rallied 5.6% in the premarket.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STT":"道富银行","S":"SentinelOne, Inc","RLX":"雾芯科技","PLAY":"Dave & Buster","CHPT":"ChargePoint Holdings Inc.","TOL":"托尔兄弟",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","BLK":"贝莱德","BNTX":"BioNTech SE","THO":"索尔工业","PD":"PagerDuty, Inc.",".SPX":"S&P 500 Index","WEBR":"Weber Inc.","SFIX":"Stitch Fix Inc.","PFE":"辉瑞","CPB":"金宝汤"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183863090","content_text":"U.S. futures climbed for a third day after rising the most since March on Tuesday,as investors assessed the uncertain effects of the Omicron variant on the economy.\nAt 8:00 a.m. ET, Dow e-minis were up 48 points, or 0.13%.The S&P 500 e-minis were up 8 points, or 0.17%, and Nasdaq 100 e-minis were up 38.25 points, or 0.23%.\n\nMarkets cheered news that BioNTech and Pfizer said that a three-shot course of their COVID-19 vaccine was shown to generate a neutralising effect against the new Omicron variant in a laboratory test.\nStocks making the biggest moves premarket:\nPfizer(PFE),BioNTech(BNTX) – The companies said studies showed that three doses of their Covid-19 vaccine neutralized the omicron variant, while two doses still offered protection. Pfizer and BioNTech also said they’re continuing to work on an omicron-specific vaccine. Pfizer and BioNTech came well off earlier premarket lows on the news, with Pfizer up 0.7% and BioNTech trimming its loss to 1%.\nRLX Technology(RLX) – RLX Technology announced that its board of directors has authorized a share repurchase program under which the Company may repurchase up to $500 million of its shares over a period until December 31, 2023.The shares jumped 9.7% in premarket trading.\nSentinelOne(S) – SentinelOne stock plunged 10% in premarket trading after soaring 13.4% yesterday.SentinelOne reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.18) by 44.44 percent. This is a 69.41 percent increase over losses of $(0.85) per share from the same period last year. The company reported quarterly sales of $56.02 million which beat the analyst consensus estimate of $49.57 million by 13.01 percent.\nStitch Fix(SFIX) – Stitch was hammered by 24.3% in the premarket after issuing current-quarter revenue guidance and membership metrics that fell short of Wall Street forecasts. The online apparel retailer did post a narrower-than-expected loss for its latest quarter and better-than-expected revenue, but not enough to sway investor concerns.\nChargePoint Holdings(CHPT) – ChargePoint posted an adjusted loss of 14 cents per share for its latest quarter, 1 cent wider than anticipated, while the charging station network operator saw revenue slightly above estimates. The company did give stronger-than-expected current-quarter revenue guidance and raised its full-year outlook. Despite the upbeat outlook, ChargePoint fell 3.8% in premarket trading.\nPagerDuty(PD) – PagerDuty reported an adjusted quarterly loss of 7 cents per share, 2 cents narrower than analysts had predicted, while revenue topped Street forecasts. The maker of IT response software also gave better-than-expected current-quarter revenue guidance, and its stock surged 11% in premarket action.\nCampbell Soup(CPB) – The food producer beat estimates by 8 cents with adjusted quarterly earnings of 89 cents per share, although revenue was slightly below analyst forecasts. Campbell said demand remains elevated for its products, and that it’s been able to moderate the impact of higher input costs through strong pricing and productivity improvements. The stock fell 0.6% in the premarket.\nThor Industries(THO) – The recreational vehicle maker earned $4.34 per share for its latest quarter, well above the $3.24 consensus estimate. Revenue was also above Wall Street forecasts amid continued strong demand. Thor rose 2.5% in premarket trading.\nWeber(WEBR) – The grill maker’s stock jumped 10.3% in the premarket after it reported a narrower-than-expected loss for its latest quarter and beat Wall Street revenue forecasts. Weber lost 13 cents per share, 5 cents less than analysts had anticipated.\nToll Brothers(TOL) – Toll Brothers earned $3.02 per share for its latest quarter, compared with a consensus estimate of $2.49, while the luxury home builder also reported better-than-expected revenue. It is also projecting 20% growth in fiscal 2022 revenue as demand remains elevated. Toll added 2.1% in the premarket.\nBlackRock(BLK) – The asset management firm is pulling about $2 trillion of assets from State Street(STT), which had served as the sole custodian of BlackRock’s ETFs. BlackRock will be shifting some of its ETF custodianship to Citigroup(C),JPMorgan Chase(JPM) and Bank of America(BAC).\nDave & Buster’s(PLAY) – Dave & Buster’s beat estimates by 8 cents with a quarterly profit of 23 cents per share, while the operator of entertainment center-themed restaurants also saw revenue come in above Street forecasts. Dave & Buster’s rallied 5.6% in the premarket.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"BLK":0.9,"BNTX":0.9,"CHPT":0.9,"CPB":0.9,"ESmain":0.9,"NQmain":0.9,"YMmain":0.9,"PD":0.9,"PFE":0.9,"PLAY":0.9,"RLX":0.9,"S":0.9,"SFIX":0.9,"STT":0.9,"THO":0.9,"TOL":0.9,"WEBR":0.9}},"isVote":1,"tweetType":1,"viewCount":1461,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608869687,"gmtCreate":1638682676530,"gmtModify":1638682676687,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586429646894350","idStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/608869687","repostId":"1140678193","repostType":4,"repost":{"id":"1140678193","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638601002,"share":"https://ttm.financial/m/news/1140678193?lang=&edition=full","pubTime":"2021-12-04 14:56","market":"fut","language":"en","title":"Bitcoin and Ether prices drop sharply, falling more than 20%","url":"https://stock-news.laohu8.com/highlight/detail?id=1140678193","media":"Tiger Newspress","summary":"Bitcoin prices dropped sharply in the past 24 hours, plunging more than 20% to a low near $42,000.\nT","content":"<p>Bitcoin prices dropped sharply in the past 24 hours, plunging more than 20% to a low near $42,000.</p>\n<p>The price of Ether also dived, dropping more than 20% to a low near $3,500 in the past 24 hours.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bitcoin and Ether prices drop sharply, falling more than 20%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBitcoin and Ether prices drop sharply, falling more than 20%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-04 14:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Bitcoin prices dropped sharply in the past 24 hours, plunging more than 20% to a low near $42,000.</p>\n<p>The price of Ether also dived, dropping more than 20% to a low near $3,500 in the past 24 hours.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BITO":"ProShares Bitcoin ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140678193","content_text":"Bitcoin prices dropped sharply in the past 24 hours, plunging more than 20% to a low near $42,000.\nThe price of Ether also dived, dropping more than 20% to a low near $3,500 in the past 24 hours.","news_type":1,"symbols_score_info":{"BITO":0.9}},"isVote":1,"tweetType":1,"viewCount":880,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608322707,"gmtCreate":1638632025202,"gmtModify":1638632025316,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586429646894350","idStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/608322707","repostId":"2188853578","repostType":4,"repost":{"id":"2188853578","kind":"news","pubTimestamp":1638567812,"share":"https://ttm.financial/m/news/2188853578?lang=&edition=full","pubTime":"2021-12-04 05:43","market":"us","language":"en","title":"Wall St ends lower on Omicron worries, Fed taper angst","url":"https://stock-news.laohu8.com/highlight/detail?id=2188853578","media":"Reuters","summary":"Dec 3 (Reuters) - Wall Street's major indexes closed lower on Friday, with the Nasdaq leading the de","content":"<p>Dec 3 (Reuters) - Wall Street's major indexes closed lower on Friday, with the Nasdaq leading the declines as investors bet that a strong jobs report would not slow the Federal Reserve's withdrawal of support all while they grappled with uncertainty around the Omicron coronavirus variant.</p>\n<p>After opening higher, Wall Street spent the rest of the session in the doldrums and an elevated volatility index highlighted investor anxiety.</p>\n<p>The Labor Department's report, ahead of the session's open, showed that while nonfarm job growth rose less than expected in November, the unemployment rate dropped to 4.2%, its lowest since February 2020, and wages increased.</p>\n<p>Separately, a measure of U.S. services industry activity hit a record high in November.</p>\n<p>Both sets of data appeared to influence investor expectations for the Fed's next move towards tightening its policy. Fed Chair Jerome Powell said this week that the central bank will consider a faster wind-down of its bond-buying program, prompting speculation that interest rate hikes would also be brought forward.</p>\n<p>\"There's not enough in the jobs report to dissuade the Fed from accelerating the taper and (it) leaves the door open for a quicker rate hike than the market might have been anticipating,\" said Steve Sosnick, chief strategist at Interactive Brokers.</p>\n<p>On top of this he pointed to concerns that the Omicron variant appeared to be spreading faster than Delta, the last most prevalent version of COVID-19.</p>\n<p>The number of countries reporting Omicron cases kept rising on Friday but there was still little clarity on the severity of the disease or the level of protection provided by existing COVID-19 vaccines.</p>\n<p>The Dow Jones Industrial Average fell 59.71 points, or 0.17%, to 34,580.08, the S&P 500 lost 38.67 points, or 0.84%, to 4,538.43 and the Nasdaq Composite dropped 295.85 points, or 1.92%, to 15,085.47.</p>\n<p>The S&P, the Dow and the Nasdaq all registered declines for a week in which they swung wildly from day to day as investors reacted to Omicron news and Powell's comments.</p>\n<p>The S&P's decline of 1.2% was its second weekly decline in a row while the Nasdaq fell 2.62%, also its second straight week of losses. The Dow dropped 0.92% in its fourth consecutive weekly decline.</p>\n<p>In a clear indication of investor nerves, Wall Street's fear gauge, the CBOE Market Volatility index, went above 35, in afternoon trading, for the first time since late January. It pared some gains however to close up 9.7 points at 30.67.</p>\n<p>Meanwhile the S&P sector outperformers were defensive sectors consumer staples, closing up 1.4% and utilities, adding 1%, followed by healthcare, which climbed 0.25%.</p>\n<p>By the end of the session, consumer discretionary, down 1.8%, was the biggest loser, followed by technology , which fell 1.65%.</p>\n<p>Decliners included heavyweights such as Tesla, down 6%, and Nvidia, down 4% and both Apple Inc and Microsoft losing more than 1%.</p>\n<p>\"It's hard to argue that stocks with such huge valuations are defensive,\" said Interactive Brokers' Sosnick.</p>\n<p>And with large cap technology stocks having avoided a recent deterioration in the broader markets, Sosnick said: \"That's catching up to those stocks.\"</p>\n<p>The economically sensitive Dow fell less than its peers during the session while other cyclical sectors like industrials , materials also outperformed.</p>\n<p>DocuSign Inc closed down 42% after the electronic signature solutions firm forecast downbeat fourth-quarter revenue.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.68-to-1 ratio; on Nasdaq, a 3.39-to-1 ratio favored decliners.</p>\n<p>The S&P 500 posted 11 new 52-week highs and six new lows; the Nasdaq Composite recorded 15 new highs and 682 new lows.</p>\n<p>On U.S. exchanges 13.8 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions. (Reporting by Sinéad Carew in New York; Devik Jain, Anisha Sircar and Sruthi Shankar in Bengaluru; Editing by Marguerita Choy and Maju Samuel)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St ends lower on Omicron worries, Fed taper angst</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St ends lower on Omicron worries, Fed taper angst\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-04 05:43 GMT+8 <a href=https://finance.yahoo.com/news/us-stocks-wall-st-ends-214332016.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dec 3 (Reuters) - Wall Street's major indexes closed lower on Friday, with the Nasdaq leading the declines as investors bet that a strong jobs report would not slow the Federal Reserve's withdrawal of...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-st-ends-214332016.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4539":"次新股",".SPX":"S&P 500 Index","BK4079":"房地产服务",".DJI":"道琼斯","COMP":"Compass, Inc.",".IXIC":"NASDAQ Composite"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-st-ends-214332016.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2188853578","content_text":"Dec 3 (Reuters) - Wall Street's major indexes closed lower on Friday, with the Nasdaq leading the declines as investors bet that a strong jobs report would not slow the Federal Reserve's withdrawal of support all while they grappled with uncertainty around the Omicron coronavirus variant.\nAfter opening higher, Wall Street spent the rest of the session in the doldrums and an elevated volatility index highlighted investor anxiety.\nThe Labor Department's report, ahead of the session's open, showed that while nonfarm job growth rose less than expected in November, the unemployment rate dropped to 4.2%, its lowest since February 2020, and wages increased.\nSeparately, a measure of U.S. services industry activity hit a record high in November.\nBoth sets of data appeared to influence investor expectations for the Fed's next move towards tightening its policy. Fed Chair Jerome Powell said this week that the central bank will consider a faster wind-down of its bond-buying program, prompting speculation that interest rate hikes would also be brought forward.\n\"There's not enough in the jobs report to dissuade the Fed from accelerating the taper and (it) leaves the door open for a quicker rate hike than the market might have been anticipating,\" said Steve Sosnick, chief strategist at Interactive Brokers.\nOn top of this he pointed to concerns that the Omicron variant appeared to be spreading faster than Delta, the last most prevalent version of COVID-19.\nThe number of countries reporting Omicron cases kept rising on Friday but there was still little clarity on the severity of the disease or the level of protection provided by existing COVID-19 vaccines.\nThe Dow Jones Industrial Average fell 59.71 points, or 0.17%, to 34,580.08, the S&P 500 lost 38.67 points, or 0.84%, to 4,538.43 and the Nasdaq Composite dropped 295.85 points, or 1.92%, to 15,085.47.\nThe S&P, the Dow and the Nasdaq all registered declines for a week in which they swung wildly from day to day as investors reacted to Omicron news and Powell's comments.\nThe S&P's decline of 1.2% was its second weekly decline in a row while the Nasdaq fell 2.62%, also its second straight week of losses. The Dow dropped 0.92% in its fourth consecutive weekly decline.\nIn a clear indication of investor nerves, Wall Street's fear gauge, the CBOE Market Volatility index, went above 35, in afternoon trading, for the first time since late January. It pared some gains however to close up 9.7 points at 30.67.\nMeanwhile the S&P sector outperformers were defensive sectors consumer staples, closing up 1.4% and utilities, adding 1%, followed by healthcare, which climbed 0.25%.\nBy the end of the session, consumer discretionary, down 1.8%, was the biggest loser, followed by technology , which fell 1.65%.\nDecliners included heavyweights such as Tesla, down 6%, and Nvidia, down 4% and both Apple Inc and Microsoft losing more than 1%.\n\"It's hard to argue that stocks with such huge valuations are defensive,\" said Interactive Brokers' Sosnick.\nAnd with large cap technology stocks having avoided a recent deterioration in the broader markets, Sosnick said: \"That's catching up to those stocks.\"\nThe economically sensitive Dow fell less than its peers during the session while other cyclical sectors like industrials , materials also outperformed.\nDocuSign Inc closed down 42% after the electronic signature solutions firm forecast downbeat fourth-quarter revenue.\nDeclining issues outnumbered advancing ones on the NYSE by a 2.68-to-1 ratio; on Nasdaq, a 3.39-to-1 ratio favored decliners.\nThe S&P 500 posted 11 new 52-week highs and six new lows; the Nasdaq Composite recorded 15 new highs and 682 new lows.\nOn U.S. exchanges 13.8 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions. (Reporting by Sinéad Carew in New York; Devik Jain, Anisha Sircar and Sruthi Shankar in Bengaluru; Editing by Marguerita Choy and Maju Samuel)","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"COMP":0.9,"NQmain":0.9}},"isVote":1,"tweetType":1,"viewCount":533,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608322481,"gmtCreate":1638632009469,"gmtModify":1638632009635,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586429646894350","idStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608322481","repostId":"1174181873","repostType":4,"repost":{"id":"1174181873","kind":"news","pubTimestamp":1638578178,"share":"https://ttm.financial/m/news/1174181873?lang=&edition=full","pubTime":"2021-12-04 08:36","market":"us","language":"en","title":"US IPO Week Ahead: Digital banking and cloud infrastructure lead a 4 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1174181873","media":"renaissancecap...","summary":"The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billi","content":"<p>The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billion.</p>\n<p>Buffett-backed <b>Nu Holdings</b>(NU) plans to raise $2.5 billion at a $41.1 billion market cap. Operating as Nubank, this Brazilian online-only bank was formed in 2013 to launch a no-fees credit card offering with a mobile-first customer experience, but has since expanded to offer various other financial products. Nu has grown rapidly since its inception, with a current base of nearly 50 million customers, though revenue per customer has been falling as its base grows.</p>\n<p>Cloud infrastructure platform <b>HashiCorp</b>(HCP) plans to raise $1.1 billion at a $14.0 billion market cap. This VC-backed company provides a suite of solutions that standardize and automate the provisioning, securing, connecting, and running of cloud infrastructure at scale. While it has demonstrated rapid growth and a sticky customer base, HashiCorp is highly unprofitable due to S&M spend.</p>\n<p>Cannabis finance REIT <b>Chicago Atlantic Real Estate Finance</b>(REFI) plans to raise $106 million at a $296 million market cap. This newly-formed REIT is focused on originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties. Its current portfolio consists of senior loans to state-licensed operators in the cannabis industry.</p>\n<p>Canadian gold exploration company <b>Austin Gold</b>(AUST) plans to raise $15 million at a $64 million market cap. This Canadian gold exploration company currently has interests in four properties located in the state of Nevada, with just one property that it considers material at this time. Austin Gold has not generated any operating revenues to date.</p>","source":"lsy1619493174116","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: Digital banking and cloud infrastructure lead a 4 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: Digital banking and cloud infrastructure lead a 4 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-04 08:36 GMT+8 <a href=https://www.renaissancecapital.com/IPO-Center/News/89235/US-IPO-Week-Ahead-Digital-banking-and-cloud-infrastructure-lead-a-4-IPO-wee><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billion.\nBuffett-backed Nu Holdings(NU) plans to raise $2.5 billion at a $41.1 billion market cap. ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89235/US-IPO-Week-Ahead-Digital-banking-and-cloud-infrastructure-lead-a-4-IPO-wee\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HCP":"HashiCorp, Inc.","NU":"Nu Holdings Ltd.","REFI":"Chicago Atlantic Real Estate Finance, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89235/US-IPO-Week-Ahead-Digital-banking-and-cloud-infrastructure-lead-a-4-IPO-wee","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174181873","content_text":"The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billion.\nBuffett-backed Nu Holdings(NU) plans to raise $2.5 billion at a $41.1 billion market cap. Operating as Nubank, this Brazilian online-only bank was formed in 2013 to launch a no-fees credit card offering with a mobile-first customer experience, but has since expanded to offer various other financial products. Nu has grown rapidly since its inception, with a current base of nearly 50 million customers, though revenue per customer has been falling as its base grows.\nCloud infrastructure platform HashiCorp(HCP) plans to raise $1.1 billion at a $14.0 billion market cap. This VC-backed company provides a suite of solutions that standardize and automate the provisioning, securing, connecting, and running of cloud infrastructure at scale. While it has demonstrated rapid growth and a sticky customer base, HashiCorp is highly unprofitable due to S&M spend.\nCannabis finance REIT Chicago Atlantic Real Estate Finance(REFI) plans to raise $106 million at a $296 million market cap. This newly-formed REIT is focused on originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties. Its current portfolio consists of senior loans to state-licensed operators in the cannabis industry.\nCanadian gold exploration company Austin Gold(AUST) plans to raise $15 million at a $64 million market cap. This Canadian gold exploration company currently has interests in four properties located in the state of Nevada, with just one property that it considers material at this time. Austin Gold has not generated any operating revenues to date.","news_type":1,"symbols_score_info":{"HCP":0.9,"NU":0.9,"REFI":0.9}},"isVote":1,"tweetType":1,"viewCount":616,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601229198,"gmtCreate":1638537069067,"gmtModify":1638537069186,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586429646894350","idStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment ","listText":"Like and comment ","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601229198","repostId":"2188525803","repostType":4,"repost":{"id":"2188525803","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638536111,"share":"https://ttm.financial/m/news/2188525803?lang=&edition=full","pubTime":"2021-12-03 20:55","market":"us","language":"en","title":"Bank of Montreal beats profit estimates, raises dividend by 25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2188525803","media":"Reuters","summary":"TORONTO (Reuters) - Bank of Montreal closed out Canadian banks' results season with better-than-expe","content":"<p>TORONTO (Reuters) - Bank of Montreal closed out Canadian banks' results season with better-than-expected fourth-quarter earnings on Friday, as strong growth across all major businesses drove adjusted earnings up 38% from a year earlier, and lifted its dividend 25%.</p>\n<p>Canada's fourth-largest lender increased its dividend to C$1.33 from C$1.06 in prior quarters, and said it would buy back up to 22.5 million, or 3.5%, of outstanding shares.</p>\n<p>While BMO recovered loan-loss provisions of C$126 million ($98.19 million) during the three months ended Oct. 31, it posted strong growth even excluding that impact. Its net interest margin, excluding trading, dipped.</p>\n<p>Adjusted pre-tax, pre-provision earnings rose 15% in its Canadian banking business, 17% in the U.S., 29% in its wealth management unit and 28% in capital markets, with revenue across the bank up 10%.</p>\n<p>Adjusted non-interest expenses increased 6% from a year earlier, largely driven by higher employee-related costs, the bank said.</p>\n<p>Net income excluding <a href=\"https://laohu8.com/S/AONE.U\">one</a>-off items rose to C$2.23 billion ($1.77 billion), or C$3.33 per share, in the three months ended Oct. 31, compared with C$1.61 billion, or C$2.41 per share, a year earlier. Analysts had expected C$3.21 a share, according to IBES data from Refinitiv.</p>\n<p>($1 = 1.2832 Canadian dollars)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bank of Montreal beats profit estimates, raises dividend by 25%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBank of Montreal beats profit estimates, raises dividend by 25%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-03 20:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TORONTO (Reuters) - Bank of Montreal closed out Canadian banks' results season with better-than-expected fourth-quarter earnings on Friday, as strong growth across all major businesses drove adjusted earnings up 38% from a year earlier, and lifted its dividend 25%.</p>\n<p>Canada's fourth-largest lender increased its dividend to C$1.33 from C$1.06 in prior quarters, and said it would buy back up to 22.5 million, or 3.5%, of outstanding shares.</p>\n<p>While BMO recovered loan-loss provisions of C$126 million ($98.19 million) during the three months ended Oct. 31, it posted strong growth even excluding that impact. Its net interest margin, excluding trading, dipped.</p>\n<p>Adjusted pre-tax, pre-provision earnings rose 15% in its Canadian banking business, 17% in the U.S., 29% in its wealth management unit and 28% in capital markets, with revenue across the bank up 10%.</p>\n<p>Adjusted non-interest expenses increased 6% from a year earlier, largely driven by higher employee-related costs, the bank said.</p>\n<p>Net income excluding <a href=\"https://laohu8.com/S/AONE.U\">one</a>-off items rose to C$2.23 billion ($1.77 billion), or C$3.33 per share, in the three months ended Oct. 31, compared with C$1.61 billion, or C$2.41 per share, a year earlier. Analysts had expected C$3.21 a share, according to IBES data from Refinitiv.</p>\n<p>($1 = 1.2832 Canadian dollars)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4207":"综合性银行","BMO":"蒙特利尔银行"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188525803","content_text":"TORONTO (Reuters) - Bank of Montreal closed out Canadian banks' results season with better-than-expected fourth-quarter earnings on Friday, as strong growth across all major businesses drove adjusted earnings up 38% from a year earlier, and lifted its dividend 25%.\nCanada's fourth-largest lender increased its dividend to C$1.33 from C$1.06 in prior quarters, and said it would buy back up to 22.5 million, or 3.5%, of outstanding shares.\nWhile BMO recovered loan-loss provisions of C$126 million ($98.19 million) during the three months ended Oct. 31, it posted strong growth even excluding that impact. Its net interest margin, excluding trading, dipped.\nAdjusted pre-tax, pre-provision earnings rose 15% in its Canadian banking business, 17% in the U.S., 29% in its wealth management unit and 28% in capital markets, with revenue across the bank up 10%.\nAdjusted non-interest expenses increased 6% from a year earlier, largely driven by higher employee-related costs, the bank said.\nNet income excluding one-off items rose to C$2.23 billion ($1.77 billion), or C$3.33 per share, in the three months ended Oct. 31, compared with C$1.61 billion, or C$2.41 per share, a year earlier. Analysts had expected C$3.21 a share, according to IBES data from Refinitiv.\n($1 = 1.2832 Canadian dollars)","news_type":1,"symbols_score_info":{"BMO":0.9}},"isVote":1,"tweetType":1,"viewCount":723,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603711531,"gmtCreate":1638451901248,"gmtModify":1638451901400,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586429646894350","idStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/603711531","repostId":"2188159513","repostType":4,"repost":{"id":"2188159513","kind":"highlight","pubTimestamp":1638451583,"share":"https://ttm.financial/m/news/2188159513?lang=&edition=full","pubTime":"2021-12-02 21:26","market":"us","language":"en","title":"The omicron panic is overdone. Buy the dips in these stocks, says JPMorgan.","url":"https://stock-news.laohu8.com/highlight/detail?id=2188159513","media":"MarketWatch","summary":"Stock futures are pointing to a rebound, after reports of the first U.S. omicron coronavirus case cl","content":"<p></p>\n<p>Stock futures are pointing to a rebound, after reports of the first U.S. omicron coronavirus case clobbered Wall Street in a wild day of trading.</p>\n<p>For our <b>call of the day</b>, we’re back at the JPMorgan house, which suggested markets have been overreacting to the new variant. “What if ‘nu’ variant omicron ends up as positive for risk?” strategists asked, concluding that investors should be buying market dips among some key stocks. Note JPM recently released a fairly bullish outlook for stocks in 2022.</p>\n<p>“Over the last several days markets have been in turmoil over the new COVID variant omicron. However, data on omicron is sparse, information contradictory, and some media has been exaggerating risks and highlighting worst case scenarios,” chief global strategist Marko Kolanovic and quant strategist Bram Kaplan wrote in a note to clients.</p>\n<p>They pointed fingers at a “media blitz” on Thanksgiving evening, one of the lowest market liquidity points in a year, that sent growth-sensitive assets crashing. They took issue with a selloff sparked by Moderna’s CEO, who dashed hopes that current vaccines will work against omicron. They argued his comments have been “invalidated by reports from Pfizer, Oxford, the WHO and the Israeli Health Ministry.”</p>\n<p>Kolanovic and Kaplan said their clients are less worried about the variant and more about flight restrictions, which have included barring South African flights, but not European ones, where cases have also been spotted.</p>\n<p>They described assessments of omicron’s potential transmissibility as confusing at best. “In simple terms, when older variants are spreading via breakthrough infections, new variants will always appear to be significantly more transmissible than older ones.” They backed this up with a tweet by biomathemetician Gabriela Gomes.</p>\n<p>Early reports suggest it may be less deadly, and if confirmed in coming weeks, that could turn omicron into a positive for markets, said the pair. Kolanovic and Kaplan raised the possibility that a less severe and more contagious variant may crowd out more severe variants, potentially speeding up the end of the pandemic and turning it into more of a seasonal flu. That’s amid vaccines and a growing list of treatments to tackle COVID, said the strategists.</p>\n<p>“If the market were to anticipate that scenario — omicron could be a catalyst for steepening (not flattening) the yield curve, rotation from growth to value, selloff in COVID and lockdown beneficiaries and rally in reopening themes,” said the team.</p>\n<p>“Also, if that scenario were to happen, instead of skipping two letters and naming it omicron, the WHO could have skipped all the way to omega. As such, we view the recent selloff in these segments as an opportunity to buy the dip in cyclicals, commodities and reopening themes, and to position for higher bond yields and steepening,” said the bank’s strategists.</p>\n<p>Here’s hoping they’re right.</p>\n<p></p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The omicron panic is overdone. Buy the dips in these stocks, says JPMorgan.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe omicron panic is overdone. Buy the dips in these stocks, says JPMorgan.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-02 21:26 GMT+8 <a href=https://www.marketwatch.com/story/the-omicron-panic-is-overdone-buy-the-dips-in-these-stocks-says-jpmorgan-11638447971?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stock futures are pointing to a rebound, after reports of the first U.S. omicron coronavirus case clobbered Wall Street in a wild day of trading.\nFor our call of the day, we’re back at the JPMorgan ...</p>\n\n<a href=\"https://www.marketwatch.com/story/the-omicron-panic-is-overdone-buy-the-dips-in-these-stocks-says-jpmorgan-11638447971?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4547":"WSB热门概念","BK4505":"高瓴资本持仓","BK4515":"5G概念","AAPL":"苹果","BK4559":"巴菲特持仓","BK4504":"桥水持仓","BK4550":"红杉资本持仓","BK4507":"流媒体概念","BK4548":"巴美列捷福持仓","BK4170":"电脑硬件、储存设备及电脑周边","WMT":"沃尔玛","GME":"游戏驿站","BK4551":"寇图资本持仓","BK4155":"大卖场与超市","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","BK4501":"段永平概念","BK4553":"喜马拉雅资本持仓","BK4527":"明星科技股","BK4099":"汽车制造商","BK4534":"瑞士信贷持仓","BK4076":"电脑与电子产品零售","BK4555":"新能源车","BK4533":"AQR资本管理(全球第二大对冲基金)","TSLA":"特斯拉","BK4566":"资本集团"},"source_url":"https://www.marketwatch.com/story/the-omicron-panic-is-overdone-buy-the-dips-in-these-stocks-says-jpmorgan-11638447971?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188159513","content_text":"Stock futures are pointing to a rebound, after reports of the first U.S. omicron coronavirus case clobbered Wall Street in a wild day of trading.\nFor our call of the day, we’re back at the JPMorgan house, which suggested markets have been overreacting to the new variant. “What if ‘nu’ variant omicron ends up as positive for risk?” strategists asked, concluding that investors should be buying market dips among some key stocks. Note JPM recently released a fairly bullish outlook for stocks in 2022.\n“Over the last several days markets have been in turmoil over the new COVID variant omicron. However, data on omicron is sparse, information contradictory, and some media has been exaggerating risks and highlighting worst case scenarios,” chief global strategist Marko Kolanovic and quant strategist Bram Kaplan wrote in a note to clients.\nThey pointed fingers at a “media blitz” on Thanksgiving evening, one of the lowest market liquidity points in a year, that sent growth-sensitive assets crashing. They took issue with a selloff sparked by Moderna’s CEO, who dashed hopes that current vaccines will work against omicron. They argued his comments have been “invalidated by reports from Pfizer, Oxford, the WHO and the Israeli Health Ministry.”\nKolanovic and Kaplan said their clients are less worried about the variant and more about flight restrictions, which have included barring South African flights, but not European ones, where cases have also been spotted.\nThey described assessments of omicron’s potential transmissibility as confusing at best. “In simple terms, when older variants are spreading via breakthrough infections, new variants will always appear to be significantly more transmissible than older ones.” They backed this up with a tweet by biomathemetician Gabriela Gomes.\nEarly reports suggest it may be less deadly, and if confirmed in coming weeks, that could turn omicron into a positive for markets, said the pair. Kolanovic and Kaplan raised the possibility that a less severe and more contagious variant may crowd out more severe variants, potentially speeding up the end of the pandemic and turning it into more of a seasonal flu. That’s amid vaccines and a growing list of treatments to tackle COVID, said the strategists.\n“If the market were to anticipate that scenario — omicron could be a catalyst for steepening (not flattening) the yield curve, rotation from growth to value, selloff in COVID and lockdown beneficiaries and rally in reopening themes,” said the team.\n“Also, if that scenario were to happen, instead of skipping two letters and naming it omicron, the WHO could have skipped all the way to omega. As such, we view the recent selloff in these segments as an opportunity to buy the dip in cyclicals, commodities and reopening themes, and to position for higher bond yields and steepening,” said the bank’s strategists.\nHere’s hoping they’re right.","news_type":1,"symbols_score_info":{"AAPL":0.9,"END":0.9,"GME":0.9,"TSLA":0.9,"WE":0.9,"WMT":0.9}},"isVote":1,"tweetType":1,"viewCount":974,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603711278,"gmtCreate":1638451878518,"gmtModify":1638451878674,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586429646894350","idStr":"3586429646894350"},"themes":[],"htmlText":"Like and commenr","listText":"Like and commenr","text":"Like and commenr","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/603711278","repostId":"1125510270","repostType":4,"repost":{"id":"1125510270","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638452126,"share":"https://ttm.financial/m/news/1125510270?lang=&edition=full","pubTime":"2021-12-02 21:35","market":"us","language":"en","title":"Toplines Before US Market Open on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1125510270","media":"Tiger Newspress","summary":"U.S. stock futures mixed on Thursday, although increasing cases of the new Omicron coronavirus varia","content":"<p>U.S. stock futures mixed on Thursday, although increasing cases of the new Omicron coronavirus variant across the world continued to drive volatility in markets.</p>\n<p>At 8:35 a.m. ET, Dow e-minis were up 245 points, or 0.72%, S&P 500 e-minis were up 17 points, or 0.38%, and Nasdaq 100 e-minis were down 27 points, or 0.17%.</p>\n<p><img src=\"https://static.tigerbbs.com/2b46ba3e880fd83794b36ecb59d650af\" tg-width=\"402\" tg-height=\"183\" referrerpolicy=\"no-referrer\"></p>\n<p>Initial claims for unemployment insurance rose last week but held at levels consistent with how the job market looked before the Covid-19 pandemic devastated the U.S. jobs picture, the Labor Department reported Thursday.</p>\n<p>First-time filings for the week ended Nov. 27 totaled 222,000, less than the 240,000 Wall Street expected. That was higher than the 194,000 from the previous week, but that total, the lowest since 1969, was revised even lower from the initial 1999,000 reported.</p>\n<p>The totals are the product of heavy seasonal adjustments, though the unadjusted number was actually lower, at 211,896.</p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p><b>Grab</b> — Grab stock jumped 13% in premarket trading.Grab, Southeast Asia's biggest ride-hailing and food delivery firm,lists on Nasdaq on Thursday following its $40 billion merger with special-purpose acquisition company (SPAC) Altimeter Growth Corp.</p>\n<p><b>Snowflake</b> — The cloud data company's shares jumped more than 13.8% after the company reported quarterly results that beat revenue estimates. Snowflake also reported sales of $334 million during the third quarter, which exceeded the $306 million expected by analysts surveyed by Refinitiv.</p>\n<p><b>Apple</b> — Shares of Apple fell 2.5% after the company told some of its suppliers there could be slowing demand for iPhone 13 models, according to a report by Bloomberg. It previously expected the reduction in its initial production goal to be made up in 2022 but said that may not materialize now.</p>\n<p><b>Boeing</b>— Shares of the aircraft maker rose 5.5% after Bloomberg reported it’s in talks with the new owners of previously bankrupt Jet Airways about bringing its fleet of 11 planes to more than 100 in five years. Jet Airways made an order for 225 of Boeing’s 737 Max aircraft that it could revisit, a deal which would be worth more than $12 billion, according to the report.</p>\n<p><b>Signet Jewelers</b> — Shares of Signet Jewelers gained about 1.1% in the premarket after the company posted a better-than-expected earnings report. Signet notched a profit of $1.43 per share, 71 cents higher than the Refinitiv consensus estimate. Revenue also came in higher than projected. Signet raised its fiscal 2022 guidance.</p>\n<p><b>Five Below</b> — The retailer’s shares gained more than 11% after reporting quarterly results that beat on both earnings and revenue. It also reported an increase in comparable-store sales of 14.8%, smashing the estimates of 5.3%, according to Refinitiv.</p>\n<p><b>Okta</b> — Shares of the identity company added 3.5% following the company’s quarterly results. Okta brought in a quarterly loss of 7 cents per share, which is narrower than the 24 cents per share loss estimated by analysts. It also beat revenue estimates and issued fourth-quarter guidance above estimates.</p>\n<p><b>Lands’ End</b> — Lands’ End saw its shares sink more than 18% in early morning trading after reporting lower-than-expected third-quarter revenue. The apparel retailer posted revenue of $375.8 million versus the StreetAccount consensus estimate of $398 million. Lands’ End earned 22 cents per share, in line with projections. The company also issued fourth-quarter earnings and revenue guidance below expectations.</p>\n<p><b>Dollar General</b> — Dollar General shares fell 3.1% after the company revealed plans to open 1,000 Popshelf stores by the end of the 2025 fiscal year. The vision for Popshelf, aimed at wealthier suburban shoppers, was announced a year ago. There are currently 30 Popshelf stores in six states.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-02 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock futures mixed on Thursday, although increasing cases of the new Omicron coronavirus variant across the world continued to drive volatility in markets.</p>\n<p>At 8:35 a.m. ET, Dow e-minis were up 245 points, or 0.72%, S&P 500 e-minis were up 17 points, or 0.38%, and Nasdaq 100 e-minis were down 27 points, or 0.17%.</p>\n<p><img src=\"https://static.tigerbbs.com/2b46ba3e880fd83794b36ecb59d650af\" tg-width=\"402\" tg-height=\"183\" referrerpolicy=\"no-referrer\"></p>\n<p>Initial claims for unemployment insurance rose last week but held at levels consistent with how the job market looked before the Covid-19 pandemic devastated the U.S. jobs picture, the Labor Department reported Thursday.</p>\n<p>First-time filings for the week ended Nov. 27 totaled 222,000, less than the 240,000 Wall Street expected. That was higher than the 194,000 from the previous week, but that total, the lowest since 1969, was revised even lower from the initial 1999,000 reported.</p>\n<p>The totals are the product of heavy seasonal adjustments, though the unadjusted number was actually lower, at 211,896.</p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p><b>Grab</b> — Grab stock jumped 13% in premarket trading.Grab, Southeast Asia's biggest ride-hailing and food delivery firm,lists on Nasdaq on Thursday following its $40 billion merger with special-purpose acquisition company (SPAC) Altimeter Growth Corp.</p>\n<p><b>Snowflake</b> — The cloud data company's shares jumped more than 13.8% after the company reported quarterly results that beat revenue estimates. Snowflake also reported sales of $334 million during the third quarter, which exceeded the $306 million expected by analysts surveyed by Refinitiv.</p>\n<p><b>Apple</b> — Shares of Apple fell 2.5% after the company told some of its suppliers there could be slowing demand for iPhone 13 models, according to a report by Bloomberg. It previously expected the reduction in its initial production goal to be made up in 2022 but said that may not materialize now.</p>\n<p><b>Boeing</b>— Shares of the aircraft maker rose 5.5% after Bloomberg reported it’s in talks with the new owners of previously bankrupt Jet Airways about bringing its fleet of 11 planes to more than 100 in five years. Jet Airways made an order for 225 of Boeing’s 737 Max aircraft that it could revisit, a deal which would be worth more than $12 billion, according to the report.</p>\n<p><b>Signet Jewelers</b> — Shares of Signet Jewelers gained about 1.1% in the premarket after the company posted a better-than-expected earnings report. Signet notched a profit of $1.43 per share, 71 cents higher than the Refinitiv consensus estimate. Revenue also came in higher than projected. Signet raised its fiscal 2022 guidance.</p>\n<p><b>Five Below</b> — The retailer’s shares gained more than 11% after reporting quarterly results that beat on both earnings and revenue. It also reported an increase in comparable-store sales of 14.8%, smashing the estimates of 5.3%, according to Refinitiv.</p>\n<p><b>Okta</b> — Shares of the identity company added 3.5% following the company’s quarterly results. Okta brought in a quarterly loss of 7 cents per share, which is narrower than the 24 cents per share loss estimated by analysts. It also beat revenue estimates and issued fourth-quarter guidance above estimates.</p>\n<p><b>Lands’ End</b> — Lands’ End saw its shares sink more than 18% in early morning trading after reporting lower-than-expected third-quarter revenue. The apparel retailer posted revenue of $375.8 million versus the StreetAccount consensus estimate of $398 million. Lands’ End earned 22 cents per share, in line with projections. The company also issued fourth-quarter earnings and revenue guidance below expectations.</p>\n<p><b>Dollar General</b> — Dollar General shares fell 3.1% after the company revealed plans to open 1,000 Popshelf stores by the end of the 2025 fiscal year. The vision for Popshelf, aimed at wealthier suburban shoppers, was announced a year ago. There are currently 30 Popshelf stores in six states.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LE":"Lands End Inc",".SPX":"S&P 500 Index","SNOW":"Snowflake","BA":"波音","DG":"美国达乐公司",".DJI":"道琼斯","OKTA":"Okta Inc.","SIG":"西格内特珠宝",".IXIC":"NASDAQ Composite","GRAB":"Grab Holdings","FIVE":"Five Below","AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125510270","content_text":"U.S. stock futures mixed on Thursday, although increasing cases of the new Omicron coronavirus variant across the world continued to drive volatility in markets.\nAt 8:35 a.m. ET, Dow e-minis were up 245 points, or 0.72%, S&P 500 e-minis were up 17 points, or 0.38%, and Nasdaq 100 e-minis were down 27 points, or 0.17%.\n\nInitial claims for unemployment insurance rose last week but held at levels consistent with how the job market looked before the Covid-19 pandemic devastated the U.S. jobs picture, the Labor Department reported Thursday.\nFirst-time filings for the week ended Nov. 27 totaled 222,000, less than the 240,000 Wall Street expected. That was higher than the 194,000 from the previous week, but that total, the lowest since 1969, was revised even lower from the initial 1999,000 reported.\nThe totals are the product of heavy seasonal adjustments, though the unadjusted number was actually lower, at 211,896.\nStocks making the biggest moves premarket:\nGrab — Grab stock jumped 13% in premarket trading.Grab, Southeast Asia's biggest ride-hailing and food delivery firm,lists on Nasdaq on Thursday following its $40 billion merger with special-purpose acquisition company (SPAC) Altimeter Growth Corp.\nSnowflake — The cloud data company's shares jumped more than 13.8% after the company reported quarterly results that beat revenue estimates. Snowflake also reported sales of $334 million during the third quarter, which exceeded the $306 million expected by analysts surveyed by Refinitiv.\nApple — Shares of Apple fell 2.5% after the company told some of its suppliers there could be slowing demand for iPhone 13 models, according to a report by Bloomberg. It previously expected the reduction in its initial production goal to be made up in 2022 but said that may not materialize now.\nBoeing— Shares of the aircraft maker rose 5.5% after Bloomberg reported it’s in talks with the new owners of previously bankrupt Jet Airways about bringing its fleet of 11 planes to more than 100 in five years. Jet Airways made an order for 225 of Boeing’s 737 Max aircraft that it could revisit, a deal which would be worth more than $12 billion, according to the report.\nSignet Jewelers — Shares of Signet Jewelers gained about 1.1% in the premarket after the company posted a better-than-expected earnings report. Signet notched a profit of $1.43 per share, 71 cents higher than the Refinitiv consensus estimate. Revenue also came in higher than projected. Signet raised its fiscal 2022 guidance.\nFive Below — The retailer’s shares gained more than 11% after reporting quarterly results that beat on both earnings and revenue. It also reported an increase in comparable-store sales of 14.8%, smashing the estimates of 5.3%, according to Refinitiv.\nOkta — Shares of the identity company added 3.5% following the company’s quarterly results. Okta brought in a quarterly loss of 7 cents per share, which is narrower than the 24 cents per share loss estimated by analysts. It also beat revenue estimates and issued fourth-quarter guidance above estimates.\nLands’ End — Lands’ End saw its shares sink more than 18% in early morning trading after reporting lower-than-expected third-quarter revenue. The apparel retailer posted revenue of $375.8 million versus the StreetAccount consensus estimate of $398 million. Lands’ End earned 22 cents per share, in line with projections. The company also issued fourth-quarter earnings and revenue guidance below expectations.\nDollar General — Dollar General shares fell 3.1% after the company revealed plans to open 1,000 Popshelf stores by the end of the 2025 fiscal year. The vision for Popshelf, aimed at wealthier suburban shoppers, was announced a year ago. There are currently 30 Popshelf stores in six states.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"AAPL":0.9,"BA":0.9,"DG":0.9,"FIVE":0.9,"ESmain":0.9,"NQmain":0.9,"YMmain":0.9,"GRAB":0.9,"LE":0.9,"OKTA":0.9,"SIG":0.9,"SNOW":0.9}},"isVote":1,"tweetType":1,"viewCount":594,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609675925,"gmtCreate":1638283546171,"gmtModify":1638283546291,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586429646894350","idStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609675925","repostId":"1174359019","repostType":4,"repost":{"id":"1174359019","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638282153,"share":"https://ttm.financial/m/news/1174359019?lang=&edition=full","pubTime":"2021-11-30 22:22","market":"us","language":"en","title":"ImmunoGen Stock Soars On Positive Data From Ovarian Cancer Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1174359019","media":"Tiger Newspress","summary":"ImmunoGen shares soared 46% Tuesday after the cancer drug specialists said its ovarian cancer treatm","content":"<p>ImmunoGen shares soared 46% Tuesday after the cancer drug specialists said its ovarian cancer treatment met the primary goals of a late-stage study.</p>\n<p><img src=\"https://static.tigerbbs.com/77ef54f585fc3671ff475aa8ed50d2be\" tg-width=\"850\" tg-height=\"819\" referrerpolicy=\"no-referrer\"></p>\n<p>ImmunoGen said mirvetuximab, its treatment for patients with platinum-resistant ovarian cancer, performed well in a pivotal SORAYA trial. Mirvetuximab had a confirmed objective response rate (ORR) of 32.4%, the drugmaker said, with a duration of response of 5.9 months in the 106-person trial.</p>\n<p>ImmunoGen said the data would be submitted to the U.S. Food & Drug Administration as party of the agency's' Biologics License Application process in the first quarter of next year.</p>\n<p>\"This is an exciting moment, both for the field of ovarian cancer and for ImmunoGen, and the outcomes from SORAYA further validate our longstanding history of innovation in ADCs,\" said ECEO Mark Enyedy. \"We are moving forward expeditiously to complete the BLA for mirvetuximab, with the goal of submitting the application to FDA for accelerated approval in the first quarter of 2022. In parallel, commercial preparations are well underway to support the potential launch of mirvetuximab next year.\"</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ImmunoGen Stock Soars On Positive Data From Ovarian Cancer Drug Trial</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nImmunoGen Stock Soars On Positive Data From Ovarian Cancer Drug Trial\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-30 22:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>ImmunoGen shares soared 46% Tuesday after the cancer drug specialists said its ovarian cancer treatment met the primary goals of a late-stage study.</p>\n<p><img src=\"https://static.tigerbbs.com/77ef54f585fc3671ff475aa8ed50d2be\" tg-width=\"850\" tg-height=\"819\" referrerpolicy=\"no-referrer\"></p>\n<p>ImmunoGen said mirvetuximab, its treatment for patients with platinum-resistant ovarian cancer, performed well in a pivotal SORAYA trial. Mirvetuximab had a confirmed objective response rate (ORR) of 32.4%, the drugmaker said, with a duration of response of 5.9 months in the 106-person trial.</p>\n<p>ImmunoGen said the data would be submitted to the U.S. Food & Drug Administration as party of the agency's' Biologics License Application process in the first quarter of next year.</p>\n<p>\"This is an exciting moment, both for the field of ovarian cancer and for ImmunoGen, and the outcomes from SORAYA further validate our longstanding history of innovation in ADCs,\" said ECEO Mark Enyedy. \"We are moving forward expeditiously to complete the BLA for mirvetuximab, with the goal of submitting the application to FDA for accelerated approval in the first quarter of 2022. In parallel, commercial preparations are well underway to support the potential launch of mirvetuximab next year.\"</p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IMGN":"ImmunoGen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174359019","content_text":"ImmunoGen shares soared 46% Tuesday after the cancer drug specialists said its ovarian cancer treatment met the primary goals of a late-stage study.\n\nImmunoGen said mirvetuximab, its treatment for patients with platinum-resistant ovarian cancer, performed well in a pivotal SORAYA trial. Mirvetuximab had a confirmed objective response rate (ORR) of 32.4%, the drugmaker said, with a duration of response of 5.9 months in the 106-person trial.\nImmunoGen said the data would be submitted to the U.S. Food & Drug Administration as party of the agency's' Biologics License Application process in the first quarter of next year.\n\"This is an exciting moment, both for the field of ovarian cancer and for ImmunoGen, and the outcomes from SORAYA further validate our longstanding history of innovation in ADCs,\" said ECEO Mark Enyedy. \"We are moving forward expeditiously to complete the BLA for mirvetuximab, with the goal of submitting the application to FDA for accelerated approval in the first quarter of 2022. In parallel, commercial preparations are well underway to support the potential launch of mirvetuximab next year.\"","news_type":1,"symbols_score_info":{"IMGN":0.9}},"isVote":1,"tweetType":1,"viewCount":453,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609672501,"gmtCreate":1638283517660,"gmtModify":1638283517776,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586429646894350","idStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/609672501","repostId":"1137874601","repostType":4,"repost":{"id":"1137874601","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638283295,"share":"https://ttm.financial/m/news/1137874601?lang=&edition=full","pubTime":"2021-11-30 22:41","market":"us","language":"en","title":"Blockchain stocks climbed in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1137874601","media":"Tiger Newspress","summary":"Blockchain stocks climbed in morning trading.Riot Blockchain,Marathon Digital,Coinbase,Canaan and Th","content":"<p>Blockchain stocks climbed in morning trading.Riot Blockchain,Marathon Digital,Coinbase,Canaan and The9 rose about 2%.</p>\n<p><img src=\"https://static.tigerbbs.com/c7eb0aac146941578f4f85ad0dec90de\" tg-width=\"406\" tg-height=\"353\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Blockchain stocks climbed in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBlockchain stocks climbed in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-30 22:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Blockchain stocks climbed in morning trading.Riot Blockchain,Marathon Digital,Coinbase,Canaan and The9 rose about 2%.</p>\n<p><img src=\"https://static.tigerbbs.com/c7eb0aac146941578f4f85ad0dec90de\" tg-width=\"406\" tg-height=\"353\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RIOT":"Riot Platforms"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137874601","content_text":"Blockchain stocks climbed in morning trading.Riot Blockchain,Marathon Digital,Coinbase,Canaan and The9 rose about 2%.","news_type":1,"symbols_score_info":{"RIOT":0.9}},"isVote":1,"tweetType":1,"viewCount":546,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609672842,"gmtCreate":1638283503893,"gmtModify":1638283504040,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586429646894350","idStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609672842","repostId":"1167187587","repostType":4,"repost":{"id":"1167187587","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638282732,"share":"https://ttm.financial/m/news/1167187587?lang=&edition=full","pubTime":"2021-11-30 22:32","market":"us","language":"en","title":"Stocks open lower as investors assess omicron concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1167187587","media":"Tiger Newspress","summary":"Stocks tumbled on Tuesday, reversing Monday's rebound on Wall Street, as investors reassessed risks ","content":"<p>Stocks tumbled on Tuesday, reversing Monday's rebound on Wall Street, as investors reassessed risks associated with the new omicron Covid variant.</p>\n<p>The Dow Jones Industrial Average dropped about 290 points, or 0.8%. The S&P 500 shed 0.64%. The technology-heavy Nasdaq Composite shed about 0.4%. The small-cap benchmark Russell 2000 dropped 0.7%.</p>\n<p><img src=\"https://static.tigerbbs.com/078050fb74fa44676c309ee766ee815d\" tg-width=\"1080\" tg-height=\"472\" referrerpolicy=\"no-referrer\"></p>\n<p>Tuesday's reversal came after Moderna CEO Stephane Bancel told the Financial Times that he expects existing vaccines to be less effective against the new variant. The CEO told the paper there could be a \"material drop\" in the current vaccines' effectiveness against this variant. Bancel told CNBC on Monday that it could take months to develop and ship an omicron-specific vaccine. Moderna was down nearly 4%.</p>\n<p>Separately,Regeneron said its antibody treatment may have reduced effectiveness against omicron. Regeneron shares lost about 1%.</p>\n<p>Travel shares, which led Friday's drop and then gained on Monday, were taking hits once again Tuesday.Expedia Group fell 2%,Norwegian Cruise Line Holdings and American Airlines shares tumbled about 2%.</p>\n<p>Bucking the broader market's trend, stay-at-home stock Netflix rose 1.4% and Tesla gained 1.5%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks open lower as investors assess omicron concerns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks open lower as investors assess omicron concerns\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-30 22:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Stocks tumbled on Tuesday, reversing Monday's rebound on Wall Street, as investors reassessed risks associated with the new omicron Covid variant.</p>\n<p>The Dow Jones Industrial Average dropped about 290 points, or 0.8%. The S&P 500 shed 0.64%. The technology-heavy Nasdaq Composite shed about 0.4%. The small-cap benchmark Russell 2000 dropped 0.7%.</p>\n<p><img src=\"https://static.tigerbbs.com/078050fb74fa44676c309ee766ee815d\" tg-width=\"1080\" tg-height=\"472\" referrerpolicy=\"no-referrer\"></p>\n<p>Tuesday's reversal came after Moderna CEO Stephane Bancel told the Financial Times that he expects existing vaccines to be less effective against the new variant. The CEO told the paper there could be a \"material drop\" in the current vaccines' effectiveness against this variant. Bancel told CNBC on Monday that it could take months to develop and ship an omicron-specific vaccine. Moderna was down nearly 4%.</p>\n<p>Separately,Regeneron said its antibody treatment may have reduced effectiveness against omicron. Regeneron shares lost about 1%.</p>\n<p>Travel shares, which led Friday's drop and then gained on Monday, were taking hits once again Tuesday.Expedia Group fell 2%,Norwegian Cruise Line Holdings and American Airlines shares tumbled about 2%.</p>\n<p>Bucking the broader market's trend, stay-at-home stock Netflix rose 1.4% and Tesla gained 1.5%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167187587","content_text":"Stocks tumbled on Tuesday, reversing Monday's rebound on Wall Street, as investors reassessed risks associated with the new omicron Covid variant.\nThe Dow Jones Industrial Average dropped about 290 points, or 0.8%. The S&P 500 shed 0.64%. The technology-heavy Nasdaq Composite shed about 0.4%. The small-cap benchmark Russell 2000 dropped 0.7%.\n\nTuesday's reversal came after Moderna CEO Stephane Bancel told the Financial Times that he expects existing vaccines to be less effective against the new variant. The CEO told the paper there could be a \"material drop\" in the current vaccines' effectiveness against this variant. Bancel told CNBC on Monday that it could take months to develop and ship an omicron-specific vaccine. Moderna was down nearly 4%.\nSeparately,Regeneron said its antibody treatment may have reduced effectiveness against omicron. Regeneron shares lost about 1%.\nTravel shares, which led Friday's drop and then gained on Monday, were taking hits once again Tuesday.Expedia Group fell 2%,Norwegian Cruise Line Holdings and American Airlines shares tumbled about 2%.\nBucking the broader market's trend, stay-at-home stock Netflix rose 1.4% and Tesla gained 1.5%.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":336,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600194970,"gmtCreate":1638082039019,"gmtModify":1638082039197,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586429646894350","idStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment ","listText":"Like and comment ","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/600194970","repostId":"2186328547","repostType":4,"repost":{"id":"2186328547","kind":"highlight","pubTimestamp":1638069455,"share":"https://ttm.financial/m/news/2186328547?lang=&edition=full","pubTime":"2021-11-28 11:17","market":"us","language":"en","title":"Google, Dell Lead Five Diverse Stocks Near Buy Points","url":"https://stock-news.laohu8.com/highlight/detail?id=2186328547","media":"ADELIA CELLINI LINECKER","summary":"Google leads five stocks to watch this week around buy points. It's on IBD Leaderboard, Long-Term Leaders and the IBD 50.","content":"<p>Google parent <b>Alphabet</b>, computer maker <b>Dell Technologies</b>, steelmaker <b>Nucor</b>, Chip-equipment maker <b>Lam Research</b> and rental-home investor <b>Invitation Homes</b> are five stocks to watch this week near buy points.</p>\n<p>The recent plunges in many hot software stocks amid renewed sector rotation underscores the importance of having diversified leaders in your portfolio. But with the market selling off sharply Friday, this time led by energy and financial stocks, investors should be cautious about new buys.</p>\n<p>Google, Nucor stock and Invitation Homes have pulled back modestly below buy points. Dell stock has bounced from its 50-day line, and Lam Research is closing in on a buy point.</p>\n<p>Google stock and Nucor are on IBD Leaderboard. GOOGL stock also is on IBD Long-Term Leaders and the IBD 50. Dell is on SwingTrader.</p>\n<h2><b>Google Stock</b></h2>\n<p>Shares fell 4.5% to 2,845.64 in last week's stock market trading. Google stock closed just below its 50-day line and 10-week moving average. Shares have retreated modestly below a flat-base buy point of 2,925.17, according to MarketSmith. An alternate entry would be 3,019.43 from a four-weeks-tight pattern.</p>\n<p>Investors could use a rebound off the 50-day/10-week line as a possible entry. That's a good place to buy Long-Term Leaders stocks such as GOOGL.</p>\n<p>Google's relative strength line is going sideways, but is still near all-time highs. Its RS Rating is 88 out of a possible 99, while its EPS Rating is 98.</p>\n<p>Google beat Wall Street estimates for the third quarter. It had EPS of $27.99 vs. views for $23.48. Sales came in at $65.12 billion vs. estimates of $63.34 billion.</p>\n<p>In a call with investors on Oct. 26, CEO Ruth Porat said Apple's privacy settings changes, which now ask iPhone users for explicit permission to track them, had a modest impact on YouTube revenue.</p>\n<p>Google's ad revenue climbed 43% to $53.13 billion. That's up from $37.1 billion in the year-ago period and slightly higher than the prior quarter. YouTube ads rose to $7.21 billion, up from $5.04 billion last year.</p>\n<h2><b>Dell Stock</b></h2>\n<p>Dell stock rose 2.1% to 56.18 last week. Shares now have a flat base with a 58.53 buy point. Dell stock bounced from its 50-day line on Thursday, flashing an early buy signal on strong earnings. But shares pulled back modestly Friday. Investors might now want to wait for Dell to get above Thursday's high of 58, or simply wait for a breakout.</p>\n<p>On Nov. 23, Dell reported third-quarter earnings of $2.37 a share, a year-over-year increase of 17%, on a 21% jump in sales to $28.39 billion, both above analyst views. </p>\n<p>It was Dell's best third quarter in its history, driven by growth in all business units, customer segments and geographies, as well as broad strength across commercial PCs, servers and storage, the company said in a written statement.</p>\n<p>Dell was Wednesday's IBD Stock Of The Day.</p>\n<p>Meanwhile, rival <b>HP</b> gapped out of a base Wednesday on its earnings.</p>\n<h2><b>Nucor Stock</b></h2>\n<p>Shares rose 1% last week to 113.98. Nucor stock broke out past a cup-with-handle buy point of 119.42 on Nov. 22, but gave up most of that day's 6% gain by Friday's close. Its relative strength line is ticking downward but still near multiyear highs. Its RS Rating is 93, while its EPS Rating is 96.</p>\n<p>Steelmakers like Nucor have a had a stellar year supplying homebuilders in a record year and gearing up for massive infrastructure spending. IBD's Steel-Producers industry group has soared nearly 86% year to date.</p>\n<p>Nucor has had four straight quarters of triple-digit earnings growth and four quarters in a row of accelerating sales growth.</p>\n<p>Rival <b><a href=\"https://laohu8.com/S/STLD\">Steel Dynamics</a></b> broke out past a cup-with-handle buy point of 69.01 intraday on Nov. 22, but has since fallen below that buy point.</p>\n<h2><b>Invitation Homes Stock</b></h2>\n<p>INVH stock broke out past a cup-with-handle buy point of 41.93 on Nov. 24, but retreated just below it on Friday. INVH stock edged up 0.6% to 41.15 for the week.</p>\n<p>Invitation Homes has an RS Rating of 93 and an EPS Rating of 96.</p>\n<p>The recent housing boom isn't just helping homebuilders. As raw materials prices spike up and supplies remain tight, folks are delaying home buying or renting homes while renovations and new homes take longer to complete. That's pushed up rents across the board.</p>\n<p>As a result, Invitation Homes, the largest owner of rental homes in the U.S., has seen soaring demand. The company, a real estate investment trust, or REIT, owns more than 80,000 homes, which it rents out.</p>\n<p>In October, Invitation Homes reported better-than-expected Q3 results. The company was able to raise rents by 11% amid the housing shortage.</p>\n<h2><b>Lam Research Stock</b></h2>\n<p>Shares pulled back late last week, perhaps starting work on a handle. Chip-equipment maker Lam Research has been steadily moving toward a 673.90 buy point from a consolidation going back to early June or April. </p>\n<p>Its relative strength line is rising again after several months of sideways movement. Lam's RS Rating is 80, while its EPS Rating is 94. The company has posted seven straight quarters of earnings and revenue growth, amid sky-high demand for its products across all industries.</p>","source":"lsy1610449120050","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Google, Dell Lead Five Diverse Stocks Near Buy Points</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoogle, Dell Lead Five Diverse Stocks Near Buy Points\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-28 11:17 GMT+8 <a href=https://www.investors.com/news/google-dell-lead-five-diverse-stocks-near-buy-points/?src=A00519A=aflTigerBrokers><strong>ADELIA CELLINI LINECKER</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Google parent Alphabet, computer maker Dell Technologies, steelmaker Nucor, Chip-equipment maker Lam Research and rental-home investor Invitation Homes are five stocks to watch this week near buy ...</p>\n\n<a href=\"https://www.investors.com/news/google-dell-lead-five-diverse-stocks-near-buy-points/?src=A00519A=aflTigerBrokers\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DELL":"戴尔","INVH":"Invitation Homes Inc.","GOOG":"谷歌","LRCX":"拉姆研究","NUE":"纽柯钢铁"},"source_url":"https://www.investors.com/news/google-dell-lead-five-diverse-stocks-near-buy-points/?src=A00519A=aflTigerBrokers","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186328547","content_text":"Google parent Alphabet, computer maker Dell Technologies, steelmaker Nucor, Chip-equipment maker Lam Research and rental-home investor Invitation Homes are five stocks to watch this week near buy points.\nThe recent plunges in many hot software stocks amid renewed sector rotation underscores the importance of having diversified leaders in your portfolio. But with the market selling off sharply Friday, this time led by energy and financial stocks, investors should be cautious about new buys.\nGoogle, Nucor stock and Invitation Homes have pulled back modestly below buy points. Dell stock has bounced from its 50-day line, and Lam Research is closing in on a buy point.\nGoogle stock and Nucor are on IBD Leaderboard. GOOGL stock also is on IBD Long-Term Leaders and the IBD 50. Dell is on SwingTrader.\nGoogle Stock\nShares fell 4.5% to 2,845.64 in last week's stock market trading. Google stock closed just below its 50-day line and 10-week moving average. Shares have retreated modestly below a flat-base buy point of 2,925.17, according to MarketSmith. An alternate entry would be 3,019.43 from a four-weeks-tight pattern.\nInvestors could use a rebound off the 50-day/10-week line as a possible entry. That's a good place to buy Long-Term Leaders stocks such as GOOGL.\nGoogle's relative strength line is going sideways, but is still near all-time highs. Its RS Rating is 88 out of a possible 99, while its EPS Rating is 98.\nGoogle beat Wall Street estimates for the third quarter. It had EPS of $27.99 vs. views for $23.48. Sales came in at $65.12 billion vs. estimates of $63.34 billion.\nIn a call with investors on Oct. 26, CEO Ruth Porat said Apple's privacy settings changes, which now ask iPhone users for explicit permission to track them, had a modest impact on YouTube revenue.\nGoogle's ad revenue climbed 43% to $53.13 billion. That's up from $37.1 billion in the year-ago period and slightly higher than the prior quarter. YouTube ads rose to $7.21 billion, up from $5.04 billion last year.\nDell Stock\nDell stock rose 2.1% to 56.18 last week. Shares now have a flat base with a 58.53 buy point. Dell stock bounced from its 50-day line on Thursday, flashing an early buy signal on strong earnings. But shares pulled back modestly Friday. Investors might now want to wait for Dell to get above Thursday's high of 58, or simply wait for a breakout.\nOn Nov. 23, Dell reported third-quarter earnings of $2.37 a share, a year-over-year increase of 17%, on a 21% jump in sales to $28.39 billion, both above analyst views. \nIt was Dell's best third quarter in its history, driven by growth in all business units, customer segments and geographies, as well as broad strength across commercial PCs, servers and storage, the company said in a written statement.\nDell was Wednesday's IBD Stock Of The Day.\nMeanwhile, rival HP gapped out of a base Wednesday on its earnings.\nNucor Stock\nShares rose 1% last week to 113.98. Nucor stock broke out past a cup-with-handle buy point of 119.42 on Nov. 22, but gave up most of that day's 6% gain by Friday's close. Its relative strength line is ticking downward but still near multiyear highs. Its RS Rating is 93, while its EPS Rating is 96.\nSteelmakers like Nucor have a had a stellar year supplying homebuilders in a record year and gearing up for massive infrastructure spending. IBD's Steel-Producers industry group has soared nearly 86% year to date.\nNucor has had four straight quarters of triple-digit earnings growth and four quarters in a row of accelerating sales growth.\nRival Steel Dynamics broke out past a cup-with-handle buy point of 69.01 intraday on Nov. 22, but has since fallen below that buy point.\nInvitation Homes Stock\nINVH stock broke out past a cup-with-handle buy point of 41.93 on Nov. 24, but retreated just below it on Friday. INVH stock edged up 0.6% to 41.15 for the week.\nInvitation Homes has an RS Rating of 93 and an EPS Rating of 96.\nThe recent housing boom isn't just helping homebuilders. As raw materials prices spike up and supplies remain tight, folks are delaying home buying or renting homes while renovations and new homes take longer to complete. That's pushed up rents across the board.\nAs a result, Invitation Homes, the largest owner of rental homes in the U.S., has seen soaring demand. The company, a real estate investment trust, or REIT, owns more than 80,000 homes, which it rents out.\nIn October, Invitation Homes reported better-than-expected Q3 results. The company was able to raise rents by 11% amid the housing shortage.\nLam Research Stock\nShares pulled back late last week, perhaps starting work on a handle. Chip-equipment maker Lam Research has been steadily moving toward a 673.90 buy point from a consolidation going back to early June or April. \nIts relative strength line is rising again after several months of sideways movement. Lam's RS Rating is 80, while its EPS Rating is 94. The company has posted seven straight quarters of earnings and revenue growth, amid sky-high demand for its products across all industries.","news_type":1,"symbols_score_info":{"DELL":0.9,"GOOG":0.9,"INVH":0.9,"LRCX":0.9,"NUE":0.9}},"isVote":1,"tweetType":1,"viewCount":499,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":876491164,"gmtCreate":1637336194547,"gmtModify":1637336194919,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586429646894350","authorIdStr":"3586429646894350"},"themes":[],"htmlText":"Liked","listText":"Liked","text":"Liked","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/876491164","repostId":"1114542201","repostType":4,"repost":{"id":"1114542201","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637335740,"share":"https://ttm.financial/m/news/1114542201?lang=&edition=full","pubTime":"2021-11-19 23:29","market":"us","language":"en","title":"Boeing Dreamliner Defects Bog Down Production","url":"https://stock-news.laohu8.com/highlight/detail?id=1114542201","media":"Tiger Newspress","summary":"Boeing stock dropped 4% in morning trading as Boeing Dreamliner defected bog down production.\n\nBoein","content":"<p>Boeing stock dropped 4% in morning trading as Boeing Dreamliner defected bog down production.</p>\n<p><img src=\"https://static.tigerbbs.com/3c6c1e62a6a6a253da601f54af830508\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Boeing Co. has further slowed production of 787 Dreamliners as it addresses defects that are delaying deliveries of new jets and complicating airlines’ plans, people familiar with the matter said.</p>\n<p>The plane maker is holding off completing the new wide-body jets at its North Charleston, S.C., factory as workers and engineers address problems related to areas surrounding passenger and cargo doors on aircraft already under construction, these people said.</p>\n<p>The latest production slowdown began in recent days and could last a few weeks as Boeing seeks expertise from other aerospace manufacturers in addressing the door issue, some of these people said. In late October, Boeing disclosed it was producing about two Dreamliners a month, down from a planned monthly rate of five,to resolve production issues.</p>\n<p>A string of production snafus has hampered Boeing’s ability to deliver new Dreamliners for much of the last year, fueling the manufacturer’s financial losses and making it difficult for airlines to build schedules for jets often used in international travel. The plane maker has faced increased scrutiny internally, by air-safety regulators and lawmakers after two of its 737 MAX jets crashed in 2018 and 2019, claiming 346 lives.</p>\n<p>A Boeing spokeswoman said work continues at its Dreamliner factory and production “rates will continue to be dynamic” as the manufacturer focuses on resuming normal assembly, performs inspections and repairs finished aircraft awaiting delivery.</p>\n<p>Boeing is increasingly likely to restart handing over new Dreamliners to its customers in February or March at the earliest, longer than previously anticipated, people familiar with the matter said.</p>\n<p>The company has been seeking Federal Aviation Administration approval for its proposed pre-delivery inspections to ensure new aircraft meet federal rules and match Boeing’s regulator-approved designs. An FAA spokesman said the agency won’t sign off on inspections until its safety experts are satisfied.</p>\n<p>“This is a case of us looking at every single aspect of design and manufacturing with the airplane, making sure that we’re complying, we’re conforming to the design and we will bring that airplane back as soon as that makes sense,” Ihssane Mounir, Boeing’s commercial sales chief, said Nov. 13 at an air show in Dubai.</p>\n<p>In an Oct. 27 call with analysts, Chief Executive David Calhoun said defective titanium parts were the “long pole in the tent” among remaining production problems to address.</p>\n<p>The door issue has since emerged as the most vexing among Boeing’s 787 problems, people familiar with the matter said. Other defects being addressed are related to items such as certain aluminum parts and windows, some of these people said. Boeing has largely been dealing with tiny gaps where sections of the aircraft join together. Such gaps could lead to premature fatigue that may require repairs sooner than anticipated.</p>\n<p>The Boeing spokeswoman said the company is confident its approach would lead to stability in its 787 production. “We are taking the time needed to ensure the highest levels of quality,” she said.</p>\n<p>None of the defects being addressed pose immediate safety concerns with Dreamliners currently flying, the Boeing spokeswoman said.</p>\n<p>With deliveries largely halted since October 2020, the Chicago-based aerospace giant said it had built up an inventory of 105 Dreamliners as of the end of the third quarter this year, according to securities filings. The undelivered jets are worth more than $25 billion.</p>\n<p>The delivery halt has choked off an important source of cash flow for Boeing as it emerges from the coronavirus pandemic’s blow to aircraft demand. It is also complicating airlines’ plans as international travel rebounds. Dreamliners are Boeing’s flagship wide-body jets and are often used on long-haul flights.</p>\n<p>American Airlines Group Inc. said it had trimmed its flying plans due to the delayed arrival of its new 787s.</p>\n<p>“Due to the continued uncertainty in the delivery schedule, we have proactively removed these aircraft from our winter schedule to minimize potential passenger disruption,” Derek Kerr, the airline’s finance chief, said on an Oct. 21 earnings call.</p>\n<p>The FAA launched a broad review of Boeing’s Dreamliner production in late 2020.</p>\n<p>On Thursday, Democratic and Republican leaders of the U.S. House Transportation Committee and its aviation subcommittee requested that the Department of Transportation’s inspector general review the FAA’s manufacturing oversight and “the effectiveness of the FAA’s actions to resolve 787 production issues,” according to a letter reviewed by The Wall Street Journal.</p>\n<p>Representatives of the DOT’s inspector general’s office didn’t immediately respond to requests for comment.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Boeing Dreamliner Defects Bog Down Production</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBoeing Dreamliner Defects Bog Down Production\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-19 23:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Boeing stock dropped 4% in morning trading as Boeing Dreamliner defected bog down production.</p>\n<p><img src=\"https://static.tigerbbs.com/3c6c1e62a6a6a253da601f54af830508\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Boeing Co. has further slowed production of 787 Dreamliners as it addresses defects that are delaying deliveries of new jets and complicating airlines’ plans, people familiar with the matter said.</p>\n<p>The plane maker is holding off completing the new wide-body jets at its North Charleston, S.C., factory as workers and engineers address problems related to areas surrounding passenger and cargo doors on aircraft already under construction, these people said.</p>\n<p>The latest production slowdown began in recent days and could last a few weeks as Boeing seeks expertise from other aerospace manufacturers in addressing the door issue, some of these people said. In late October, Boeing disclosed it was producing about two Dreamliners a month, down from a planned monthly rate of five,to resolve production issues.</p>\n<p>A string of production snafus has hampered Boeing’s ability to deliver new Dreamliners for much of the last year, fueling the manufacturer’s financial losses and making it difficult for airlines to build schedules for jets often used in international travel. The plane maker has faced increased scrutiny internally, by air-safety regulators and lawmakers after two of its 737 MAX jets crashed in 2018 and 2019, claiming 346 lives.</p>\n<p>A Boeing spokeswoman said work continues at its Dreamliner factory and production “rates will continue to be dynamic” as the manufacturer focuses on resuming normal assembly, performs inspections and repairs finished aircraft awaiting delivery.</p>\n<p>Boeing is increasingly likely to restart handing over new Dreamliners to its customers in February or March at the earliest, longer than previously anticipated, people familiar with the matter said.</p>\n<p>The company has been seeking Federal Aviation Administration approval for its proposed pre-delivery inspections to ensure new aircraft meet federal rules and match Boeing’s regulator-approved designs. An FAA spokesman said the agency won’t sign off on inspections until its safety experts are satisfied.</p>\n<p>“This is a case of us looking at every single aspect of design and manufacturing with the airplane, making sure that we’re complying, we’re conforming to the design and we will bring that airplane back as soon as that makes sense,” Ihssane Mounir, Boeing’s commercial sales chief, said Nov. 13 at an air show in Dubai.</p>\n<p>In an Oct. 27 call with analysts, Chief Executive David Calhoun said defective titanium parts were the “long pole in the tent” among remaining production problems to address.</p>\n<p>The door issue has since emerged as the most vexing among Boeing’s 787 problems, people familiar with the matter said. Other defects being addressed are related to items such as certain aluminum parts and windows, some of these people said. Boeing has largely been dealing with tiny gaps where sections of the aircraft join together. Such gaps could lead to premature fatigue that may require repairs sooner than anticipated.</p>\n<p>The Boeing spokeswoman said the company is confident its approach would lead to stability in its 787 production. “We are taking the time needed to ensure the highest levels of quality,” she said.</p>\n<p>None of the defects being addressed pose immediate safety concerns with Dreamliners currently flying, the Boeing spokeswoman said.</p>\n<p>With deliveries largely halted since October 2020, the Chicago-based aerospace giant said it had built up an inventory of 105 Dreamliners as of the end of the third quarter this year, according to securities filings. The undelivered jets are worth more than $25 billion.</p>\n<p>The delivery halt has choked off an important source of cash flow for Boeing as it emerges from the coronavirus pandemic’s blow to aircraft demand. It is also complicating airlines’ plans as international travel rebounds. Dreamliners are Boeing’s flagship wide-body jets and are often used on long-haul flights.</p>\n<p>American Airlines Group Inc. said it had trimmed its flying plans due to the delayed arrival of its new 787s.</p>\n<p>“Due to the continued uncertainty in the delivery schedule, we have proactively removed these aircraft from our winter schedule to minimize potential passenger disruption,” Derek Kerr, the airline’s finance chief, said on an Oct. 21 earnings call.</p>\n<p>The FAA launched a broad review of Boeing’s Dreamliner production in late 2020.</p>\n<p>On Thursday, Democratic and Republican leaders of the U.S. House Transportation Committee and its aviation subcommittee requested that the Department of Transportation’s inspector general review the FAA’s manufacturing oversight and “the effectiveness of the FAA’s actions to resolve 787 production issues,” according to a letter reviewed by The Wall Street Journal.</p>\n<p>Representatives of the DOT’s inspector general’s office didn’t immediately respond to requests for comment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BA":"波音"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114542201","content_text":"Boeing stock dropped 4% in morning trading as Boeing Dreamliner defected bog down production.\n\nBoeing Co. has further slowed production of 787 Dreamliners as it addresses defects that are delaying deliveries of new jets and complicating airlines’ plans, people familiar with the matter said.\nThe plane maker is holding off completing the new wide-body jets at its North Charleston, S.C., factory as workers and engineers address problems related to areas surrounding passenger and cargo doors on aircraft already under construction, these people said.\nThe latest production slowdown began in recent days and could last a few weeks as Boeing seeks expertise from other aerospace manufacturers in addressing the door issue, some of these people said. In late October, Boeing disclosed it was producing about two Dreamliners a month, down from a planned monthly rate of five,to resolve production issues.\nA string of production snafus has hampered Boeing’s ability to deliver new Dreamliners for much of the last year, fueling the manufacturer’s financial losses and making it difficult for airlines to build schedules for jets often used in international travel. The plane maker has faced increased scrutiny internally, by air-safety regulators and lawmakers after two of its 737 MAX jets crashed in 2018 and 2019, claiming 346 lives.\nA Boeing spokeswoman said work continues at its Dreamliner factory and production “rates will continue to be dynamic” as the manufacturer focuses on resuming normal assembly, performs inspections and repairs finished aircraft awaiting delivery.\nBoeing is increasingly likely to restart handing over new Dreamliners to its customers in February or March at the earliest, longer than previously anticipated, people familiar with the matter said.\nThe company has been seeking Federal Aviation Administration approval for its proposed pre-delivery inspections to ensure new aircraft meet federal rules and match Boeing’s regulator-approved designs. An FAA spokesman said the agency won’t sign off on inspections until its safety experts are satisfied.\n“This is a case of us looking at every single aspect of design and manufacturing with the airplane, making sure that we’re complying, we’re conforming to the design and we will bring that airplane back as soon as that makes sense,” Ihssane Mounir, Boeing’s commercial sales chief, said Nov. 13 at an air show in Dubai.\nIn an Oct. 27 call with analysts, Chief Executive David Calhoun said defective titanium parts were the “long pole in the tent” among remaining production problems to address.\nThe door issue has since emerged as the most vexing among Boeing’s 787 problems, people familiar with the matter said. Other defects being addressed are related to items such as certain aluminum parts and windows, some of these people said. Boeing has largely been dealing with tiny gaps where sections of the aircraft join together. Such gaps could lead to premature fatigue that may require repairs sooner than anticipated.\nThe Boeing spokeswoman said the company is confident its approach would lead to stability in its 787 production. “We are taking the time needed to ensure the highest levels of quality,” she said.\nNone of the defects being addressed pose immediate safety concerns with Dreamliners currently flying, the Boeing spokeswoman said.\nWith deliveries largely halted since October 2020, the Chicago-based aerospace giant said it had built up an inventory of 105 Dreamliners as of the end of the third quarter this year, according to securities filings. The undelivered jets are worth more than $25 billion.\nThe delivery halt has choked off an important source of cash flow for Boeing as it emerges from the coronavirus pandemic’s blow to aircraft demand. It is also complicating airlines’ plans as international travel rebounds. Dreamliners are Boeing’s flagship wide-body jets and are often used on long-haul flights.\nAmerican Airlines Group Inc. said it had trimmed its flying plans due to the delayed arrival of its new 787s.\n“Due to the continued uncertainty in the delivery schedule, we have proactively removed these aircraft from our winter schedule to minimize potential passenger disruption,” Derek Kerr, the airline’s finance chief, said on an Oct. 21 earnings call.\nThe FAA launched a broad review of Boeing’s Dreamliner production in late 2020.\nOn Thursday, Democratic and Republican leaders of the U.S. House Transportation Committee and its aviation subcommittee requested that the Department of Transportation’s inspector general review the FAA’s manufacturing oversight and “the effectiveness of the FAA’s actions to resolve 787 production issues,” according to a letter reviewed by The Wall Street Journal.\nRepresentatives of the DOT’s inspector general’s office didn’t immediately respond to requests for comment.","news_type":1,"symbols_score_info":{"BA":0.9}},"isVote":1,"tweetType":1,"viewCount":386,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":157331326,"gmtCreate":1625564386065,"gmtModify":1633939605368,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586429646894350","authorIdStr":"3586429646894350"},"themes":[],"htmlText":"Comment n like","listText":"Comment n like","text":"Comment n like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/157331326","repostId":"2149351733","repostType":4,"repost":{"id":"2149351733","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1625564057,"share":"https://ttm.financial/m/news/2149351733?lang=&edition=full","pubTime":"2021-07-06 17:34","market":"sh","language":"en","title":"Hong Kong shares slip as healthcare stocks drop in line with mainland peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2149351733","media":"Reuters","summary":"* HK->Shanghai Connect daily quota used 3.7%, Shanghai->HK daily quota used 3.6%\n* HSI -0.3%, HSCE +","content":"<p>* HK->Shanghai Connect daily quota used 3.7%, Shanghai->HK daily quota used 3.6%</p>\n<p>* HSI -0.3%, HSCE +0.0%, CSI300 -0.1%</p>\n<p>* FTSE China A50 +0.3%</p>\n<p>July 6 (Reuters) - Hong Kong stocks closed lower on Tuesday, as healthcare firms slumped in line with their mainland peers on worries over lofty valuations.</p>\n<p>** At the close of trade, the Hang Seng index was down 70.64 points or 0.25%, at 28,072.86. The Hang Seng China Enterprises index fell 0.04% to 10,269.6.</p>\n<p>** The sub-index of the Hang Seng tracking energy shares dipped 0.1%, while the IT sector rose 0.62%, the financial sector ended 0.5% higher and the property sector dipped 0.27%.</p>\n<p>** The Hang Seng healthcare index fell the most, tumbling 5.1%, tracking losses in their mainland-listed peers, where the CSI300 healthcare index declined 3.8%.</p>\n<p>** Jinxin Fertility Group Ltd , <a href=\"https://laohu8.com/S/SFOSF\">Shanghai Fosun Pharmaceutical Group Co Ltd</a> , WuXi Biologics , and Hangzhou Tigermed Consulting slumped between 8.3% and 10.6%.</p>\n<p>** The top gainer on the Hang Seng was Haidilao International Holding Ltd , which gained 4.16%, while the biggest loser was WuXi Biologics (Cayman) Inc , which fell 8.41%.</p>\n<p>** The Hang Seng tech index extended decline to finish 0.9% lower, amid continued worries over regulations.</p>\n<p>** China's antitrust regulator is set to formally block Tencent Holdings Ltd's plan to merge the country's top two videogame streaming sites, Huya and DouYu , three people familiar with the matter told Reuters.</p>\n<p>** China's main Shanghai Composite index closed down 0.11% at 3,530.26 points, while the blue-chip CSI300 index ended down 0.05%.</p>\n<p>** Around the region, MSCI's Asia ex-Japan stock index was firmer by 0.06%, while Japan's Nikkei index closed up 0.16%.</p>\n<p>** The yuan was quoted at 6.4628 per U.S. dollar at 08:22, 0.02% firmer than the previous close of 6.4639.</p>\n<p>** At close, China's A-shares were trading at a premium of 39.53% over Hong Kong-listed H-shares.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong shares slip as healthcare stocks drop in line with mainland peers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong shares slip as healthcare stocks drop in line with mainland peers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-06 17:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* HK->Shanghai Connect daily quota used 3.7%, Shanghai->HK daily quota used 3.6%</p>\n<p>* HSI -0.3%, HSCE +0.0%, CSI300 -0.1%</p>\n<p>* FTSE China A50 +0.3%</p>\n<p>July 6 (Reuters) - Hong Kong stocks closed lower on Tuesday, as healthcare firms slumped in line with their mainland peers on worries over lofty valuations.</p>\n<p>** At the close of trade, the Hang Seng index was down 70.64 points or 0.25%, at 28,072.86. The Hang Seng China Enterprises index fell 0.04% to 10,269.6.</p>\n<p>** The sub-index of the Hang Seng tracking energy shares dipped 0.1%, while the IT sector rose 0.62%, the financial sector ended 0.5% higher and the property sector dipped 0.27%.</p>\n<p>** The Hang Seng healthcare index fell the most, tumbling 5.1%, tracking losses in their mainland-listed peers, where the CSI300 healthcare index declined 3.8%.</p>\n<p>** Jinxin Fertility Group Ltd , <a href=\"https://laohu8.com/S/SFOSF\">Shanghai Fosun Pharmaceutical Group Co Ltd</a> , WuXi Biologics , and Hangzhou Tigermed Consulting slumped between 8.3% and 10.6%.</p>\n<p>** The top gainer on the Hang Seng was Haidilao International Holding Ltd , which gained 4.16%, while the biggest loser was WuXi Biologics (Cayman) Inc , which fell 8.41%.</p>\n<p>** The Hang Seng tech index extended decline to finish 0.9% lower, amid continued worries over regulations.</p>\n<p>** China's antitrust regulator is set to formally block Tencent Holdings Ltd's plan to merge the country's top two videogame streaming sites, Huya and DouYu , three people familiar with the matter told Reuters.</p>\n<p>** China's main Shanghai Composite index closed down 0.11% at 3,530.26 points, while the blue-chip CSI300 index ended down 0.05%.</p>\n<p>** Around the region, MSCI's Asia ex-Japan stock index was firmer by 0.06%, while Japan's Nikkei index closed up 0.16%.</p>\n<p>** The yuan was quoted at 6.4628 per U.S. dollar at 08:22, 0.02% firmer than the previous close of 6.4639.</p>\n<p>** At close, China's A-shares were trading at a premium of 39.53% over Hong Kong-listed H-shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HUYA":"虎牙","HSI":"恒生指数","DOYU":"斗鱼","02601":"中国太保"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2149351733","content_text":"* HK->Shanghai Connect daily quota used 3.7%, Shanghai->HK daily quota used 3.6%\n* HSI -0.3%, HSCE +0.0%, CSI300 -0.1%\n* FTSE China A50 +0.3%\nJuly 6 (Reuters) - Hong Kong stocks closed lower on Tuesday, as healthcare firms slumped in line with their mainland peers on worries over lofty valuations.\n** At the close of trade, the Hang Seng index was down 70.64 points or 0.25%, at 28,072.86. The Hang Seng China Enterprises index fell 0.04% to 10,269.6.\n** The sub-index of the Hang Seng tracking energy shares dipped 0.1%, while the IT sector rose 0.62%, the financial sector ended 0.5% higher and the property sector dipped 0.27%.\n** The Hang Seng healthcare index fell the most, tumbling 5.1%, tracking losses in their mainland-listed peers, where the CSI300 healthcare index declined 3.8%.\n** Jinxin Fertility Group Ltd , Shanghai Fosun Pharmaceutical Group Co Ltd , WuXi Biologics , and Hangzhou Tigermed Consulting slumped between 8.3% and 10.6%.\n** The top gainer on the Hang Seng was Haidilao International Holding Ltd , which gained 4.16%, while the biggest loser was WuXi Biologics (Cayman) Inc , which fell 8.41%.\n** The Hang Seng tech index extended decline to finish 0.9% lower, amid continued worries over regulations.\n** China's antitrust regulator is set to formally block Tencent Holdings Ltd's plan to merge the country's top two videogame streaming sites, Huya and DouYu , three people familiar with the matter told Reuters.\n** China's main Shanghai Composite index closed down 0.11% at 3,530.26 points, while the blue-chip CSI300 index ended down 0.05%.\n** Around the region, MSCI's Asia ex-Japan stock index was firmer by 0.06%, while Japan's Nikkei index closed up 0.16%.\n** The yuan was quoted at 6.4628 per U.S. dollar at 08:22, 0.02% firmer than the previous close of 6.4639.\n** At close, China's A-shares were trading at a premium of 39.53% over Hong Kong-listed H-shares.","news_type":1,"symbols_score_info":{"02601":0.9,"DOYU":0.9,"HSI":0.9,"HUYA":0.9}},"isVote":1,"tweetType":1,"viewCount":380,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":873528829,"gmtCreate":1636964665442,"gmtModify":1636964665764,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586429646894350","authorIdStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/873528829","repostId":"2183046479","repostType":4,"isVote":1,"tweetType":1,"viewCount":448,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870486612,"gmtCreate":1636642310541,"gmtModify":1636642377713,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586429646894350","authorIdStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment ","listText":"Like and comment ","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/870486612","repostId":"1109019041","repostType":4,"repost":{"id":"1109019041","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636641593,"share":"https://ttm.financial/m/news/1109019041?lang=&edition=full","pubTime":"2021-11-11 22:39","market":"us","language":"en","title":"JD.com gained 5% as it crushed its Singles Day sales record","url":"https://stock-news.laohu8.com/highlight/detail?id=1109019041","media":"Tiger Newspress","summary":"JD.com rose more than 5% in morning trading alongside news that the company has pushed through its Singles Day sales volume record.The sales holiday had resulted in 311.4 billion yuan in transaction volume as of 2:09 p.m.; at that point there were several hours left in a now-extended Singles Day.Last year JD volume hit 271.5 billion yuan .As with Black Friday in the United States, Singles Day used to be a 24-hour sales event but has stretched out. JD offered a presale period from Oct. 20-Oct. 3","content":"<p>JD.com rose more than 5% in morning trading alongside news that the company has pushed through its Singles Day sales volume record.</p>\n<p><img src=\"https://static.tigerbbs.com/cc68187d9be6f6c7aef7c77122119d95\" tg-width=\"857\" tg-height=\"617\" referrerpolicy=\"no-referrer\"></p>\n<p>The sales holiday had resulted in 311.4 billion yuan (about $48.6 billion) in transaction volume as of 2:09 p.m.; at that point there were several hours left in a now-extended Singles Day.</p>\n<p>Last year JD volume hit 271.5 billion yuan (which doesn't directly translate into revenue as it's business transacted across its platforms).</p>\n<p>As with Black Friday in the United States, Singles Day used to be a 24-hour sales event but has stretched out. JD offered a presale period from Oct. 20-Oct. 31, one reason that it's easier to break records now.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JD.com gained 5% as it crushed its Singles Day sales record</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJD.com gained 5% as it crushed its Singles Day sales record\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-11 22:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>JD.com rose more than 5% in morning trading alongside news that the company has pushed through its Singles Day sales volume record.</p>\n<p><img src=\"https://static.tigerbbs.com/cc68187d9be6f6c7aef7c77122119d95\" tg-width=\"857\" tg-height=\"617\" referrerpolicy=\"no-referrer\"></p>\n<p>The sales holiday had resulted in 311.4 billion yuan (about $48.6 billion) in transaction volume as of 2:09 p.m.; at that point there were several hours left in a now-extended Singles Day.</p>\n<p>Last year JD volume hit 271.5 billion yuan (which doesn't directly translate into revenue as it's business transacted across its platforms).</p>\n<p>As with Black Friday in the United States, Singles Day used to be a 24-hour sales event but has stretched out. JD offered a presale period from Oct. 20-Oct. 31, one reason that it's easier to break records now.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09618":"京东集团-SW","JD":"京东"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1109019041","content_text":"JD.com rose more than 5% in morning trading alongside news that the company has pushed through its Singles Day sales volume record.\n\nThe sales holiday had resulted in 311.4 billion yuan (about $48.6 billion) in transaction volume as of 2:09 p.m.; at that point there were several hours left in a now-extended Singles Day.\nLast year JD volume hit 271.5 billion yuan (which doesn't directly translate into revenue as it's business transacted across its platforms).\nAs with Black Friday in the United States, Singles Day used to be a 24-hour sales event but has stretched out. JD offered a presale period from Oct. 20-Oct. 31, one reason that it's easier to break records now.","news_type":1,"symbols_score_info":{"09618":0.9,"JD":0.9}},"isVote":1,"tweetType":1,"viewCount":293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840766856,"gmtCreate":1635690217811,"gmtModify":1635690217893,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586429646894350","authorIdStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/840766856","repostId":"1104228860","repostType":4,"isVote":1,"tweetType":1,"viewCount":247,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":858191831,"gmtCreate":1634998546266,"gmtModify":1634998546537,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586429646894350","authorIdStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/858191831","repostId":"2177121214","repostType":4,"isVote":1,"tweetType":1,"viewCount":279,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":824885350,"gmtCreate":1634302160859,"gmtModify":1634302312068,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586429646894350","authorIdStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment. ","listText":"Like and comment. ","text":"Like and comment.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/824885350","repostId":"1122645691","repostType":4,"repost":{"id":"1122645691","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1634301436,"share":"https://ttm.financial/m/news/1122645691?lang=&edition=full","pubTime":"2021-10-15 20:37","market":"us","language":"en","title":"Toplines Before US Market Open on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1122645691","media":"Tiger Newspress","summary":"U.S. stock futures edged higher on Friday and pointed to weekly gains for major indexes, after resul","content":"<p>U.S. stock futures edged higher on Friday and pointed to weekly gains for major indexes, after results from Goldman Sachs and retail sales data.</p>\n<p>At 08:35 a.m. ET, Dow e-minis were up 188 points, or 0.54%, S&P 500 e-minis were up 19.25 points, or 0.43%, and Nasdaq 100 e-minis were up 52.5 points, or 0.35%.</p>\n<p><img src=\"https://static.tigerbbs.com/8eb8e4448c14bc75ba9cf20cd469b47d\" tg-width=\"404\" tg-height=\"184\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman Sachs crushed analysts’ estimates on strong investment banking and trading results.The shares rose more than 2% in premarket trading.</p>\n<p>Strong results from a clutch of banks, including Citigroup and Morgan Stanley, propelled the S&P 500 to its biggest daily percentage gain since early March on Thursday, while data on the labor market and inflation eased fears over the outlook for higher rates.</p>\n<p>U.S. retail sales climb 0.7% in September, above forecast.Consumers spent at a much faster pace than expected in September, defying expectation for a pullback, the Census Bureau reported Friday.</p>\n<p>Retail sales for the month increased 0.7%, against the Dow Jones estimate for a decline of 0.2%. Excluding auto-related sales, the number rose 0.8%, better than the 0.5% forecast.</p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p><b>Moderna(MRNA)</b> – Moderna added 3.3% in premarket trading after rising 3.2% yesterday, following an FDA panel recommendation for a booster dose of its Covid-19 vaccine. The panel recommended approval of a booster for people 65 and over as well as those at high risk.</p>\n<p><b>Virgin Galactic(SPCE)</b> – Virgin Galactic shares tumbled 17.5% in the premarket after it said it would delay the launch of its commercial space service to the fourth quarter of 2022 from the third quarter. The company is taking the extra time to work on improvements to its space vehicles.</p>\n<p><b>TSMC(TSM)</b> – TSMC stock surged about 2% in premarket trading after Japan planning to subsidize TSMC plant.The world's leading contract chipmaker announced Thursday that it will build its first-ever Japanese plant, responding to years of calls by the Ministry of Economy, Trade and Industry to set up shop.</p>\n<p><b>Nio(NIO)</b> – Nio stock rose nearly 2% in premarket trading.The chinese electric vehicle maker said it would double the capacity of its Hefei plant to 240,000 vehicles a year, up from 120,000 units.</p>\n<p><b>fuboTV(FUBO)</b> – fuboTV’s Sportsbook unit struck a deal with Nascar to become the racing circuit’s authorized gaming operator. fuboTV shares added 2.2% in premarket trading.</p>\n<p><b>Alcoa(AA)</b> – Alcoa reported an adjusted quarterly profit of $2.05 per share, beating the consensus estimate of $1.80. The aluminum producer’s revenue topped estimates as well on higher aluminum prices. Alcoa jumped 6.8% in premarket action.</p>\n<p><b>Western Digital(WDC)</b> – Western Digital stock dipped 2.1% in premarket trading.Goldman Sachs downgraded the storage hardware maker's stock to \"neutral\" from \"buy\".</p>\n<p><b>Truist Financial(TFC)</b> – The bank beat estimates by 21 cents with adjusted quarterly earnings of $1.42 per share and revenue also above estimates. Truist’s results were helped by stronger fee income as well as loan and deposit growth.</p>\n<p><b>PNC Financial(PNC) </b>– PNC reported adjusted quarterly earnings of $3.75 per share, compared with a consensus estimate of $3.20 and revenue also topping Wall Street forecasts. PNC benefited from the recapture of credit loss provisions as well as the integration of BBVA USA, a deal that closed last October. PNC rose 1.3% in premarket trading.</p>\n<p><b>Pearson(PSO)</b> – Pearson tumbled 11.3% in premarket trading after the educational materials company said higher education sales have fallen 7% so far this year, even though the company maintained its full-year guidance. Pearson said enrollments at community colleges in the U.S. appear to have been hit by the delta variant of Covid-19.</p>\n<p><b>Corsair Gaming(CRSR)</b> – Corsair shares slid 5.5% in the premarket after the maker of video game-related peripheral products said supply chain issues were hurting sales. Corsair said 2021 will still be a “strong growth year.”</p>\n<p><b>23andMe(ME)</b> – The consumer genetics company’s stock surged 9% in premarket trading, following a positive mention by EMJ Capital founder and portfolio manager Eric Jackson on CNBC’s “Closing Bell” Thursday. Jackson said 23andMe should be more properly thought of as a therapeutics company in addition to being a subscription service, which he thinks bodes well for future growth.</p>\n<p><b>Del Taco(TACO)</b> – The restaurant chain reported adjusted quarterly earnings of 11 cents per share, a penny above estimates, with revenue essentially in line with Wall Street forecasts. However, comparable sales rose 1.8%, short of the 2.1% estimate from analysts surveyed by FactSet. Shares slid 3.6% in the premarket.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-15 20:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock futures edged higher on Friday and pointed to weekly gains for major indexes, after results from Goldman Sachs and retail sales data.</p>\n<p>At 08:35 a.m. ET, Dow e-minis were up 188 points, or 0.54%, S&P 500 e-minis were up 19.25 points, or 0.43%, and Nasdaq 100 e-minis were up 52.5 points, or 0.35%.</p>\n<p><img src=\"https://static.tigerbbs.com/8eb8e4448c14bc75ba9cf20cd469b47d\" tg-width=\"404\" tg-height=\"184\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman Sachs crushed analysts’ estimates on strong investment banking and trading results.The shares rose more than 2% in premarket trading.</p>\n<p>Strong results from a clutch of banks, including Citigroup and Morgan Stanley, propelled the S&P 500 to its biggest daily percentage gain since early March on Thursday, while data on the labor market and inflation eased fears over the outlook for higher rates.</p>\n<p>U.S. retail sales climb 0.7% in September, above forecast.Consumers spent at a much faster pace than expected in September, defying expectation for a pullback, the Census Bureau reported Friday.</p>\n<p>Retail sales for the month increased 0.7%, against the Dow Jones estimate for a decline of 0.2%. Excluding auto-related sales, the number rose 0.8%, better than the 0.5% forecast.</p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p><b>Moderna(MRNA)</b> – Moderna added 3.3% in premarket trading after rising 3.2% yesterday, following an FDA panel recommendation for a booster dose of its Covid-19 vaccine. The panel recommended approval of a booster for people 65 and over as well as those at high risk.</p>\n<p><b>Virgin Galactic(SPCE)</b> – Virgin Galactic shares tumbled 17.5% in the premarket after it said it would delay the launch of its commercial space service to the fourth quarter of 2022 from the third quarter. The company is taking the extra time to work on improvements to its space vehicles.</p>\n<p><b>TSMC(TSM)</b> – TSMC stock surged about 2% in premarket trading after Japan planning to subsidize TSMC plant.The world's leading contract chipmaker announced Thursday that it will build its first-ever Japanese plant, responding to years of calls by the Ministry of Economy, Trade and Industry to set up shop.</p>\n<p><b>Nio(NIO)</b> – Nio stock rose nearly 2% in premarket trading.The chinese electric vehicle maker said it would double the capacity of its Hefei plant to 240,000 vehicles a year, up from 120,000 units.</p>\n<p><b>fuboTV(FUBO)</b> – fuboTV’s Sportsbook unit struck a deal with Nascar to become the racing circuit’s authorized gaming operator. fuboTV shares added 2.2% in premarket trading.</p>\n<p><b>Alcoa(AA)</b> – Alcoa reported an adjusted quarterly profit of $2.05 per share, beating the consensus estimate of $1.80. The aluminum producer’s revenue topped estimates as well on higher aluminum prices. Alcoa jumped 6.8% in premarket action.</p>\n<p><b>Western Digital(WDC)</b> – Western Digital stock dipped 2.1% in premarket trading.Goldman Sachs downgraded the storage hardware maker's stock to \"neutral\" from \"buy\".</p>\n<p><b>Truist Financial(TFC)</b> – The bank beat estimates by 21 cents with adjusted quarterly earnings of $1.42 per share and revenue also above estimates. Truist’s results were helped by stronger fee income as well as loan and deposit growth.</p>\n<p><b>PNC Financial(PNC) </b>– PNC reported adjusted quarterly earnings of $3.75 per share, compared with a consensus estimate of $3.20 and revenue also topping Wall Street forecasts. PNC benefited from the recapture of credit loss provisions as well as the integration of BBVA USA, a deal that closed last October. PNC rose 1.3% in premarket trading.</p>\n<p><b>Pearson(PSO)</b> – Pearson tumbled 11.3% in premarket trading after the educational materials company said higher education sales have fallen 7% so far this year, even though the company maintained its full-year guidance. Pearson said enrollments at community colleges in the U.S. appear to have been hit by the delta variant of Covid-19.</p>\n<p><b>Corsair Gaming(CRSR)</b> – Corsair shares slid 5.5% in the premarket after the maker of video game-related peripheral products said supply chain issues were hurting sales. Corsair said 2021 will still be a “strong growth year.”</p>\n<p><b>23andMe(ME)</b> – The consumer genetics company’s stock surged 9% in premarket trading, following a positive mention by EMJ Capital founder and portfolio manager Eric Jackson on CNBC’s “Closing Bell” Thursday. Jackson said 23andMe should be more properly thought of as a therapeutics company in addition to being a subscription service, which he thinks bodes well for future growth.</p>\n<p><b>Del Taco(TACO)</b> – The restaurant chain reported adjusted quarterly earnings of 11 cents per share, a penny above estimates, with revenue essentially in line with Wall Street forecasts. However, comparable sales rose 1.8%, short of the 2.1% estimate from analysts surveyed by FactSet. Shares slid 3.6% in the premarket.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WDC":"西部数据","PSO":"培生","MRNA":"Moderna, Inc.","TACO":"BERTO ACQUISITION CORP","SPCE":"维珍银河",".IXIC":"NASDAQ Composite","NIO":"蔚来","TFC":"Truist Financial Corp","TSM":"台积电","PNC":"PNC金融",".DJI":"道琼斯","AA":"美国铝业","FUBO":"fuboTV Inc.","CRSR":"Corsair Gaming, Inc.",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122645691","content_text":"U.S. stock futures edged higher on Friday and pointed to weekly gains for major indexes, after results from Goldman Sachs and retail sales data.\nAt 08:35 a.m. ET, Dow e-minis were up 188 points, or 0.54%, S&P 500 e-minis were up 19.25 points, or 0.43%, and Nasdaq 100 e-minis were up 52.5 points, or 0.35%.\n\nGoldman Sachs crushed analysts’ estimates on strong investment banking and trading results.The shares rose more than 2% in premarket trading.\nStrong results from a clutch of banks, including Citigroup and Morgan Stanley, propelled the S&P 500 to its biggest daily percentage gain since early March on Thursday, while data on the labor market and inflation eased fears over the outlook for higher rates.\nU.S. retail sales climb 0.7% in September, above forecast.Consumers spent at a much faster pace than expected in September, defying expectation for a pullback, the Census Bureau reported Friday.\nRetail sales for the month increased 0.7%, against the Dow Jones estimate for a decline of 0.2%. Excluding auto-related sales, the number rose 0.8%, better than the 0.5% forecast.\nStocks making the biggest moves premarket:\nModerna(MRNA) – Moderna added 3.3% in premarket trading after rising 3.2% yesterday, following an FDA panel recommendation for a booster dose of its Covid-19 vaccine. The panel recommended approval of a booster for people 65 and over as well as those at high risk.\nVirgin Galactic(SPCE) – Virgin Galactic shares tumbled 17.5% in the premarket after it said it would delay the launch of its commercial space service to the fourth quarter of 2022 from the third quarter. The company is taking the extra time to work on improvements to its space vehicles.\nTSMC(TSM) – TSMC stock surged about 2% in premarket trading after Japan planning to subsidize TSMC plant.The world's leading contract chipmaker announced Thursday that it will build its first-ever Japanese plant, responding to years of calls by the Ministry of Economy, Trade and Industry to set up shop.\nNio(NIO) – Nio stock rose nearly 2% in premarket trading.The chinese electric vehicle maker said it would double the capacity of its Hefei plant to 240,000 vehicles a year, up from 120,000 units.\nfuboTV(FUBO) – fuboTV’s Sportsbook unit struck a deal with Nascar to become the racing circuit’s authorized gaming operator. fuboTV shares added 2.2% in premarket trading.\nAlcoa(AA) – Alcoa reported an adjusted quarterly profit of $2.05 per share, beating the consensus estimate of $1.80. The aluminum producer’s revenue topped estimates as well on higher aluminum prices. Alcoa jumped 6.8% in premarket action.\nWestern Digital(WDC) – Western Digital stock dipped 2.1% in premarket trading.Goldman Sachs downgraded the storage hardware maker's stock to \"neutral\" from \"buy\".\nTruist Financial(TFC) – The bank beat estimates by 21 cents with adjusted quarterly earnings of $1.42 per share and revenue also above estimates. Truist’s results were helped by stronger fee income as well as loan and deposit growth.\nPNC Financial(PNC) – PNC reported adjusted quarterly earnings of $3.75 per share, compared with a consensus estimate of $3.20 and revenue also topping Wall Street forecasts. PNC benefited from the recapture of credit loss provisions as well as the integration of BBVA USA, a deal that closed last October. PNC rose 1.3% in premarket trading.\nPearson(PSO) – Pearson tumbled 11.3% in premarket trading after the educational materials company said higher education sales have fallen 7% so far this year, even though the company maintained its full-year guidance. Pearson said enrollments at community colleges in the U.S. appear to have been hit by the delta variant of Covid-19.\nCorsair Gaming(CRSR) – Corsair shares slid 5.5% in the premarket after the maker of video game-related peripheral products said supply chain issues were hurting sales. Corsair said 2021 will still be a “strong growth year.”\n23andMe(ME) – The consumer genetics company’s stock surged 9% in premarket trading, following a positive mention by EMJ Capital founder and portfolio manager Eric Jackson on CNBC’s “Closing Bell” Thursday. Jackson said 23andMe should be more properly thought of as a therapeutics company in addition to being a subscription service, which he thinks bodes well for future growth.\nDel Taco(TACO) – The restaurant chain reported adjusted quarterly earnings of 11 cents per share, a penny above estimates, with revenue essentially in line with Wall Street forecasts. However, comparable sales rose 1.8%, short of the 2.1% estimate from analysts surveyed by FactSet. Shares slid 3.6% in the premarket.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"AA":0.9,"CRSR":0.9,"ESmain":0.9,"NQmain":0.9,"YMmain":0.9,"FUBO":0.9,"ME":0.9,"MRNA":0.9,"NIO":0.9,"PNC":0.9,"PSO":0.9,"SPCE":0.9,"TACO":0.9,"TFC":0.9,"TSM":0.9,"WDC":0.9}},"isVote":1,"tweetType":1,"viewCount":527,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":837876910,"gmtCreate":1629879086030,"gmtModify":1631892760442,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586429646894350","authorIdStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/837876910","repostId":"2162087564","repostType":4,"repost":{"id":"2162087564","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629836173,"share":"https://ttm.financial/m/news/2162087564?lang=&edition=full","pubTime":"2021-08-25 04:16","market":"us","language":"en","title":"Wall St extends rally, pushing S&P 500 to 50th all-time high close this year","url":"https://stock-news.laohu8.com/highlight/detail?id=2162087564","media":"Reuters","summary":"NEW YORK, Aug 24 (Reuters) - Wall Street ended higher in a late-summer, light volume rally on Tuesda","content":"<p>NEW YORK, Aug 24 (Reuters) - Wall Street ended higher in a late-summer, light volume rally on Tuesday as the FDA's full approval of a COVID-19 vaccine on Monday and the absence of negative catalysts kept risk appetite alive ahead of the much-anticipated Jackson Hole Symposium.</p>\n<p>All three major U.S. stock indexes advanced higher, with the S&P 500 and the Nasdaq closing at all-time closing highs.</p>\n<p>The session marked the S&P 500's 50th record high close so far this year.</p>\n<p>Tech and tech-adjacent megacaps were once again doing the heavy lifting, but economically sensitive cyclicals and smallcaps outperformed the broader market.</p>\n<p>\"Investors are looking at the horizon at the big Jackson Hole meeting on the horizon,\" Ryan Detrick, senior market strategist at LPL Financial in Charlotte, North Carolina, referring to the Federal Reserve’s annual economic symposium on Friday. \"But for now the feel-good from yesterday’s vaccine news is still in the air.\"</p>\n<p>The Food and Drug Administration's full approval of the Pfizer-BioNTech COVID-19 vaccine on Monday fueled optimism over economic recovery which spilled into Tuesday's session.</p>\n<p>Travel and leisure sectors, associated with economic re-engagement, outperformed the broader market. The S&P 1500 Airline and Hotel/Restaurant/Leisure indexes gained up 3.7% and 1.6%, respectively.</p>\n<p>\"We have energy, retail, travel, leisure, financials, and small caps all doing well today,\" Detrick said. \"And that’s a sign that the reopening is alive and well.\"</p>\n<p>Recent economic indicators suggest the recovery from the most abrupt recession in U.S. history is headed in the right direction, but not to the extent that is likely to prompt the Fed to tighten its dovish monetary policy.</p>\n<p>Fed Chair Jerome Powell is due to meet with other world bank leaders when the Jackson Hole Symposium convenes later this week, and his remarks will be closely parsed for any clues regarding the Fed's tapering of asset purchases and hiking key interest rates.</p>\n<p>The event will take place virtually and not in person due to the spread of COVID-19 in the county, which has reduced expectations that any major announcement will be made at the event.</p>\n<p>\"The fact that the Fed is having a virtual (Jackson Hole) meeting tells you that they might be thinking maybe they need to keep supporting the economy,\" said Detrick.</p>\n<p>The Dow Jones Industrial Average rose 30.55 points, or 0.09%, to 35,366.26, the S&P 500 gained 6.7 points, or 0.15%, to 4,486.23 and the Nasdaq Composite added 77.15 points, or 0.52%, to 15,019.80.</p>\n<p>Energy was the top gainer among the 11 major sectors in the S&P 500, boosted by the continued rally in crude prices.</p>\n<p>Best Buy Co Inc jumped 8.3% after the electronics retailer beat analyst earnings expectations and raised its full year sales forecast.</p>\n<p>U.S.-listed shares of China-based e-commerce platform Pinduoduo Inc surged 22.2% after reporting its first ever quarterly profit.</p>\n<p>JD.com gained 14.4% in the wake of the Chinese online retailer's remarks on Monday that it does not expect any business impact from a wave of regulations hitting the industry at home.</p>\n<p>Other shares of Chinese companies listed on U.S. exchanges were bouncing back as well, with the Invesco Golden Dragon ETF jumping 8.0%.</p>\n<p>Cybersecurity firm <a href=\"https://laohu8.com/S/PANW\">Palo Alto Networks</a> Inc advanced18.6% as brokerages raised their price targets following its full-year forecast beat.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.17-to-1 ratio; on Nasdaq, a 1.82-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 28 new 52-week highs and <a href=\"https://laohu8.com/S/AONE.U\">one</a> new low; the Nasdaq Composite recorded 96 new highs and 37 new lows.</p>\n<p>Volume on U.S. exchanges was 8.97 billion shares, compared with the 9.08 billion average over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St extends rally, pushing S&P 500 to 50th all-time high close this year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St extends rally, pushing S&P 500 to 50th all-time high close this year\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-25 04:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, Aug 24 (Reuters) - Wall Street ended higher in a late-summer, light volume rally on Tuesday as the FDA's full approval of a COVID-19 vaccine on Monday and the absence of negative catalysts kept risk appetite alive ahead of the much-anticipated Jackson Hole Symposium.</p>\n<p>All three major U.S. stock indexes advanced higher, with the S&P 500 and the Nasdaq closing at all-time closing highs.</p>\n<p>The session marked the S&P 500's 50th record high close so far this year.</p>\n<p>Tech and tech-adjacent megacaps were once again doing the heavy lifting, but economically sensitive cyclicals and smallcaps outperformed the broader market.</p>\n<p>\"Investors are looking at the horizon at the big Jackson Hole meeting on the horizon,\" Ryan Detrick, senior market strategist at LPL Financial in Charlotte, North Carolina, referring to the Federal Reserve’s annual economic symposium on Friday. \"But for now the feel-good from yesterday’s vaccine news is still in the air.\"</p>\n<p>The Food and Drug Administration's full approval of the Pfizer-BioNTech COVID-19 vaccine on Monday fueled optimism over economic recovery which spilled into Tuesday's session.</p>\n<p>Travel and leisure sectors, associated with economic re-engagement, outperformed the broader market. The S&P 1500 Airline and Hotel/Restaurant/Leisure indexes gained up 3.7% and 1.6%, respectively.</p>\n<p>\"We have energy, retail, travel, leisure, financials, and small caps all doing well today,\" Detrick said. \"And that’s a sign that the reopening is alive and well.\"</p>\n<p>Recent economic indicators suggest the recovery from the most abrupt recession in U.S. history is headed in the right direction, but not to the extent that is likely to prompt the Fed to tighten its dovish monetary policy.</p>\n<p>Fed Chair Jerome Powell is due to meet with other world bank leaders when the Jackson Hole Symposium convenes later this week, and his remarks will be closely parsed for any clues regarding the Fed's tapering of asset purchases and hiking key interest rates.</p>\n<p>The event will take place virtually and not in person due to the spread of COVID-19 in the county, which has reduced expectations that any major announcement will be made at the event.</p>\n<p>\"The fact that the Fed is having a virtual (Jackson Hole) meeting tells you that they might be thinking maybe they need to keep supporting the economy,\" said Detrick.</p>\n<p>The Dow Jones Industrial Average rose 30.55 points, or 0.09%, to 35,366.26, the S&P 500 gained 6.7 points, or 0.15%, to 4,486.23 and the Nasdaq Composite added 77.15 points, or 0.52%, to 15,019.80.</p>\n<p>Energy was the top gainer among the 11 major sectors in the S&P 500, boosted by the continued rally in crude prices.</p>\n<p>Best Buy Co Inc jumped 8.3% after the electronics retailer beat analyst earnings expectations and raised its full year sales forecast.</p>\n<p>U.S.-listed shares of China-based e-commerce platform Pinduoduo Inc surged 22.2% after reporting its first ever quarterly profit.</p>\n<p>JD.com gained 14.4% in the wake of the Chinese online retailer's remarks on Monday that it does not expect any business impact from a wave of regulations hitting the industry at home.</p>\n<p>Other shares of Chinese companies listed on U.S. exchanges were bouncing back as well, with the Invesco Golden Dragon ETF jumping 8.0%.</p>\n<p>Cybersecurity firm <a href=\"https://laohu8.com/S/PANW\">Palo Alto Networks</a> Inc advanced18.6% as brokerages raised their price targets following its full-year forecast beat.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.17-to-1 ratio; on Nasdaq, a 1.82-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 28 new 52-week highs and <a href=\"https://laohu8.com/S/AONE.U\">one</a> new low; the Nasdaq Composite recorded 96 new highs and 37 new lows.</p>\n<p>Volume on U.S. exchanges was 8.97 billion shares, compared with the 9.08 billion average over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","OEF":"标普100指数ETF-iShares",".DJI":"道琼斯","UPRO":"三倍做多标普500ETF","IVV":"标普500指数ETF","SSO":"两倍做多标普500ETF",".IXIC":"NASDAQ Composite","SDS":"两倍做空标普500ETF","SH":"标普500反向ETF","SPXU":"三倍做空标普500ETF","OEX":"标普100","SPY":"标普500ETF",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162087564","content_text":"NEW YORK, Aug 24 (Reuters) - Wall Street ended higher in a late-summer, light volume rally on Tuesday as the FDA's full approval of a COVID-19 vaccine on Monday and the absence of negative catalysts kept risk appetite alive ahead of the much-anticipated Jackson Hole Symposium.\nAll three major U.S. stock indexes advanced higher, with the S&P 500 and the Nasdaq closing at all-time closing highs.\nThe session marked the S&P 500's 50th record high close so far this year.\nTech and tech-adjacent megacaps were once again doing the heavy lifting, but economically sensitive cyclicals and smallcaps outperformed the broader market.\n\"Investors are looking at the horizon at the big Jackson Hole meeting on the horizon,\" Ryan Detrick, senior market strategist at LPL Financial in Charlotte, North Carolina, referring to the Federal Reserve’s annual economic symposium on Friday. \"But for now the feel-good from yesterday’s vaccine news is still in the air.\"\nThe Food and Drug Administration's full approval of the Pfizer-BioNTech COVID-19 vaccine on Monday fueled optimism over economic recovery which spilled into Tuesday's session.\nTravel and leisure sectors, associated with economic re-engagement, outperformed the broader market. The S&P 1500 Airline and Hotel/Restaurant/Leisure indexes gained up 3.7% and 1.6%, respectively.\n\"We have energy, retail, travel, leisure, financials, and small caps all doing well today,\" Detrick said. \"And that’s a sign that the reopening is alive and well.\"\nRecent economic indicators suggest the recovery from the most abrupt recession in U.S. history is headed in the right direction, but not to the extent that is likely to prompt the Fed to tighten its dovish monetary policy.\nFed Chair Jerome Powell is due to meet with other world bank leaders when the Jackson Hole Symposium convenes later this week, and his remarks will be closely parsed for any clues regarding the Fed's tapering of asset purchases and hiking key interest rates.\nThe event will take place virtually and not in person due to the spread of COVID-19 in the county, which has reduced expectations that any major announcement will be made at the event.\n\"The fact that the Fed is having a virtual (Jackson Hole) meeting tells you that they might be thinking maybe they need to keep supporting the economy,\" said Detrick.\nThe Dow Jones Industrial Average rose 30.55 points, or 0.09%, to 35,366.26, the S&P 500 gained 6.7 points, or 0.15%, to 4,486.23 and the Nasdaq Composite added 77.15 points, or 0.52%, to 15,019.80.\nEnergy was the top gainer among the 11 major sectors in the S&P 500, boosted by the continued rally in crude prices.\nBest Buy Co Inc jumped 8.3% after the electronics retailer beat analyst earnings expectations and raised its full year sales forecast.\nU.S.-listed shares of China-based e-commerce platform Pinduoduo Inc surged 22.2% after reporting its first ever quarterly profit.\nJD.com gained 14.4% in the wake of the Chinese online retailer's remarks on Monday that it does not expect any business impact from a wave of regulations hitting the industry at home.\nOther shares of Chinese companies listed on U.S. exchanges were bouncing back as well, with the Invesco Golden Dragon ETF jumping 8.0%.\nCybersecurity firm Palo Alto Networks Inc advanced18.6% as brokerages raised their price targets following its full-year forecast beat.\nAdvancing issues outnumbered declining ones on the NYSE by a 2.17-to-1 ratio; on Nasdaq, a 1.82-to-1 ratio favored advancers.\nThe S&P 500 posted 28 new 52-week highs and one new low; the Nasdaq Composite recorded 96 new highs and 37 new lows.\nVolume on U.S. exchanges was 8.97 billion shares, compared with the 9.08 billion average over the last 20 trading days.","news_type":1,"symbols_score_info":{"161125":0.9,"513500":0.9,".DJI":0.9,".IXIC":0.9,".SPX":0.9,"ESmain":0.9,"IVV":0.9,"OEF":0.9,"OEX":0.9,"SDS":0.9,"SH":0.9,"SPXU":0.9,"SPY":0.9,"SSO":0.9,"UPRO":0.9}},"isVote":1,"tweetType":1,"viewCount":188,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":842569372,"gmtCreate":1636202738230,"gmtModify":1636202738521,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586429646894350","authorIdStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/842569372","repostId":"1173813098","repostType":4,"repost":{"id":"1173813098","kind":"news","pubTimestamp":1636156499,"share":"https://ttm.financial/m/news/1173813098?lang=&edition=full","pubTime":"2021-11-06 07:54","market":"us","language":"en","title":"Wall St books records, weekly gains on strong jobs report, Pfizer COVID-19 pill cheer","url":"https://stock-news.laohu8.com/highlight/detail?id=1173813098","media":"Reuters","summary":"(Reuters) - Wall Street's main indexes scored record closing highs on Friday and booked solid gains ","content":"<p>(Reuters) - Wall Street's main indexes scored record closing highs on Friday and booked solid gains for the week following a strong U.S. jobs report and positive data for Pfizer's experimental pill against COVID-19.</p>\n<p>The S&P 500 and the Nasdaq notched record high closes for their seventh straight sessions, while the Dow Jones Industrial Average also closed at a record. All three indexes posted weekly gains for their fifth straight weeks.</p>\n<p>The Labor Department report showed U.S. employment increased more than expected in October as the headwind from the surge in COVID-19 infections over the summer subsided.</p>\n<p>A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease. Pfizer shares jumped about 11%.</p>\n<p>The news kept the run going for equities after investors earlier in the week digested the Federal Reserve's decision to start reducing its monthly bond purchases put in place to support the economy.</p>\n<p>\"Momentum that we have seen this week has continued, and the jobs report and the Pfizer announcement certainly are providing positive datapoints for investors to put more money into the market right now,” said Chuck Carlson, chief executive officer at Horizon Investment Services in Hammond, Indiana.</p>\n<p>The Dow Jones Industrial Average rose 203.72 points, or 0.56%, to 36,327.95, the S&P 500 gained 17.47 points, or 0.37%, to 4,697.53 and the Nasdaq Composite added 31.28 points, or 0.2%, to 15,971.59.</p>\n<p>For the week, the S&P 500 rose 2%, the Dow added 1.42%, while the Nasdaq gained 3.05%.</p>\n<p>Travel stocks rose following Pfizer's announcement, with the S&P 1500 airlines index climbing 7%, and cruise operators Carnival Corp, Royal Caribbean Cruises and Norwegian Cruise rising between about 8% to 9%.</p>\n<p>\"Still early to be definitive but this (pill) looks like a true game changer for many industries like leisure and transportation, you're seeing it reflected in the prices,\" said Andre Bakhos, managing director at New Vines Capital LLC in Bernardsville, New Jersey.</p>\n<p>Among S&P 500 sectors, energy and industrials led the way, rising 1.4% and 1%, respectively.</p>\n<p>Healthcare was the only sector that ended negative, falling 1%. The Pfizer news weighed on shares of competitors such as Merck, which fell nearly 10%, and COVID-19 vaccine makers such as Moderna, which slumped 16.6%.</p>\n<p>Shares of so-called \"stay-at-home\" names fell, with <a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video Communications down 6.2% and Netflix Inc off 3.4%.</p>\n<p>Better-than-expected third-quarter earnings have helped lift sentiment for equities. With about 440 companies having reported, S&P 500 earnings are expected to have climbed 41.5% in the third quarter from a year earlier, according to Refinitiv IBES.</p>\n<p>Pinterest Inc shares climbed 5.9% after the company's strong fourth-quarter revenue forecast.</p>\n<p>Peloton Interactive Inc shares slumped 35.3% after the company slashed its full-year sales forecast by up to $1 billion.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.16-to-1 ratio; on Nasdaq, a 1.22-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 83 new 52-week highs and two new lows; the Nasdaq Composite recorded 303 new highs and 80 new lows.</p>\n<p>About 11.5 billion shares changed hands in U.S. exchanges, compared with the 10.5 billion daily average over the last 20 sessions.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St books records, weekly gains on strong jobs report, Pfizer COVID-19 pill cheer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St books records, weekly gains on strong jobs report, Pfizer COVID-19 pill cheer\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-06 07:54 GMT+8 <a href=https://www.streetinsider.com/dr/news.php?id=19167545><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Wall Street's main indexes scored record closing highs on Friday and booked solid gains for the week following a strong U.S. jobs report and positive data for Pfizer's experimental pill ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19167545\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19167545","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173813098","content_text":"(Reuters) - Wall Street's main indexes scored record closing highs on Friday and booked solid gains for the week following a strong U.S. jobs report and positive data for Pfizer's experimental pill against COVID-19.\nThe S&P 500 and the Nasdaq notched record high closes for their seventh straight sessions, while the Dow Jones Industrial Average also closed at a record. All three indexes posted weekly gains for their fifth straight weeks.\nThe Labor Department report showed U.S. employment increased more than expected in October as the headwind from the surge in COVID-19 infections over the summer subsided.\nA trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease. Pfizer shares jumped about 11%.\nThe news kept the run going for equities after investors earlier in the week digested the Federal Reserve's decision to start reducing its monthly bond purchases put in place to support the economy.\n\"Momentum that we have seen this week has continued, and the jobs report and the Pfizer announcement certainly are providing positive datapoints for investors to put more money into the market right now,” said Chuck Carlson, chief executive officer at Horizon Investment Services in Hammond, Indiana.\nThe Dow Jones Industrial Average rose 203.72 points, or 0.56%, to 36,327.95, the S&P 500 gained 17.47 points, or 0.37%, to 4,697.53 and the Nasdaq Composite added 31.28 points, or 0.2%, to 15,971.59.\nFor the week, the S&P 500 rose 2%, the Dow added 1.42%, while the Nasdaq gained 3.05%.\nTravel stocks rose following Pfizer's announcement, with the S&P 1500 airlines index climbing 7%, and cruise operators Carnival Corp, Royal Caribbean Cruises and Norwegian Cruise rising between about 8% to 9%.\n\"Still early to be definitive but this (pill) looks like a true game changer for many industries like leisure and transportation, you're seeing it reflected in the prices,\" said Andre Bakhos, managing director at New Vines Capital LLC in Bernardsville, New Jersey.\nAmong S&P 500 sectors, energy and industrials led the way, rising 1.4% and 1%, respectively.\nHealthcare was the only sector that ended negative, falling 1%. The Pfizer news weighed on shares of competitors such as Merck, which fell nearly 10%, and COVID-19 vaccine makers such as Moderna, which slumped 16.6%.\nShares of so-called \"stay-at-home\" names fell, with Zoom Video Communications down 6.2% and Netflix Inc off 3.4%.\nBetter-than-expected third-quarter earnings have helped lift sentiment for equities. With about 440 companies having reported, S&P 500 earnings are expected to have climbed 41.5% in the third quarter from a year earlier, according to Refinitiv IBES.\nPinterest Inc shares climbed 5.9% after the company's strong fourth-quarter revenue forecast.\nPeloton Interactive Inc shares slumped 35.3% after the company slashed its full-year sales forecast by up to $1 billion.\nAdvancing issues outnumbered declining ones on the NYSE by a 2.16-to-1 ratio; on Nasdaq, a 1.22-to-1 ratio favored advancers.\nThe S&P 500 posted 83 new 52-week highs and two new lows; the Nasdaq Composite recorded 303 new highs and 80 new lows.\nAbout 11.5 billion shares changed hands in U.S. exchanges, compared with the 10.5 billion daily average over the last 20 sessions.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":391,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":826093511,"gmtCreate":1633955445170,"gmtModify":1633955445249,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586429646894350","authorIdStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/826093511","repostId":"1156360441","repostType":4,"repost":{"id":"1156360441","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633953919,"share":"https://ttm.financial/m/news/1156360441?lang=&edition=full","pubTime":"2021-10-11 20:05","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1156360441","media":"Tiger Newspress","summary":"U.S. stock index futures slipped on Monday as surging commodity prices added to inflation worries, w","content":"<p>U.S. stock index futures slipped on Monday as surging commodity prices added to inflation worries, which could cloud the earnings season set to start with Wall Street banks later this week.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were down 73 points, or 0.21%, S&P 500 e-minis were down 16.75 points, or 0.38%, and Nasdaq 100 e-minis were down 97.25 points, or 0.66%.</p>\n<p><img src=\"https://static.tigerbbs.com/e91213bb69c8218f2af2440452afd34a\" tg-width=\"1080\" tg-height=\"399\" width=\"100%\" height=\"auto\"></p>\n<p>Rising raw material costs, labor shortages and other supply chain bottlenecks have raised concerns of elevated prices denting corporate profit.</p>\n<p>U.S. oil rose nearly 3% and touched a seven-year high as an energy crisis gripping the major economies showed no sign of easing.</p>\n<p>But it lifted shares of Chevron Corp, Exxon Mobil Corp and APA Corp between 1.2% and 3% in premarket trading.</p>\n<p>Mega-caps Apple Inc, Microsoft Corp and Amazon.com Inc fell between 0.6% and 1%.</p>\n<p>Earnings season will kick off this week, with JPMorgan Chase & Co reporting on Wednesday, followed by Bank of America Corp, Morgan Stanley and Citigroup Inc on Thursday and Goldman Sachs Group Inc on Friday.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>Southwest Airlines</b><b>(LUV)</b> – The airline canceled more than 1,800 flights over the weekend, citing bad weather, air traffic control issues and staff shortages. Southwest disputed speculation that its high level of cancellations compared to other airlines was due to employee protests of a Covid-19 vaccine mandate. Southwest fell 3.1% in premarket trading.</p>\n<p><b>SoFi Technologies(SOFI) </b>– The fintech company’s stock rallied 3.8% in premarket action after Morgan Stanley initiated coverage with an “overweight” rating, calling it a “powerful revenue growth story” as it gains market share in the consumer finance space.</p>\n<p><b>Apple(AAPL)</b> – Apple asked a judge to delay changes to its App Store that would require it to allow developers to bypass Apple’s in-app payment system. The changes stemmed from the case involving “Fortnite” creator Epic Games and is scheduled to go into effect December 9, but Apple is asking that its appeal be allowed to play out first.</p>\n<p><b>Merck(MRK) </b>– The drugmaker and partner Ridgeback Biotherapeutics announced the submission of an Emergency Use Authorization application to the Food and Drug Administration for their oral Covid-19 treatment molnupiravir. That follows positive study results that were unveiled earlier this month.</p>\n<p><b>Starbucks(SBUX)</b> – The coffee chain’s shares added 1.2% in the premarket after Deutsche Bank upgraded the stock to “buy” from “hold,” citing “incredible” U.S. momentum and the prospect of sustained unit growth in China.</p>\n<p><b>Aspen Technology(AZPN)</b> – The industrial software maker announced a deal to merge with two of Emerson Electric’s software businesses in a deal worth approximately $11 billion. The cash-and-stock deal is valued at about $160 per share, with Aspen Technology holders receiving $87 per share in cash and 0.42 shares in the combined company for each share they now own. Aspen Technology had been up nearly 13% over the past two sessions since reports of talks between the two companies first surfaced.</p>\n<p><b>Deere & Co.(DE)</b> – Workers at the heavy equipment maker represented by the United Auto Workers Union rejected a tentative contract agreement. Union members say they want bigger raises and benefits than those proposed in the rejected six-year deal, based on strong profits for Deere.</p>\n<p><b>Xpeng(XPEV)</b> – The China-based electric vehicle maker said it has surpassed 100,000 cars produced, coming six years after the company launched. Shares rose 1.3% in the premarket, while Chinese rival Nio gained 1.5%.</p>\n<p><b>ConocoPhillips(COP)</b> – The energy producer's shares were downgraded to \"neutral\" from \"buy\" at Goldman Sachs, which cited valuation for the move. The stock has gained 88% this year and was up another 1.3% in the premarket.</p>\n<p><b>Cleveland-Cliffs(CLF)</b> – The steel and iron producer's shares gained 1.8% in premarket trading after it announced the acquisition of iron scrap processor Ferrous Processing and Trading for about $775 million.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-11 20:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock index futures slipped on Monday as surging commodity prices added to inflation worries, which could cloud the earnings season set to start with Wall Street banks later this week.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were down 73 points, or 0.21%, S&P 500 e-minis were down 16.75 points, or 0.38%, and Nasdaq 100 e-minis were down 97.25 points, or 0.66%.</p>\n<p><img src=\"https://static.tigerbbs.com/e91213bb69c8218f2af2440452afd34a\" tg-width=\"1080\" tg-height=\"399\" width=\"100%\" height=\"auto\"></p>\n<p>Rising raw material costs, labor shortages and other supply chain bottlenecks have raised concerns of elevated prices denting corporate profit.</p>\n<p>U.S. oil rose nearly 3% and touched a seven-year high as an energy crisis gripping the major economies showed no sign of easing.</p>\n<p>But it lifted shares of Chevron Corp, Exxon Mobil Corp and APA Corp between 1.2% and 3% in premarket trading.</p>\n<p>Mega-caps Apple Inc, Microsoft Corp and Amazon.com Inc fell between 0.6% and 1%.</p>\n<p>Earnings season will kick off this week, with JPMorgan Chase & Co reporting on Wednesday, followed by Bank of America Corp, Morgan Stanley and Citigroup Inc on Thursday and Goldman Sachs Group Inc on Friday.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>Southwest Airlines</b><b>(LUV)</b> – The airline canceled more than 1,800 flights over the weekend, citing bad weather, air traffic control issues and staff shortages. Southwest disputed speculation that its high level of cancellations compared to other airlines was due to employee protests of a Covid-19 vaccine mandate. Southwest fell 3.1% in premarket trading.</p>\n<p><b>SoFi Technologies(SOFI) </b>– The fintech company’s stock rallied 3.8% in premarket action after Morgan Stanley initiated coverage with an “overweight” rating, calling it a “powerful revenue growth story” as it gains market share in the consumer finance space.</p>\n<p><b>Apple(AAPL)</b> – Apple asked a judge to delay changes to its App Store that would require it to allow developers to bypass Apple’s in-app payment system. The changes stemmed from the case involving “Fortnite” creator Epic Games and is scheduled to go into effect December 9, but Apple is asking that its appeal be allowed to play out first.</p>\n<p><b>Merck(MRK) </b>– The drugmaker and partner Ridgeback Biotherapeutics announced the submission of an Emergency Use Authorization application to the Food and Drug Administration for their oral Covid-19 treatment molnupiravir. That follows positive study results that were unveiled earlier this month.</p>\n<p><b>Starbucks(SBUX)</b> – The coffee chain’s shares added 1.2% in the premarket after Deutsche Bank upgraded the stock to “buy” from “hold,” citing “incredible” U.S. momentum and the prospect of sustained unit growth in China.</p>\n<p><b>Aspen Technology(AZPN)</b> – The industrial software maker announced a deal to merge with two of Emerson Electric’s software businesses in a deal worth approximately $11 billion. The cash-and-stock deal is valued at about $160 per share, with Aspen Technology holders receiving $87 per share in cash and 0.42 shares in the combined company for each share they now own. Aspen Technology had been up nearly 13% over the past two sessions since reports of talks between the two companies first surfaced.</p>\n<p><b>Deere & Co.(DE)</b> – Workers at the heavy equipment maker represented by the United Auto Workers Union rejected a tentative contract agreement. Union members say they want bigger raises and benefits than those proposed in the rejected six-year deal, based on strong profits for Deere.</p>\n<p><b>Xpeng(XPEV)</b> – The China-based electric vehicle maker said it has surpassed 100,000 cars produced, coming six years after the company launched. Shares rose 1.3% in the premarket, while Chinese rival Nio gained 1.5%.</p>\n<p><b>ConocoPhillips(COP)</b> – The energy producer's shares were downgraded to \"neutral\" from \"buy\" at Goldman Sachs, which cited valuation for the move. The stock has gained 88% this year and was up another 1.3% in the premarket.</p>\n<p><b>Cleveland-Cliffs(CLF)</b> – The steel and iron producer's shares gained 1.8% in premarket trading after it announced the acquisition of iron scrap processor Ferrous Processing and Trading for about $775 million.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SBUX":"星巴克","C":"花旗","CLF":"克利夫兰克里夫","BAC":"美国银行","DE":"迪尔股份有限公司","XOM":"埃克森美孚","XPEV":"小鹏汽车","AAPL":"苹果","NIO":"蔚来","AZPN":"艾斯本","LUV":"西南航空","SOFI":"SoFi Technologies Inc.","APA":"阿帕契","CVX":"雪佛龙","JPM":"摩根大通",".DJI":"道琼斯","GS":"高盛","MS":"摩根士丹利","COP":"康菲石油","MRK":"默沙东",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156360441","content_text":"U.S. stock index futures slipped on Monday as surging commodity prices added to inflation worries, which could cloud the earnings season set to start with Wall Street banks later this week.\nAt 8:00 a.m. ET, Dow e-minis were down 73 points, or 0.21%, S&P 500 e-minis were down 16.75 points, or 0.38%, and Nasdaq 100 e-minis were down 97.25 points, or 0.66%.\n\nRising raw material costs, labor shortages and other supply chain bottlenecks have raised concerns of elevated prices denting corporate profit.\nU.S. oil rose nearly 3% and touched a seven-year high as an energy crisis gripping the major economies showed no sign of easing.\nBut it lifted shares of Chevron Corp, Exxon Mobil Corp and APA Corp between 1.2% and 3% in premarket trading.\nMega-caps Apple Inc, Microsoft Corp and Amazon.com Inc fell between 0.6% and 1%.\nEarnings season will kick off this week, with JPMorgan Chase & Co reporting on Wednesday, followed by Bank of America Corp, Morgan Stanley and Citigroup Inc on Thursday and Goldman Sachs Group Inc on Friday.\nStocks making the biggest moves in the premarket:\nSouthwest Airlines(LUV) – The airline canceled more than 1,800 flights over the weekend, citing bad weather, air traffic control issues and staff shortages. Southwest disputed speculation that its high level of cancellations compared to other airlines was due to employee protests of a Covid-19 vaccine mandate. Southwest fell 3.1% in premarket trading.\nSoFi Technologies(SOFI) – The fintech company’s stock rallied 3.8% in premarket action after Morgan Stanley initiated coverage with an “overweight” rating, calling it a “powerful revenue growth story” as it gains market share in the consumer finance space.\nApple(AAPL) – Apple asked a judge to delay changes to its App Store that would require it to allow developers to bypass Apple’s in-app payment system. The changes stemmed from the case involving “Fortnite” creator Epic Games and is scheduled to go into effect December 9, but Apple is asking that its appeal be allowed to play out first.\nMerck(MRK) – The drugmaker and partner Ridgeback Biotherapeutics announced the submission of an Emergency Use Authorization application to the Food and Drug Administration for their oral Covid-19 treatment molnupiravir. That follows positive study results that were unveiled earlier this month.\nStarbucks(SBUX) – The coffee chain’s shares added 1.2% in the premarket after Deutsche Bank upgraded the stock to “buy” from “hold,” citing “incredible” U.S. momentum and the prospect of sustained unit growth in China.\nAspen Technology(AZPN) – The industrial software maker announced a deal to merge with two of Emerson Electric’s software businesses in a deal worth approximately $11 billion. The cash-and-stock deal is valued at about $160 per share, with Aspen Technology holders receiving $87 per share in cash and 0.42 shares in the combined company for each share they now own. Aspen Technology had been up nearly 13% over the past two sessions since reports of talks between the two companies first surfaced.\nDeere & Co.(DE) – Workers at the heavy equipment maker represented by the United Auto Workers Union rejected a tentative contract agreement. Union members say they want bigger raises and benefits than those proposed in the rejected six-year deal, based on strong profits for Deere.\nXpeng(XPEV) – The China-based electric vehicle maker said it has surpassed 100,000 cars produced, coming six years after the company launched. Shares rose 1.3% in the premarket, while Chinese rival Nio gained 1.5%.\nConocoPhillips(COP) – The energy producer's shares were downgraded to \"neutral\" from \"buy\" at Goldman Sachs, which cited valuation for the move. The stock has gained 88% this year and was up another 1.3% in the premarket.\nCleveland-Cliffs(CLF) – The steel and iron producer's shares gained 1.8% in premarket trading after it announced the acquisition of iron scrap processor Ferrous Processing and Trading for about $775 million.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"AAPL":0.9,"APA":0.9,"AZPN":0.9,"BAC":0.9,"C":0.9,"CLF":0.9,"COP":0.9,"CVX":0.9,"DE":0.9,"ESmain":0.9,"NQmain":0.9,"YMmain":0.9,"GS":0.9,"JPM":0.9,"LUV":0.9,"MRK":0.9,"MS":0.9,"NIO":0.9,"SBUX":0.9,"SOFI":0.9,"XOM":0.9,"XPEV":0.9}},"isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865581796,"gmtCreate":1633001204950,"gmtModify":1633001205218,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586429646894350","authorIdStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/865581796","repostId":"2171930838","repostType":4,"isVote":1,"tweetType":1,"viewCount":468,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":886575977,"gmtCreate":1631610541399,"gmtModify":1631891053168,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586429646894350","authorIdStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment ","listText":"Like and comment ","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/886575977","repostId":"1160275332","repostType":4,"repost":{"id":"1160275332","kind":"news","pubTimestamp":1631604098,"share":"https://ttm.financial/m/news/1160275332?lang=&edition=full","pubTime":"2021-09-14 15:21","market":"us","language":"en","title":"Busy IPO market this week poised to make 2021 the biggest year ever by proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=1160275332","media":"MarketWatch","summary":"Swiss running-shoe company backed by Roger Federer and drive-through coffee chain expected to hit th","content":"<p>Swiss running-shoe company backed by Roger Federer and drive-through coffee chain expected to hit the market this week </p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/18111af5f5bda21b3128860fe616c5ca\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Swiss tennis giant Roger Federer is a backer of one of this week's bigger IPOs.</span></p>\n<p></p>\n<p></p>\n<p>After a flurry of initial-public-offering launches last week set the market up for a busy fall for deals, 11 are expected to price this week and raise more than $3 billion in proceeds. </p>\n<p></p>\n<p>If all deals materialize, it will make 2021 the biggest year for IPO proceeds ever, and shatter the previous record by about 30%, according to Bill Smith, founder and chief executive of Renaissance Capital, a provider of institutional research and exchange-traded funds oriented around IPOs. The market is expected to see some 375 deals for the year, raising $125 billion, according to Renaissance, beating the $97 billion raised in 2000 during the dot-com boom. </p>\n<p></p>\n<p>“After the long summer break, this week is a litmus test for upcoming tech, biotech, and consumer IPOs,” Smith wrote in a market commentary. The list includes a Swiss running-shoe company backed by tennis giant Roger Federer, a drive-through coffee kiosk operator and a mortgage insurer that was spun out of insurer Genworth Financial. </p>\n<p></p>\n<p>The biggest deal of the week is expected to come from Thoughtworks,a Chicago-based technology consultancy that will go public at a valuation of up to $6.1 billion.</p>\n<p>The company, which expects to change its name from Turing Holding Corp. to Thoughtworks with completion of the IPO, said a total of 36.84 million shares will be offered, split between the company and selling shareholders.</p>\n<p></p>\n<p>The deal is expected to price at between $18 and $20 a share, and the stock will trade on the Nasdaq under the ticker symbol “TWKS.” Goldman Sachs and JPMorgan are the lead underwriters. The company recorded net income of $79.3 million on revenue of $803.4 million in 2020, after income of $28.4 million on revenue of $772.2 million in 2019.</p>\n<p>The Swiss athletic-footwear maker On Holding is expected to raise up to $622 million at a valuation of almost $6 billion. On has applied to list 31.1 million shares priced at $18 to $20 each on the New York Stock Exchange, under the ticker symbol “ONON.”</p>\n<p></p>\n<p>Goldman Sachs, Morgan Stanley and Morgan Stanley are lead underwriters in a syndicate of nine banks on the On deal. Proceeds are to be used for general corporate purposes. The company has a line that it co-developed with Federer.</p>\n<p></p>\n<p>The company had net income of 3.8 million Swiss francs ($4.1 million) in the six months through June 30, after a loss of 33.1 million francs in the year-earlier period, according to its IPO documents. Sales came to 315.5 million francs, up from 170.9 million francs.</p>\n<p></p>\n<p>Also from Switzerland, sports betting site Sportrader Group AG plans to offer 19 million shares priced at $25 to $28 each, for a valuation of up to $31 billion. The company has applied to list on Nasdaq under the ticker symbol “SRAD.” JPMorgan, Morgan Stanley, Citigroup and UBS are lead underwriters in a syndicate of 13 banks working on the deal.</p>\n<p></p>\n<p>Proceeds are to be used for working capital and to spur growth. The company had a net profit of $29.9 million in the first six months of the year, on revenue of $321 million, according to its filing documents.</p>\n<p></p>\n<p>Dutch Bros Inc.,an operator of drive-through shops that serve hot and cold drinks mostly in western U.S. states, is planning to offer 21.1 million shares priced at $18 to $20 each in its IPO, valuing the company at up to $3.3 billion.</p>\n<p></p>\n<p>BofA Securities, JPMorgan and Jefferies are lead underwriters in a syndicate of 13 banks working on the deal. The company has applied to list on the New York Stock Exchange under the ticker symbol “BROS.”</p>\n<p>Proceeds are to be used to purchase additional Class A shares — the company is planning to have four classes of stock with differing voting rights. The company had a net loss of $13.6 million, or 32 cents a share, in the first six months of the year, narrower than the loss of $16.5 million, or 38 cents a share, posted in the year-earlier period. Revenue fell to $227.9 million from $327.4 million.</p>\n<p></p>\n<p><b>Rounding out the list are:</b></p>\n<p>• Definitive Healthcare Corp., a Massachusetts-based provider of healthcare commercial intelligence, is planning to offer 15.56 million shares in its PO, which is expected to price between $21 and $24 a share. At that pricing, the company could be valued at up to $3.55 billion.</p>\n<p>• Enact Holdings Inc., a mortgage insurer owned by Genworth, is planning to offer 13.3 million shares priced at $19 to $20 each. The company would be valued at $3.3 billion at the top of that range. The company said all shares will be sold by Genworth and it will not receive any proceeds. It has applied to list on Nasdaq under the ticker “ACT.” Goldman Sachs and JPMorgan are lead underwriters in a team of nine banks working on the deal.</p>\n<p>• ForgeRock<a href=\"https://www.marketwatch.com/investing/stock/FORG?mod=MW_story_quote&mod=article_inline\" target=\"_blank\">,</a> a California-based identity security platform, is looking to raise up to $264 million with an offering of 11 million shares priced between $21 and $24 a share. That pricing would value the company a valuation of up to $1.91 billion.</p>\n<p>The stock is expected to list on the NYSE under the ticker symbol “FORG.” Morgan Stanley and JPMorgan are the lead underwriters. The company recorded a net loss of $41.8 million on revenue of $127.6 million in 2020, after a loss of $36.9 million on revenue of $104.5 million in 2019.</p>\n<p><b>•</b>Dice Therapeutics is expected to raise up to $170 million at a valuation of up to $583 million and list on Nasdaq under the ticker symbol “DICE.” The biotech is developing therapies to treat chronic diseases in the field of immunology.</p>\n<p><b>•</b>Surgical robotics developer Procept BioRobotics,is aiming to raise up to $132 million at a valuation of about $1 billion with plans to list on Nasdaq under the ticker symbol “PRCT.” BofA Securities and Goldman Sachs are lead underwriters.</p>\n<p>“We develop, manufacture and sell the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia, or BPH,” the company says in its IPO documents.</p>\n<p><b>•</b>Tyra Biosciences is aiming to raise $107.2 million in IPO proceeds at a valuation of $589 million. The biotech’s leading product candidate is a treatment for bladder cancer. It has applied to list on Nasdaq under the symbol “TYRA.”</p>\n<p><b>•</b>EzFill Holdings, an app-based mobile fueling company in South Florida, is planning to raise $25 million at a valuation of $100 million. The company has applied to list on Nasdaq under the ticker symbol “EZFL.” ThinkEquity is sole underwriter.</p>\n<p>The Renaissance IPO ETF has gained 6% to date in 2021, while the S&P 500 has advanced 19%.</p>\n<p></p>\n<p></p>\n<p></p>\n<p></p>\n<p></p>\n<p></p>\n<p></p>\n<p></p>\n<p></p>\n<p></p>\n<p></p>\n<p></p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Busy IPO market this week poised to make 2021 the biggest year ever by proceeds</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBusy IPO market this week poised to make 2021 the biggest year ever by proceeds\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-14 15:21 GMT+8 <a href=https://www.marketwatch.com/story/busy-ipo-market-this-week-may-make-2021-the-biggest-year-for-proceeds-and-break-previous-record-by-30-11631554372?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Swiss running-shoe company backed by Roger Federer and drive-through coffee chain expected to hit the market this week \nSwiss tennis giant Roger Federer is a backer of one of this week's bigger IPOs.\n...</p>\n\n<a href=\"https://www.marketwatch.com/story/busy-ipo-market-this-week-may-make-2021-the-biggest-year-for-proceeds-and-break-previous-record-by-30-11631554372?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PRCT":"PROCEPT BioRobotics",".DJI":"道琼斯","BROS":"Dutch Bros Inc.","ONON":"On Holding AG","FORG":"ForgeRock, Inc.",".SPX":"S&P 500 Index","DH":"Definitive Healthcare Corp.","SRAD":"Sportradar Group AG","DRNA":"Dicerna Pharmaceuticals, Inc.","TYRA":"Tyra Biosciences, Inc.",".IXIC":"NASDAQ Composite","TWKS":"Thoughtworks Holding Inc."},"source_url":"https://www.marketwatch.com/story/busy-ipo-market-this-week-may-make-2021-the-biggest-year-for-proceeds-and-break-previous-record-by-30-11631554372?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160275332","content_text":"Swiss running-shoe company backed by Roger Federer and drive-through coffee chain expected to hit the market this week \nSwiss tennis giant Roger Federer is a backer of one of this week's bigger IPOs.\n\n\nAfter a flurry of initial-public-offering launches last week set the market up for a busy fall for deals, 11 are expected to price this week and raise more than $3 billion in proceeds. \n\nIf all deals materialize, it will make 2021 the biggest year for IPO proceeds ever, and shatter the previous record by about 30%, according to Bill Smith, founder and chief executive of Renaissance Capital, a provider of institutional research and exchange-traded funds oriented around IPOs. The market is expected to see some 375 deals for the year, raising $125 billion, according to Renaissance, beating the $97 billion raised in 2000 during the dot-com boom. \n\n“After the long summer break, this week is a litmus test for upcoming tech, biotech, and consumer IPOs,” Smith wrote in a market commentary. The list includes a Swiss running-shoe company backed by tennis giant Roger Federer, a drive-through coffee kiosk operator and a mortgage insurer that was spun out of insurer Genworth Financial. \n\nThe biggest deal of the week is expected to come from Thoughtworks,a Chicago-based technology consultancy that will go public at a valuation of up to $6.1 billion.\nThe company, which expects to change its name from Turing Holding Corp. to Thoughtworks with completion of the IPO, said a total of 36.84 million shares will be offered, split between the company and selling shareholders.\n\nThe deal is expected to price at between $18 and $20 a share, and the stock will trade on the Nasdaq under the ticker symbol “TWKS.” Goldman Sachs and JPMorgan are the lead underwriters. The company recorded net income of $79.3 million on revenue of $803.4 million in 2020, after income of $28.4 million on revenue of $772.2 million in 2019.\nThe Swiss athletic-footwear maker On Holding is expected to raise up to $622 million at a valuation of almost $6 billion. On has applied to list 31.1 million shares priced at $18 to $20 each on the New York Stock Exchange, under the ticker symbol “ONON.”\n\nGoldman Sachs, Morgan Stanley and Morgan Stanley are lead underwriters in a syndicate of nine banks on the On deal. Proceeds are to be used for general corporate purposes. The company has a line that it co-developed with Federer.\n\nThe company had net income of 3.8 million Swiss francs ($4.1 million) in the six months through June 30, after a loss of 33.1 million francs in the year-earlier period, according to its IPO documents. Sales came to 315.5 million francs, up from 170.9 million francs.\n\nAlso from Switzerland, sports betting site Sportrader Group AG plans to offer 19 million shares priced at $25 to $28 each, for a valuation of up to $31 billion. The company has applied to list on Nasdaq under the ticker symbol “SRAD.” JPMorgan, Morgan Stanley, Citigroup and UBS are lead underwriters in a syndicate of 13 banks working on the deal.\n\nProceeds are to be used for working capital and to spur growth. The company had a net profit of $29.9 million in the first six months of the year, on revenue of $321 million, according to its filing documents.\n\nDutch Bros Inc.,an operator of drive-through shops that serve hot and cold drinks mostly in western U.S. states, is planning to offer 21.1 million shares priced at $18 to $20 each in its IPO, valuing the company at up to $3.3 billion.\n\nBofA Securities, JPMorgan and Jefferies are lead underwriters in a syndicate of 13 banks working on the deal. The company has applied to list on the New York Stock Exchange under the ticker symbol “BROS.”\nProceeds are to be used to purchase additional Class A shares — the company is planning to have four classes of stock with differing voting rights. The company had a net loss of $13.6 million, or 32 cents a share, in the first six months of the year, narrower than the loss of $16.5 million, or 38 cents a share, posted in the year-earlier period. Revenue fell to $227.9 million from $327.4 million.\n\nRounding out the list are:\n• Definitive Healthcare Corp., a Massachusetts-based provider of healthcare commercial intelligence, is planning to offer 15.56 million shares in its PO, which is expected to price between $21 and $24 a share. At that pricing, the company could be valued at up to $3.55 billion.\n• Enact Holdings Inc., a mortgage insurer owned by Genworth, is planning to offer 13.3 million shares priced at $19 to $20 each. The company would be valued at $3.3 billion at the top of that range. The company said all shares will be sold by Genworth and it will not receive any proceeds. It has applied to list on Nasdaq under the ticker “ACT.” Goldman Sachs and JPMorgan are lead underwriters in a team of nine banks working on the deal.\n• ForgeRock, a California-based identity security platform, is looking to raise up to $264 million with an offering of 11 million shares priced between $21 and $24 a share. That pricing would value the company a valuation of up to $1.91 billion.\nThe stock is expected to list on the NYSE under the ticker symbol “FORG.” Morgan Stanley and JPMorgan are the lead underwriters. The company recorded a net loss of $41.8 million on revenue of $127.6 million in 2020, after a loss of $36.9 million on revenue of $104.5 million in 2019.\n•Dice Therapeutics is expected to raise up to $170 million at a valuation of up to $583 million and list on Nasdaq under the ticker symbol “DICE.” The biotech is developing therapies to treat chronic diseases in the field of immunology.\n•Surgical robotics developer Procept BioRobotics,is aiming to raise up to $132 million at a valuation of about $1 billion with plans to list on Nasdaq under the ticker symbol “PRCT.” BofA Securities and Goldman Sachs are lead underwriters.\n“We develop, manufacture and sell the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia, or BPH,” the company says in its IPO documents.\n•Tyra Biosciences is aiming to raise $107.2 million in IPO proceeds at a valuation of $589 million. The biotech’s leading product candidate is a treatment for bladder cancer. It has applied to list on Nasdaq under the symbol “TYRA.”\n•EzFill Holdings, an app-based mobile fueling company in South Florida, is planning to raise $25 million at a valuation of $100 million. The company has applied to list on Nasdaq under the ticker symbol “EZFL.” ThinkEquity is sole underwriter.\nThe Renaissance IPO ETF has gained 6% to date in 2021, while the S&P 500 has advanced 19%.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"ACT.UK":0.9,"BROS":0.9,"DH":0.9,"DRNA":0.9,"FORG":0.9,"ONON":0.9,"PRCT":0.9,"SRAD":0.9,"TWKS":0.9,"TYRA":0.9}},"isVote":1,"tweetType":1,"viewCount":140,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":175197508,"gmtCreate":1627011865004,"gmtModify":1633768783383,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586429646894350","authorIdStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/175197508","repostId":"1164478982","repostType":4,"isVote":1,"tweetType":1,"viewCount":341,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":602710172,"gmtCreate":1639065290056,"gmtModify":1639065969239,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586429646894350","authorIdStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/602710172","repostId":"1134628800","repostType":4,"repost":{"id":"1134628800","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639064594,"share":"https://ttm.financial/m/news/1134628800?lang=&edition=full","pubTime":"2021-12-09 23:43","market":"us","language":"en","title":"10 Biggest Price Target Changes For Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=1134628800","media":"Benzinga","summary":"SVB Leerink boosted the price target on Edwards Lifesciences Corporation from $130 to $135. Edwards ","content":"<ul>\n <li>SVB Leerink boosted the price target on <b>Edwards Lifesciences Corporation</b> from $130 to $135. Edwards Lifesciences shares rose 1% to trade at $120.68 on Thursday.</li>\n <li>Keybanc raised <b>The Sherwin-Williams Company</b> price target from $350 to $384. Sherwin-Williams shares rose 1% to $345.68 on Thursday.</li>\n <li>Piper Sandler cut <b>Udemy, Inc.</b> price target from $37 to $34. Udemy shares fell 2% to trade at $20.65 on Thursday.</li>\n <li>Needham lowered the price target on <b>Esperion Therapeutics, Inc.</b> from $20 to $12. Esperion Therapeutics shares dropped 9% to $5.34 on Thursday.</li>\n <li>JP Morgan lifted <b>Phillips 66</b> price target from $83 to $93. Phillips 66 shares rose 0.7% to $72.36 on Thursday.</li>\n <li>RBC Capital cut the price target for <b>Cincinnati Financial Corporation</b> from $135 to $130. Cincinnati Financial shares fell 1.7% to $115.23 on Thursday.</li>\n <li>Chardan Capital raised <b>Dicerna Pharmaceuticals, Inc.</b> price target from $28 to $38.25. Dicerna Pharmaceuticals shares rose 0.1% to $38.03 on Thursday.</li>\n <li>Morgan Stanley boosted the price target on <b>Oshkosh Corporation</b> from $134 to $144. Oshkosh shares fell 1.4% to trade at $111.45 on Thursday.</li>\n <li>Wells Fargo cut the price target for <b>Dow Inc.</b> from $75 to $67. Dow shares fell 0.8% to $54.49 on Thursday.</li>\n <li>Barclays raised <b>McKesson Corporation</b> price target from $270 to $290. McKesson shares rose 1.1% to $229.33 on Thursday.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10 Biggest Price Target Changes For Thursday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10 Biggest Price Target Changes For Thursday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-09 23:43</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>SVB Leerink boosted the price target on <b>Edwards Lifesciences Corporation</b> from $130 to $135. Edwards Lifesciences shares rose 1% to trade at $120.68 on Thursday.</li>\n <li>Keybanc raised <b>The Sherwin-Williams Company</b> price target from $350 to $384. Sherwin-Williams shares rose 1% to $345.68 on Thursday.</li>\n <li>Piper Sandler cut <b>Udemy, Inc.</b> price target from $37 to $34. Udemy shares fell 2% to trade at $20.65 on Thursday.</li>\n <li>Needham lowered the price target on <b>Esperion Therapeutics, Inc.</b> from $20 to $12. Esperion Therapeutics shares dropped 9% to $5.34 on Thursday.</li>\n <li>JP Morgan lifted <b>Phillips 66</b> price target from $83 to $93. Phillips 66 shares rose 0.7% to $72.36 on Thursday.</li>\n <li>RBC Capital cut the price target for <b>Cincinnati Financial Corporation</b> from $135 to $130. Cincinnati Financial shares fell 1.7% to $115.23 on Thursday.</li>\n <li>Chardan Capital raised <b>Dicerna Pharmaceuticals, Inc.</b> price target from $28 to $38.25. Dicerna Pharmaceuticals shares rose 0.1% to $38.03 on Thursday.</li>\n <li>Morgan Stanley boosted the price target on <b>Oshkosh Corporation</b> from $134 to $144. Oshkosh shares fell 1.4% to trade at $111.45 on Thursday.</li>\n <li>Wells Fargo cut the price target for <b>Dow Inc.</b> from $75 to $67. Dow shares fell 0.8% to $54.49 on Thursday.</li>\n <li>Barclays raised <b>McKesson Corporation</b> price target from $270 to $290. McKesson shares rose 1.1% to $229.33 on Thursday.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ESPR":"Esperion Therapeutics Inc.","DOW":"陶氏化学","SHW":"宣伟公司","OSK":"Oshkosh","PSX":"Phillips 66","UDMY":"Udemy, Inc.","CINF":"辛辛那提金融","EW":"爱德华兹","DRNA":"Dicerna Pharmaceuticals, Inc.","MCK":"麦克森药物批发"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134628800","content_text":"SVB Leerink boosted the price target on Edwards Lifesciences Corporation from $130 to $135. Edwards Lifesciences shares rose 1% to trade at $120.68 on Thursday.\nKeybanc raised The Sherwin-Williams Company price target from $350 to $384. Sherwin-Williams shares rose 1% to $345.68 on Thursday.\nPiper Sandler cut Udemy, Inc. price target from $37 to $34. Udemy shares fell 2% to trade at $20.65 on Thursday.\nNeedham lowered the price target on Esperion Therapeutics, Inc. from $20 to $12. Esperion Therapeutics shares dropped 9% to $5.34 on Thursday.\nJP Morgan lifted Phillips 66 price target from $83 to $93. Phillips 66 shares rose 0.7% to $72.36 on Thursday.\nRBC Capital cut the price target for Cincinnati Financial Corporation from $135 to $130. Cincinnati Financial shares fell 1.7% to $115.23 on Thursday.\nChardan Capital raised Dicerna Pharmaceuticals, Inc. price target from $28 to $38.25. Dicerna Pharmaceuticals shares rose 0.1% to $38.03 on Thursday.\nMorgan Stanley boosted the price target on Oshkosh Corporation from $134 to $144. Oshkosh shares fell 1.4% to trade at $111.45 on Thursday.\nWells Fargo cut the price target for Dow Inc. from $75 to $67. Dow shares fell 0.8% to $54.49 on Thursday.\nBarclays raised McKesson Corporation price target from $270 to $290. McKesson shares rose 1.1% to $229.33 on Thursday.","news_type":1,"symbols_score_info":{"CINF":0.9,"DOW":0.9,"DRNA":0.9,"ESPR":0.9,"EW":0.9,"MCK":0.9,"OSK":0.9,"PSX":0.9,"SHW":0.9,"UDMY":0.9}},"isVote":1,"tweetType":1,"viewCount":1836,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609672501,"gmtCreate":1638283517660,"gmtModify":1638283517776,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586429646894350","authorIdStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/609672501","repostId":"1137874601","repostType":4,"repost":{"id":"1137874601","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638283295,"share":"https://ttm.financial/m/news/1137874601?lang=&edition=full","pubTime":"2021-11-30 22:41","market":"us","language":"en","title":"Blockchain stocks climbed in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1137874601","media":"Tiger Newspress","summary":"Blockchain stocks climbed in morning trading.Riot Blockchain,Marathon Digital,Coinbase,Canaan and Th","content":"<p>Blockchain stocks climbed in morning trading.Riot Blockchain,Marathon Digital,Coinbase,Canaan and The9 rose about 2%.</p>\n<p><img src=\"https://static.tigerbbs.com/c7eb0aac146941578f4f85ad0dec90de\" tg-width=\"406\" tg-height=\"353\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Blockchain stocks climbed in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBlockchain stocks climbed in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-30 22:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Blockchain stocks climbed in morning trading.Riot Blockchain,Marathon Digital,Coinbase,Canaan and The9 rose about 2%.</p>\n<p><img src=\"https://static.tigerbbs.com/c7eb0aac146941578f4f85ad0dec90de\" tg-width=\"406\" tg-height=\"353\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RIOT":"Riot Platforms"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137874601","content_text":"Blockchain stocks climbed in morning trading.Riot Blockchain,Marathon Digital,Coinbase,Canaan and The9 rose about 2%.","news_type":1,"symbols_score_info":{"RIOT":0.9}},"isVote":1,"tweetType":1,"viewCount":546,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":881011317,"gmtCreate":1631281063439,"gmtModify":1631891053212,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586429646894350","authorIdStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/881011317","repostId":"2166237337","repostType":4,"repost":{"id":"2166237337","kind":"highlight","pubTimestamp":1631280187,"share":"https://ttm.financial/m/news/2166237337?lang=&edition=full","pubTime":"2021-09-10 21:23","market":"us","language":"en","title":"4 of the Safest Dividend Stocks That'll Help You Crush Inflation","url":"https://stock-news.laohu8.com/highlight/detail?id=2166237337","media":"Motley Fool","summary":"Inflation is high today, but don't get scared. These four dividend stocks have handily beat inflation over the long term.","content":"<p>Right now inflation is spiking, so it's on everyone's mind. But it's always there, slowly eating away at the buying power of your dividends over time. The best way to deal with inflation is to own some dividend stocks with historically high levels of dividend growth. Here are four to consider today to help you win the prolonged war against inflation.</p>\n<h3>1. We gotta eat</h3>\n<p><b>Hormel Foods</b> (NYSE:HRL) owns well-regarded, often iconic, brands like SPAM, Skippy, Planters, and Wholly Guacamole. It is fiscally conservative and focuses on innovation. The food maker is expanding overseas and reaching into new distribution segments, augmenting its already strong position in the U.S. grocery and foodservice space. There is a lot to like about this company.</p>\n<p><img src=\"https://static.tigerbbs.com/06bccf8aa0aa78d1c0a7e773d5ea3f85\" tg-width=\"700\" tg-height=\"463\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<p>The stock's 2.3% dividend yield may not be huge, but is well above the miserly 1.3% on offer from the <b>S&P 500</b> index. But the real magic is that Hormel has increased its dividend annually for 55 consecutive years. The average annualized hike over the past decade was a massive 15%. That's five times the 3% historical rate of inflation growth.</p>\n<p>The best part here, however, is that this Dividend King's yield is toward the high end of its historical range. That's partly due to the impact rising inflation will have on its business in the near term (which will probably slow near-term dividend growth some), but the company's long-term history suggests it will adjust and reward investors with strong dividend growth while it does.</p>\n<h3>2. Most people like it hot</h3>\n<p><b>A. O. Smith</b> (NYSE:AOS) makes hot water heaters, which is not a particularly sexy business unless you have to take a cold shower. Then you realize why the developing world, notably China and India, are such massive growth opportunities for the company. This is not a new trend or <a href=\"https://laohu8.com/S/AONE.U\">one</a> that's likely to be short-term in nature. Basically, A. O. Smith has a growing business in areas where an expanding middle class all want the luxury of hot water on demand. And that, as it were, is backed by a solid and stable foundation in the North American market, where replacements of older systems is the driving force. It has been a potent mix for dividend investors.</p>\n<p>Like Hormel, A. O. Smith's dividend yield, at around 1.4%, is not giant. But its dividend growth has been nothing short of incredible, at an annualized 21% over the past decade. For reference, the industrial company is a Dividend Aristocrat with 28 years' worth of dividend increases under its belt. Simply put, the buying power of A. O. Smith's dividend has grown massively over time and easily kept investors ahead of inflation. Recent dividend hikes have been less impressive, to be fair, but they continue to outpace inflation by a sizable margin.</p>\n<h3>3. Not as mundane as it seems</h3>\n<p><b>NextEra Energy</b> (NYSE:NEE) might be a bit of a shock on this list, given that utilities are generally looked at as slow, safe, and boring. And that's a great description for the company's Florida Power & Light business, which is one of the largest electric utility operations in the United States. Not only is it big -- this business has long benefited from the southward migration that's been taking place in the country. The thing is, that's just half of what NextEra does. The rest of the business is being a giant provider of renewable power, a high-growth sector that has helped to fuel this utility's dividend growth for many years.</p>\n<p><img src=\"https://media.ycharts.com/charts/2ca1f5068ba536739137e72323751cae.png\" tg-width=\"720\" tg-height=\"483\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>HRL Dividend Per Share (Quarterly) data by YCharts</p>\n<p>NextEra's dividend has increased at a 10% annualized clip over the past decade, a pace management believes is sustainable over the near term. That's huge growth for a utility. And, perhaps just as interesting, this is no flash-in-the-pan company, given its 27-year string of annual dividend increases. The stock's 1.8% yield is on the low side for a utility, but if you are trying to tame inflation with dividend growth stocks, NextEra is a strong option and could add valuable diversification to your portfolio.</p>\n<h3>4. A slow transition</h3>\n<p><b>Enbridge</b> (NYSE:ENB), the last name on this list, juxtaposes against NextEra, given that its core business is operating midstream energy assets that help move oil and natural gas around the world. The big picture here is important, however, because while clean energy is definitely growing in importance, it will likely be decades before carbon fuels are expunged from the global energy pie. So Enbridge's massive, virtually irreplaceable, and largely fee-based business likely has a long future ahead of it. In fact, the company continues to invest in its midstream operations even as it has started to build out its own renewables business, so it doesn't get left behind over the long term.</p>\n<p>But what's interesting here is that Enbridge has increased its dividend at a robust 10% clip over the past decade. Oh, and the fat 6.6% dividend yield thanks to the company's energy industry ties is pretty interesting, too. The dividend, for reference, has been increased annually for 26 consecutive years. The company also has material investment plans that should keep its dividend growing. The rate of growth, given the rising cost environment, may not match the historical rate, but it should still beat inflation. That makes this a great mix of yield and inflation protection.</p>\n<h3>You can fight inflation</h3>\n<p>Inflation, like most things in life, waxes and wanes over time. Right now inflation is top of mind because it is elevated, but it is something that dividend investors should always be thinking about. Growing the buying power of your dividends is a massive benefit that is far too often overlooked in a search for the biggest yields. Use today's inflation fears as a lesson that dividend growth rates stand toe to toe with yield in their importance and do a deep dive into Hormel, A. O. Smith, NextEra, and Enbridge today.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 of the Safest Dividend Stocks That'll Help You Crush Inflation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 of the Safest Dividend Stocks That'll Help You Crush Inflation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-10 21:23 GMT+8 <a href=https://www.fool.com/investing/2021/09/10/4-of-the-safest-dividend-stocks-thatll-help-you-cr/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Right now inflation is spiking, so it's on everyone's mind. But it's always there, slowly eating away at the buying power of your dividends over time. The best way to deal with inflation is to own ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/10/4-of-the-safest-dividend-stocks-thatll-help-you-cr/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AOS":"A.O.史密斯","HRL":"荷美尔","NEE":"新纪元能源","ENB":"安桥"},"source_url":"https://www.fool.com/investing/2021/09/10/4-of-the-safest-dividend-stocks-thatll-help-you-cr/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2166237337","content_text":"Right now inflation is spiking, so it's on everyone's mind. But it's always there, slowly eating away at the buying power of your dividends over time. The best way to deal with inflation is to own some dividend stocks with historically high levels of dividend growth. Here are four to consider today to help you win the prolonged war against inflation.\n1. We gotta eat\nHormel Foods (NYSE:HRL) owns well-regarded, often iconic, brands like SPAM, Skippy, Planters, and Wholly Guacamole. It is fiscally conservative and focuses on innovation. The food maker is expanding overseas and reaching into new distribution segments, augmenting its already strong position in the U.S. grocery and foodservice space. There is a lot to like about this company.\n\nImage source: Getty Images.\nThe stock's 2.3% dividend yield may not be huge, but is well above the miserly 1.3% on offer from the S&P 500 index. But the real magic is that Hormel has increased its dividend annually for 55 consecutive years. The average annualized hike over the past decade was a massive 15%. That's five times the 3% historical rate of inflation growth.\nThe best part here, however, is that this Dividend King's yield is toward the high end of its historical range. That's partly due to the impact rising inflation will have on its business in the near term (which will probably slow near-term dividend growth some), but the company's long-term history suggests it will adjust and reward investors with strong dividend growth while it does.\n2. Most people like it hot\nA. O. Smith (NYSE:AOS) makes hot water heaters, which is not a particularly sexy business unless you have to take a cold shower. Then you realize why the developing world, notably China and India, are such massive growth opportunities for the company. This is not a new trend or one that's likely to be short-term in nature. Basically, A. O. Smith has a growing business in areas where an expanding middle class all want the luxury of hot water on demand. And that, as it were, is backed by a solid and stable foundation in the North American market, where replacements of older systems is the driving force. It has been a potent mix for dividend investors.\nLike Hormel, A. O. Smith's dividend yield, at around 1.4%, is not giant. But its dividend growth has been nothing short of incredible, at an annualized 21% over the past decade. For reference, the industrial company is a Dividend Aristocrat with 28 years' worth of dividend increases under its belt. Simply put, the buying power of A. O. Smith's dividend has grown massively over time and easily kept investors ahead of inflation. Recent dividend hikes have been less impressive, to be fair, but they continue to outpace inflation by a sizable margin.\n3. Not as mundane as it seems\nNextEra Energy (NYSE:NEE) might be a bit of a shock on this list, given that utilities are generally looked at as slow, safe, and boring. And that's a great description for the company's Florida Power & Light business, which is one of the largest electric utility operations in the United States. Not only is it big -- this business has long benefited from the southward migration that's been taking place in the country. The thing is, that's just half of what NextEra does. The rest of the business is being a giant provider of renewable power, a high-growth sector that has helped to fuel this utility's dividend growth for many years.\n\nHRL Dividend Per Share (Quarterly) data by YCharts\nNextEra's dividend has increased at a 10% annualized clip over the past decade, a pace management believes is sustainable over the near term. That's huge growth for a utility. And, perhaps just as interesting, this is no flash-in-the-pan company, given its 27-year string of annual dividend increases. The stock's 1.8% yield is on the low side for a utility, but if you are trying to tame inflation with dividend growth stocks, NextEra is a strong option and could add valuable diversification to your portfolio.\n4. A slow transition\nEnbridge (NYSE:ENB), the last name on this list, juxtaposes against NextEra, given that its core business is operating midstream energy assets that help move oil and natural gas around the world. The big picture here is important, however, because while clean energy is definitely growing in importance, it will likely be decades before carbon fuels are expunged from the global energy pie. So Enbridge's massive, virtually irreplaceable, and largely fee-based business likely has a long future ahead of it. In fact, the company continues to invest in its midstream operations even as it has started to build out its own renewables business, so it doesn't get left behind over the long term.\nBut what's interesting here is that Enbridge has increased its dividend at a robust 10% clip over the past decade. Oh, and the fat 6.6% dividend yield thanks to the company's energy industry ties is pretty interesting, too. The dividend, for reference, has been increased annually for 26 consecutive years. The company also has material investment plans that should keep its dividend growing. The rate of growth, given the rising cost environment, may not match the historical rate, but it should still beat inflation. That makes this a great mix of yield and inflation protection.\nYou can fight inflation\nInflation, like most things in life, waxes and wanes over time. Right now inflation is top of mind because it is elevated, but it is something that dividend investors should always be thinking about. Growing the buying power of your dividends is a massive benefit that is far too often overlooked in a search for the biggest yields. Use today's inflation fears as a lesson that dividend growth rates stand toe to toe with yield in their importance and do a deep dive into Hormel, A. O. Smith, NextEra, and Enbridge today.","news_type":1,"symbols_score_info":{"AOS":0.9,"ENB":0.9,"HRL":0.9,"NEE":0.9}},"isVote":1,"tweetType":1,"viewCount":202,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":808007287,"gmtCreate":1627540583949,"gmtModify":1633763971170,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586429646894350","authorIdStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment ","listText":"Like and comment ","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/808007287","repostId":"2155970036","repostType":4,"repost":{"id":"2155970036","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627540126,"share":"https://ttm.financial/m/news/2155970036?lang=&edition=full","pubTime":"2021-07-29 14:28","market":"hk","language":"en","title":"China's funeral group Fu Shou Yuan eyes best day in 3 years on robust forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2155970036","media":"Reuters","summary":"** Shares of burial and funeral services provider Fu Shou Yuan International Group Ltd jump l0.1%, o","content":"<p>** Shares of burial and funeral services provider Fu Shou Yuan International Group Ltd jump l0.1%, on course for their best day since August 2018</p>\n<p>** Stock rises as far as HK$7.73, its highest since June 30 and extending gains for a second session</p>\n<p>** Shanghai-based co expects profit and total comprehensive income of not less than 450 mln yuan ($69.5 mln) for the six months ended in June, up from 307.4 mln yuan a year ago</p>\n<p>** Cites revenue growth of more than 50% on improving operation capability, contribution from newly-acquired projects and business recovery from the COVID-19 pandemic</p>\n<p>** Says financial position is stable and it is confident about long-term business prospects</p>\n<p>** Citi reiterates \"buy\", saying stock has fallen 20% since early June on concerns over regulation risk</p>\n<p>** Says sees no escalation of regulation risk for the deathcare industry amid its small 150 bln yuan market size and little correlation to CPI growth</p>\n<p>** The Hong Kong Hang Seng Commerce & Industry Index jumps 5.1%, and the Hang Seng Composite Index surges 3.5%</p>\n<p>** The Hang Seng China Enterprises Index rises 3.6%, and the benchmark index climbs 3.1%</p>\n<p>** By last close, the stock had slid 6.6% this year ($1 = 6.4724 Chinese yuan)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China's funeral group Fu Shou Yuan eyes best day in 3 years on robust forecast</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina's funeral group Fu Shou Yuan eyes best day in 3 years on robust forecast\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-29 14:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>** Shares of burial and funeral services provider Fu Shou Yuan International Group Ltd jump l0.1%, on course for their best day since August 2018</p>\n<p>** Stock rises as far as HK$7.73, its highest since June 30 and extending gains for a second session</p>\n<p>** Shanghai-based co expects profit and total comprehensive income of not less than 450 mln yuan ($69.5 mln) for the six months ended in June, up from 307.4 mln yuan a year ago</p>\n<p>** Cites revenue growth of more than 50% on improving operation capability, contribution from newly-acquired projects and business recovery from the COVID-19 pandemic</p>\n<p>** Says financial position is stable and it is confident about long-term business prospects</p>\n<p>** Citi reiterates \"buy\", saying stock has fallen 20% since early June on concerns over regulation risk</p>\n<p>** Says sees no escalation of regulation risk for the deathcare industry amid its small 150 bln yuan market size and little correlation to CPI growth</p>\n<p>** The Hong Kong Hang Seng Commerce & Industry Index jumps 5.1%, and the Hang Seng Composite Index surges 3.5%</p>\n<p>** The Hang Seng China Enterprises Index rises 3.6%, and the benchmark index climbs 3.1%</p>\n<p>** By last close, the stock had slid 6.6% this year ($1 = 6.4724 Chinese yuan)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"01448":"福寿园"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155970036","content_text":"** Shares of burial and funeral services provider Fu Shou Yuan International Group Ltd jump l0.1%, on course for their best day since August 2018\n** Stock rises as far as HK$7.73, its highest since June 30 and extending gains for a second session\n** Shanghai-based co expects profit and total comprehensive income of not less than 450 mln yuan ($69.5 mln) for the six months ended in June, up from 307.4 mln yuan a year ago\n** Cites revenue growth of more than 50% on improving operation capability, contribution from newly-acquired projects and business recovery from the COVID-19 pandemic\n** Says financial position is stable and it is confident about long-term business prospects\n** Citi reiterates \"buy\", saying stock has fallen 20% since early June on concerns over regulation risk\n** Says sees no escalation of regulation risk for the deathcare industry amid its small 150 bln yuan market size and little correlation to CPI growth\n** The Hong Kong Hang Seng Commerce & Industry Index jumps 5.1%, and the Hang Seng Composite Index surges 3.5%\n** The Hang Seng China Enterprises Index rises 3.6%, and the benchmark index climbs 3.1%\n** By last close, the stock had slid 6.6% this year ($1 = 6.4724 Chinese yuan)","news_type":1,"symbols_score_info":{"01448":0.9}},"isVote":1,"tweetType":1,"viewCount":347,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":146871931,"gmtCreate":1626070732223,"gmtModify":1633930427434,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586429646894350","authorIdStr":"3586429646894350"},"themes":[],"htmlText":"Ok. Good ","listText":"Ok. Good ","text":"Ok. Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/146871931","repostId":"2150589463","repostType":4,"repost":{"id":"2150589463","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1626068708,"share":"https://ttm.financial/m/news/2150589463?lang=&edition=full","pubTime":"2021-07-12 13:45","market":"sh","language":"en","title":"Singapore's Temasek set to post record portfolio in global equities rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2150589463","media":"Reuters","summary":"SINGAPORE, July 12 (Reuters) - Singapore state investor Temasek Holdings' portfolio value likely reb","content":"<p>SINGAPORE, July 12 (Reuters) - Singapore state investor Temasek Holdings' portfolio value likely rebounded to scale a record in the year ending March, boosted by a rally in global markets and the public listing of some of its holdings.</p>\n<p>Analysts expect the value of Temasek's assets to have jumped over 20% in the year ending March, pushing up the portfolio value to roughly S$375 billion ($277.7 billion) - after dipping 2.2% to S$306 billion a year ago - which marked the first drop after three consecutive years of gains.</p>\n<p>The long-term outlook for Temasek, <a href=\"https://laohu8.com/S/AONE\">one</a> of the world's biggest state investors, has been clouded by its support to pandemic-hit businesses. Temasek bulked up funding to Singapore Airlines and offshore marine services firm Sembcorp Marine , among others.</p>\n<p>\"We have seen broad economic growth and a rebound in financial markets, but there are industries which are facing headwinds, so the challenge for big long-term investors like Temasek and GIC really is about managing portfolios in which occasionally, some sectors will take a hit,\" said Song Seng Wun, an economist at CIMB Private Banking.</p>\n<p>Temasek is anchored in Asia, with a 66% exposure to the region as measured by underlying assets, most of which are in China and Singapore. But the investor has been stepping up investments in the United States, especially in the tech sector.</p>\n<p>Temasek said it will give details of its annual performance this week, while larger investor GIC will publish its annual report later this month.</p>\n<p>Analysts expect no major change to Temasek's strategy, though senior executive Dilhan Pillay is set to take over as the CEO of the investment firm from Ho Ching, who is retiring after heading Temasek for 17 years.</p>\n<p>Unlike many state investors, the majority of Temasek's investments are in equities, with unlisted assets making up a record 48% of its portfolio in the year to March 2020.</p>\n<p>Global equities have surged over the past financial year, with MSCI's Asia shares ex-Japan index rallying 55% and Singapore's Straits Times index rising 28%.</p>\n<p>\"There remains a flood of liquidity, so competition for funding is still fierce,\" said Song.</p>\n<p>Among the shares held by Temasek that posted strong gains over the past financial year, DBS Group surged 55%, Standard Chartered rose 12% and China Construction Bank gained 16%.</p>\n<p>Some other firms in Temasek's portfolio, notably Airbnb and food delivery firm Doordash , had public listings.</p>\n<p>\"I don't expect Temasek's medium to long term strategy to change due to any result this year - it is obviously ruled by a long term horizon and aims at anticipating the market by being <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the world's largest and most active investors in VC (venture capital) and technology,\" said Diego Lopez, managing director of sovereign wealth fund tracker Global SWF.</p>\n<p>($1 = 1.3505 Singapore dollars)</p>\n<p>(Reporting by Anshuman Daga and Aradhana Aravindan; Editing by Sumeet Chatterjee & Simon Cameron-Moore)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore's Temasek set to post record portfolio in global equities rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore's Temasek set to post record portfolio in global equities rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-12 13:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SINGAPORE, July 12 (Reuters) - Singapore state investor Temasek Holdings' portfolio value likely rebounded to scale a record in the year ending March, boosted by a rally in global markets and the public listing of some of its holdings.</p>\n<p>Analysts expect the value of Temasek's assets to have jumped over 20% in the year ending March, pushing up the portfolio value to roughly S$375 billion ($277.7 billion) - after dipping 2.2% to S$306 billion a year ago - which marked the first drop after three consecutive years of gains.</p>\n<p>The long-term outlook for Temasek, <a href=\"https://laohu8.com/S/AONE\">one</a> of the world's biggest state investors, has been clouded by its support to pandemic-hit businesses. Temasek bulked up funding to Singapore Airlines and offshore marine services firm Sembcorp Marine , among others.</p>\n<p>\"We have seen broad economic growth and a rebound in financial markets, but there are industries which are facing headwinds, so the challenge for big long-term investors like Temasek and GIC really is about managing portfolios in which occasionally, some sectors will take a hit,\" said Song Seng Wun, an economist at CIMB Private Banking.</p>\n<p>Temasek is anchored in Asia, with a 66% exposure to the region as measured by underlying assets, most of which are in China and Singapore. But the investor has been stepping up investments in the United States, especially in the tech sector.</p>\n<p>Temasek said it will give details of its annual performance this week, while larger investor GIC will publish its annual report later this month.</p>\n<p>Analysts expect no major change to Temasek's strategy, though senior executive Dilhan Pillay is set to take over as the CEO of the investment firm from Ho Ching, who is retiring after heading Temasek for 17 years.</p>\n<p>Unlike many state investors, the majority of Temasek's investments are in equities, with unlisted assets making up a record 48% of its portfolio in the year to March 2020.</p>\n<p>Global equities have surged over the past financial year, with MSCI's Asia shares ex-Japan index rallying 55% and Singapore's Straits Times index rising 28%.</p>\n<p>\"There remains a flood of liquidity, so competition for funding is still fierce,\" said Song.</p>\n<p>Among the shares held by Temasek that posted strong gains over the past financial year, DBS Group surged 55%, Standard Chartered rose 12% and China Construction Bank gained 16%.</p>\n<p>Some other firms in Temasek's portfolio, notably Airbnb and food delivery firm Doordash , had public listings.</p>\n<p>\"I don't expect Temasek's medium to long term strategy to change due to any result this year - it is obviously ruled by a long term horizon and aims at anticipating the market by being <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the world's largest and most active investors in VC (venture capital) and technology,\" said Diego Lopez, managing director of sovereign wealth fund tracker Global SWF.</p>\n<p>($1 = 1.3505 Singapore dollars)</p>\n<p>(Reporting by Anshuman Daga and Aradhana Aravindan; Editing by Sumeet Chatterjee & Simon Cameron-Moore)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2150589463","content_text":"SINGAPORE, July 12 (Reuters) - Singapore state investor Temasek Holdings' portfolio value likely rebounded to scale a record in the year ending March, boosted by a rally in global markets and the public listing of some of its holdings.\nAnalysts expect the value of Temasek's assets to have jumped over 20% in the year ending March, pushing up the portfolio value to roughly S$375 billion ($277.7 billion) - after dipping 2.2% to S$306 billion a year ago - which marked the first drop after three consecutive years of gains.\nThe long-term outlook for Temasek, one of the world's biggest state investors, has been clouded by its support to pandemic-hit businesses. Temasek bulked up funding to Singapore Airlines and offshore marine services firm Sembcorp Marine , among others.\n\"We have seen broad economic growth and a rebound in financial markets, but there are industries which are facing headwinds, so the challenge for big long-term investors like Temasek and GIC really is about managing portfolios in which occasionally, some sectors will take a hit,\" said Song Seng Wun, an economist at CIMB Private Banking.\nTemasek is anchored in Asia, with a 66% exposure to the region as measured by underlying assets, most of which are in China and Singapore. But the investor has been stepping up investments in the United States, especially in the tech sector.\nTemasek said it will give details of its annual performance this week, while larger investor GIC will publish its annual report later this month.\nAnalysts expect no major change to Temasek's strategy, though senior executive Dilhan Pillay is set to take over as the CEO of the investment firm from Ho Ching, who is retiring after heading Temasek for 17 years.\nUnlike many state investors, the majority of Temasek's investments are in equities, with unlisted assets making up a record 48% of its portfolio in the year to March 2020.\nGlobal equities have surged over the past financial year, with MSCI's Asia shares ex-Japan index rallying 55% and Singapore's Straits Times index rising 28%.\n\"There remains a flood of liquidity, so competition for funding is still fierce,\" said Song.\nAmong the shares held by Temasek that posted strong gains over the past financial year, DBS Group surged 55%, Standard Chartered rose 12% and China Construction Bank gained 16%.\nSome other firms in Temasek's portfolio, notably Airbnb and food delivery firm Doordash , had public listings.\n\"I don't expect Temasek's medium to long term strategy to change due to any result this year - it is obviously ruled by a long term horizon and aims at anticipating the market by being one of the world's largest and most active investors in VC (venture capital) and technology,\" said Diego Lopez, managing director of sovereign wealth fund tracker Global SWF.\n($1 = 1.3505 Singapore dollars)\n(Reporting by Anshuman Daga and Aradhana Aravindan; Editing by Sumeet Chatterjee & Simon Cameron-Moore)","news_type":1,"symbols_score_info":{"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":179,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":875446504,"gmtCreate":1637681352753,"gmtModify":1637681352892,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586429646894350","authorIdStr":"3586429646894350"},"themes":[],"htmlText":"Like and comment ","listText":"Like and comment ","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/875446504","repostId":"1119603099","repostType":4,"repost":{"id":"1119603099","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637680476,"share":"https://ttm.financial/m/news/1119603099?lang=&edition=full","pubTime":"2021-11-23 23:14","market":"us","language":"en","title":"BioNTech shares fell nearly 7% in early trading and Moderna shares slid 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1119603099","media":"Tiger Newspress","summary":"BioNTech shares fell nearly 7% in early trading and Moderna shares slid 3%.The U.S. government asked","content":"<p>BioNTech shares fell nearly 7% in early trading and Moderna shares slid 3%.<img src=\"https://static.tigerbbs.com/89a99816fada5bf2c2120b3cda678cb6\" tg-width=\"871\" tg-height=\"599\" width=\"100%\" height=\"auto\">The U.S. government asked a federal appeals court to immediately lift a court-ordered stay on a sweeping workplace COVID-19 vaccine rule to avoid \"enormous\" harm to public health, or alternatively to allow a masking-and-testing requirement, according to a court filing.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech shares fell nearly 7% in early trading and Moderna shares slid 3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech shares fell nearly 7% in early trading and Moderna shares slid 3%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-23 23:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioNTech shares fell nearly 7% in early trading and Moderna shares slid 3%.<img src=\"https://static.tigerbbs.com/89a99816fada5bf2c2120b3cda678cb6\" tg-width=\"871\" tg-height=\"599\" width=\"100%\" height=\"auto\">The U.S. government asked a federal appeals court to immediately lift a court-ordered stay on a sweeping workplace COVID-19 vaccine rule to avoid \"enormous\" harm to public health, or alternatively to allow a masking-and-testing requirement, according to a court filing.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119603099","content_text":"BioNTech shares fell nearly 7% in early trading and Moderna shares slid 3%.The U.S. government asked a federal appeals court to immediately lift a court-ordered stay on a sweeping workplace COVID-19 vaccine rule to avoid \"enormous\" harm to public health, or alternatively to allow a masking-and-testing requirement, according to a court filing.","news_type":1,"symbols_score_info":{"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":144,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":826722097,"gmtCreate":1634058073699,"gmtModify":1634058073970,"author":{"id":"3586429646894350","authorId":"3586429646894350","name":"IcyAlchemist","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586429646894350","authorIdStr":"3586429646894350"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/826722097","repostId":"1163435173","repostType":4,"isVote":1,"tweetType":1,"viewCount":588,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}